Washington University in St. Louis

Washington University Open Scholarship
All Theses and Dissertations (ETDs)
January 2009

Improving Biocompatibility By Controlling Protein Adsorption:
Modification And Design Of Biomaterials Using Poly(Ethylene
Glycol) Microgels And Microspheres
Evan Scott
Washington University in St. Louis

Follow this and additional works at: https://openscholarship.wustl.edu/etd

Recommended Citation
Scott, Evan, "Improving Biocompatibility By Controlling Protein Adsorption: Modification And Design Of
Biomaterials Using Poly(Ethylene Glycol) Microgels And Microspheres" (2009). All Theses and
Dissertations (ETDs). 316.
https://openscholarship.wustl.edu/etd/316

This Dissertation is brought to you for free and open access by Washington University Open Scholarship. It has
been accepted for inclusion in All Theses and Dissertations (ETDs) by an authorized administrator of Washington
University Open Scholarship. For more information, please contact digital@wumail.wustl.edu.

WASHINGTON UNIVERSITY IN ST. LOUIS
Sever Institute
School of Engineering and Applied Science
Department of Biomedical Engineering
Dissertation Examination Committee:
Donald L. Elbert, Chair
Frank C.P. Yin, M.D., Ph.D.
Garland R. Marshall, Ph.D.
Rohit V. Pappu, Ph.D.
R. Reid Townsend, M.D., Ph.D.
Radhakrishna Sureshkumar, Ph.D.
IMPROVING BIOCOMPATIBILITY BY CONTROLLING PROTEIN
ADSORPTION: MODIFICATION AND DESIGN OF BIOMATERIALS
USING POLY(ETHYLENE GLYCOL) MICROGELS AND
MICROSPHERES
By
Evan Alexander Scott, Sc.B.
A dissertation presented to the
Graduate School of Arts and Sciences of
Washington University in partial fulfillment
of the requirements for the degree of
DOCTOR OF PHILOSOPHY

June, 2009
Saint Louis, Missouri

Acknowledgements
I would first like to sincerely thank my advisor, Donald Elbert, for all of his support
and guidance. He has provided me with experimental freedom and insight that has helped
foster my enthusiasm for science and research. I would also like to thank my thesis
committee (Frank Yin, Garland Marshall, Rohit Pappu, Reid Townsend, and Radhakrishna
Sureshkumar) for taking the time to advise and evaluate this work.
I want to thank everyone that I worked with in the Elbert lab. I will always treasure
my first few years in graduate school working with Shannon Alford, Megan Kaneda, and
Brad Wacker. A special thanks to Casey Donahoe, Peter Nguyen, Megan Flake, and Xioli
(Lily) He for providing such an enjoyable work environment and interesting discussions. I
would especially like to thank Michael Nichols who worked side-by-side with me on several
projects.
Finally, I would like to dedicate this work to my parents and sisters to whom I owe
everything. I want to particularly stress the essential work ethic and studious nature that was
instilled in me by my Mom, as well as my Dad’s passion for bad sci-fi movies that likely
sparked my initial interest in science as well as my imagination at a very young age. Thanks
to all the friends I made at Wash U. (Paul Watkins, Stephanie Willerth, Gary Escudero, Eric
Welsh, Dan Kuster, Paul Wanda, Keith Decker, Ben Filas, Nick Anderson, Ken Borrelli,
Philip Johnson, and Matthew Wood).

Evan Alexander Scott
Washington University in St. Louis
June, 2009
ii

Table of Contents
Acknowledgements ……………………………………………………………… ii
List of Tables ……………………………………………………………………... vi
List of Figures …………………………………………………………………….. vii
Abstract of Dissertation ………………………………………………………….. xi

Chapter 1
Introduction ……………………………………………………………………… 1
1.1
Synopsis and Objectives of Thesis …………………………………………. 5
1.2
Protein Films on Biomaterials: Biological Implications & Characterization of
Adsorbed Fibrinogen ………………………………………………………. 5
1.2.1 Relevance of Protein Films in Biomaterials Science ………………... 5
1.2.2 Fibrinogen Structure and Surface Activity …………………………. 8
1.2.3 Post-Adsorptive Structure of Fibrinogen …………………………... 11
1.3
Controlling Protein Adsorption and Bioactivity Via Surface Treatments of
Biomaterials…………………………….…………………………………... 14
1.3.1 Progression of Biomaterials Design: Improving the Biocompatibility
of Poly(ethylene terephthalate)……………………………………... 14
1.3.2 Directing Cell Adhesion & Migration: Integrin-Binding Motifs &
Sphingosine 1-Phosphate Delivery …………………………………. 18
1.3.3 Layer-by-layer Methods …………………………………………….. 22
1.3.4 Radio Frequency Glow Discharge Plasma Treatments …………….. 24
1.4
Poly(Ethylene Glycol) Hydrogels as Biomaterials ……...…………………… 26
1.4.1 Poly(Ethylene Glycol): Resistance to Protein Adsorption & Chemical
Functionalization …………………………………………………... 26
1.4.2 Poly(Ethylene Glycol) Surface Coatings ……………………………. 29
1.4.3 Poly(Ethylene Glycol) Scaffolds ……………………………………. 30

Chapter 2
Mass Spectrometric Mapping of Fibrinogen Conformations at Poly(Ethylene
Terephthalate) Interfaces ……………………………………………………….. 33
2.1
Abstract ……………………………………………………………………. 33
2.2
Introduction ………………………………………………………………... 34
2.3
Materials and Methods ……………………………………………………... 39
2.3.1 Spin Coating ………………………………………………………. 39
2.3.2 OWLS Analysis ……………………………………………………. 40
2.3.3 Analysis of OWLS Results …………………………………………. 40
2.3.4 PET Particle Fabrication …………………………………………… 41
2.3.5 Biotinylation ………………………………………………………... 42
2.3.6 MALDI-TOF Analysis ……………………………………………... 43
2.3.7 Liquid Chromatography Electrospray-Ionization Ion Trap
Tandem Mass Spectrometry………………………………………… 44
iii

2.4

2.5
2.6

2.3.8 Expression of HepG2 Proteins ……………………………………...45
2.3.9 Quantification of 13C6,15N2-Fibrinogen Concentrations in Media……. 46
2.3.10 13C6,15N2-Fibrinogen Purification …………………………………… 46
2.3.11 Preparation of 13C6,15N2-HepG2 Protein Standards ………………… 47
Results ……………………………………………………….……………... 47
2.4.1 Characterization of PET Films ……………………………………... 47
2.4.2 OWLS Analysis of Fibrinogen Adsorption onto PET ……………… 50
2.4.3 MALDI-TOF Sequence Coverage ………………………………….. 50
2.4.4 PET Particle Fabrication …………………………………………… 53
2.4.5 Biotinylation of Surface-Adsorbed Fibrinogen …………………… 55
2.4.6 Identification of Biotinylated Residues ……………………………... 58
2.4.7 Quantification of Complement C3, α2-Macroglobulin, & Fibrinogen.. 65
Discussion ………………………………………………………………….. 74
Conclusion …………………………………………………………………. 81

Chapter 3
Protein Adsorption & Cell Adhesion on Nanoscale Bioactive Coatings
Formed from Poly(Ethylene Glycol) & Albumin Microgels …..………………. 83
3.1
Abstract ……………………………………………………………………. 83
3.2
Introduction ………………………………………………………………... 84
3.3
Materials and Methods ……………………………………………………... 86
3.3.1 Synthesis of Poly(Ethylene Glycol) Vinylsulfone …………………… 86
3.3.2 Microgel Syntheses …………………………………………………. 87
3.3.3 Characterization of Microgel Formation …………………………… 88
3.3.4 Reaction with Surfaces ……………………………………………... 90
3.3.5 Cell Culture and Adhesion Experiments …………………………… 93
3.3.6 OWLS Measurements and Analysis ………………………………… 94
3.3.7 QCM-D Measurements and Analysis ………………………………. 95
3.4
Results …………………………………………………………………….... 97
3.4.1 PEG-OVS Synthesis………………………………………………. 97
3.4.2 Characterization of Microgel Formation …………………………..... 99
3.4.3 Covalent Attachment of Microgels to Glass Surfaces ……………..... 103
3.4.4 Properties & Protein Adsorption Resistance of PEG-OVS/BSA
Microgel Coatings ………………………………………………………….. 108
3.4.5 Resistance of Microgel-Coated Glass to Cell Adhesion ……………. 110
3.4.6 Application of Microgel Coating to PET surfaces …………………. 119
3.5
Discussion …………………………………………………………………. 121
3.6
Conclusion ………………………………………………………………… 125

Chapter 4
Modular Scaffolds Assembled Around Living Cells Using Poly(Ethylene
Glycol) Microspheres with Macroporation Via a Non-Cytotoxic Porogen .…..
4.1
Abstract ……………………………………………………………………
4.2
Introduction ………………………………………………………………..
4.3
Materials and Methods ……………………………………………………..
4.3.1 Poly(Ethylene Glycol) Derivatives …………………………..……...
4.3.2 Dynamic Light Scattering …………………………………………..
iv

126
126
127
134
134
134

4.4

4.5
4.6

4.3.3 Microsphere Fabrication & Characterization …..………..... 135
4.3.4 Microsphere Fabrication for Scaffolds ……………………………... 136
4.3.5 Scaffold Assembly & Cell Seeding ………………………...………... 136
4.3.6 Confocal Microscopy ………………………………………………. 137
4.3.7 Rheometry …………………………………………………………. 137
4.3.8 Statistics ……………………………………………………………. 138
Results ……………………………………………………………………... 138
4.4.1 Formation of PEG8-VS/PEG8-Amine Microspheres ……………… 138
4.4.2 Formation of PEG8-Acrylate/PEG8-Amine & PEG8-VS/BSA
Microspheres ……………………………………………………….. 145
4.4.3 Microsphere Ripening & Coalescence ……….….…...…………….... 146
4.4.4 Assembly of Modular Scaffolds …………..………………………… 151
4.4.5 Cell Interactions with Scaffolds …………………………………….. 158
Discussion ………………………………………………………………….. 167
Conclusion …………………………………………………………………. 171

Chapter 5
Conclusions ………………………………………………………………………..173
5.1
Summary of Dissertation ……………………………………………………173
5.2
Future Directions …………………………………………………………... 177
References ………………………………………………………………………… 182
Vita …………………………………………………………………………………204

v

List of Tables
Chapter 2

49

Table 2.1: XPS analysis of PET coated silicon wafers………………………………
51
Table 2.2: Summary of bFg m/a values estimated from OWLS and AFM
experiments …………………………………………………………………………
60
Table 2.3: Biotin-labeled bFg peptides identified by liquid chromatography
electrospray-ionization ion trap tandem mass spectrometry …………………………
64
Table 2.4: Sequence coverage and percentage of labeled lysines observed after
MALDI-TOF analysis of tryptic bFg peptides ………………………………………

Chapter 3

106

Table 3.1: Elemental composition of treated glass surfaces, as determined by XPS...
112
Table 3.2: Physical properties of PEG-OVS/ BSA microgels measured with OWLS
and QCM …………………………………………………………………………...

Chapter 4
Table 4.1: Summary of products resulting from microsphere fabrication methods ...

141

List of Figures
Chapter 2
Figure 2.1: Ellipsometry measurements of polyethylene terephthalate (PET) layer
thickness and uniformity on silicon wafers.……………………………………….… 48
Figure 2.2: Sequence coverage obtained for Aα, Bβ, and γ chain in-gel trypsin
digests of biotinylated bFg ………………………………………………….………. 52
Figure 2.3: Scanning electron microscopy (SEM) of fabricated PET particles …….. 54
Figure 2.4: Workflow diagram for bFg surface adsorption experiments …………... 56
Figure 2.5: SDS-PAGE gel of bFg before and after reaction with the Sulfo-NHSLC-Biotin label ……………………………………………………………………... 57
Figure 2.6: Centroided MALDI spectra corresponding to bFg trypsin digest
fragment masses from the 0.5 mg/mL adsorption experiments …………………….. 59
Figure 2.7. Normalized MALDI-TOF spectral peaks corresponding to biotinylated
lysine residues within bFg Aα, Bβ, and γ chains, labeled while in a 0.5 mg/mL
solution …………………………………………………………………………….. 61
Figure 2.8. Normalized MALDI-TOF spectral peak intensities of lysine residues
within bFg Aα, Bβ, and γ chains that were biotinylated after adsorption to a PET
surface from 1, 0.5 and 0.1 mg/mL solutions ………………………………………. 63
Figure 2.9: 3D image of bFg displaying the locations of labeled lysines after
adsorption to a PET surface from a 0.1 mg/mL solution …………………………... 66
Figure 2.10: SDS-PAGE gel displaying proteins expressed by HepG2 cells grown
in serum-free media …………………………………………………………………68
Figure 2.11: SDS-PAGE gel demonstrating the purification of carbon-13 labeled
hFg from HepG2 media by immunoprecipitation …………………………………... 69
Figure 2.12: Workflow diagram for fibrinogen peptide quantification using
C6,15N2-labeled fibrinogen internal standards ……………………………………… 70

13

Figure 2.13: Tandem spectra of unlabeled and 13C6,15N2-labeled fibrinogen gamma
chain dodecaptide ……………………………………………………………..……. 71

vii

Figure 2.14: Tandem spectra of untagged and acetylated fibrinogen gamma chain
dodecaptide ………………………………………………………………………… 72
Figure 2.15: Standard curves for isotopically labeled HepG2 proteins generated
using SILT-MS ……………………………………………………………………... 73

Chapter 3
Figure 3.1: Vapor-silanization procedure ………………………………………….. 92
Figure 3.2: NMR spectra of PEG-OVS …………………………………………... 98
Figure 3.3: Crosslinking of bovine serum albumin and poly(ethylene glycol)octavinylsulfone may lead to microgel formation if the principle of equal end-group
reactivity does not apply…………………………………………………………….. 100
Figure 3.4: Evidence for formation of microgels during the crosslinking reaction … 101
Figure 3.5: Gel permeation chromotography of PEG8-VS and PEG8-amine prereacted to dPCS ≅ 100 nm …………………………………………………………… 102
Figure 3.6: Kinetics of the crosslinking reaction between PEG-OVS and BSA …… 104
Figure 3.7: AFM analysis of microgel coatings ……………………………………. 107
Figure 3.8: OWLS analysis of fibrinogen adsorption to microgel-coated surfaces … 109
Figure 3.9: QCM-D frequency and dissipation changes illustrating the attachment
of microgels to the MPTS-silanized crystal and subsequent resistance to non-specific
protein adsorption ………………………………………………………………….. 111
Figure 3.10: Cell adhesion on microgel-coated glass at 10X magnification after a 24
h incubation with endothelial, CHO, or fibroblast cells …………………………….. 114
Figure 3.11: Cell adhesion to microgel-coated glass at 10X magnification after
repeated seedings with fibroblasts …………………………………………………... 115
Figure 3.12: Cell counting results for CHO and fibroblast adhesion to microgel
surfaces …………………………………………………………………………….. 116
Figure 3.13: CHO cell adhesion to MPTS-silanized glass reacted with PEG
coatings …………………………………………………………………………….. 117
Figure 3.14: 10X magnification of CHO cell adhesion on glass slides for 24 h
demonstrating the effects of the crosslinker and final capping step ………………… 118
viii

Figure 3.15: CHO cell adhesion at 24 h to air RFGD-treated PET films …………... 120

Chapter 4
Figure 4.1: Production of PEG microspheres in aqueous sodium sulfate solutions... 132
Figure 4.2: Assembly of microspheres into bioactive modular scaffolds in the
presence of living cells ………………………………………………………………135
Figure 4.3: PEG or PEG/BSA microspheres were formed above the cloud point
and then buffer exchanged into PBS ………………………………………………...139
Figure 4.4: Formation of microspheres was influenced by pre-reaction of PEG
derivatives below the cloud point …………………………………………………... 142
Figure 4.5: Crosslinking with vortexing during the initial reaction produced bulk
hydrogels ……………………………………………………………………………143
Figure 4.6: DLS of PEG solutions above their cloud points ……………………... 144
Figure 4.7: Zeta potentials of microspheres were determined by the charge of the
crosslinker ………………………………………………………………………….. 147
Figure 4.8: The formation of PEG8-VS/PEG8-amine microspheres was monitored
by confocal microscopy at 20X magnification using fluorescently labeled PEG ……. 148
Figure 4.9: PEG-rich droplets before and after coalescence ………………………. 149
Figure 4.10: Water-rich droplets were observed while monitoring the formation of
PEG8-VS/PEG8-amine microspheres by confocal microscopy at 20X magnification.. 150
Figure 4.11: PEG8-VS and PEG8-amine domains were found to form multiple
emulsions following coalescence …………………………………………………… 152
Figure 4.12: To visualize the porous structure, larger microspheres were produced... 153
Figure 4.13: Scaffolds may be formed by centrifuging microspheres in the presence
of 2% serum ………………………………………………………………………... 155
Figure 4.14: Photographs of modular scaffolds …………………………………... 156
Figure 4.15: Scaffolds could be fabricated with gradients of microspheres ………... 157

ix

Figure 4.16: Macroporosity was introduced in the presence of cells via dissolution
of porogenic microspheres ………………………………………………………..... 156
Figure 4.17: Confocal microscopy at 10X of a macroporous scaffold composed of
PEG8-VS/PEG8-amine microspheres, PEG8-acrylate/PEG8-amine microspheres
PEG8-VS/BSA microspheres, 48 h after formation ……………………………….... 160
Figure 4.18: Scaffolds could be formed in the presence of cells …………………… 161
Figure 4.19: Modular scaffolds formed tight seals with the walls of UV/vis cuvettes
in which they were fabricated ………………………………………………………. 163
Figure 4.20: Penetration of endothelial cells into surface pores of a modular
scaffold ……………………………………………………………………………...164
Figure 4.21: S1P, porosity, and RGD peptide affected endothelial cell migration in
modular scaffolds …………………………………………………………………... 165
Figure 4.22: Cell migration into scaffolds containing HepG2 cells ……………….... 164

x

SEVER INSTITUTE
SCHOOL OF ENGINEERING AND APPLIED SCIENCE
DEPARTMENT OF BIOMEDICAL ENGINEERING
_____________________________________________________________
ABSTRACT OF DISSERTATION
IMPROVING BIOCOMPATIBILITY BY CONTROLLING PROTEIN
ADSORPTION: MODIFICATION AND DESIGN OF BIOMATERIALS
USING POLY(ETHYLENE GLYCOL) MICROGELS AND
MICROSPHERES
by
Evan Alexander Scott
Doctor of Philosophy in Biomedical Engineering
Washington University in St. Louis, 2009
Professor Donald L. Elbert, Chairperson

_____________________________________________________________
Guided by the clinical needs of patients and developments in biology and materials
science, the primary focus of the biomaterials field remains at the solid/liquid interface
between biomaterial surfaces and biological fluids. For blood-contacting devices, biological
responses are initially elicited and directed by proteins that adsorb from this multicomponent
solution to form thin films on their surfaces. The identity, conformation, and quantity of
adsorbed proteins are related to the properties of a material’s surface. For example,
hydrophobic surfaces tend to be thrombotic via interactions between platelets and adsorbed
fibrinogen, while surface-activation of specific enzymes initiates the coagulation cascade on
hydrophilic surfaces. The objective of this thesis is to improve the design of biomaterials
through the analysis and control of adsorbing protein layers. This goal is approached
through three separate strategies. First, a proteomics-based methodology is presented for
the assessment of protein conformation at the residue level after adsorption to biomaterial
xi

surfaces. A quantitative mass spectrometric technique is additionally suggested for the
identification and quantification of proteins within adsorbed protein layers. Second, a
method is described for the covalent attachment of poly(ethylene glycol) (PEG)-based
hydrogel coatings onto biomaterials surfaces for the minimization of protein adsorption.
The coatings are applied using partially crosslinked PEG solutions containing polymer and
protein oligomers and microgels that can be designed to control cell adhesion. Finally, a
modular strategy is proposed for the assembly of bioactive PEG-based hydrogel scaffolds.
This was accomplished using novel PEG microspheres with diverse characteristics that
individually contribute to the ability of the scaffold to direct cellular infiltration. The
methodologies proposed by this thesis contribute to the recent shift in biomaterials and
tissue engineering strategies towards directed cellular responses at the molecular level.
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CHAPTER 1
Introduction
1.1

Synopsis and Objectives of Thesis
Upon exposure to blood implanted materials immediately adsorb a thin layer of

proteins onto their surfaces, and host cells and biochemical defenses are unable to interact
with the foreign material itself (Baier and Dutton 1969; Brash and Davidson 1976; Andrade
and Hlady 1986). Instead, the identity and conformation of the proteins that compose these
adsorbed layers govern the immunological, coagulatory, thrombotic, and inflammatory
responses that result (Zucker and Vroman 1969; Mohammad, Hardison et al. 1974; KottkeMarchant, Anderson et al. 1987; Anderson, Bonfield et al. 1990; Scott 1991; Tang and Eaton
1995; Shen and Horbett 2001). These responses ultimately determine the biocompatibility
and longevity of stents, vascular grafts, artificial heart valves and other blood-contacting
devices (Edmunds, Hessel II et al. 2003). The properties of adsorbed protein layers are
predominantly dependent on the composition of the solution from which the proteins
adsorb and on the characteristics of the material surface, such as chemical functionality,
charge, hydrophobicity, and topography (Slack, Posso et al. 1991). As a result, different
materials can elicit different cellular responses when exposed to the same protein solution,
and the same material can elicit different responses when exposed to solutions with different
compositions (Boisson-Vidal, Jozefonvicz et al. 1991; Brash and Ten Hove 1993; Horbett
2004; Krishnan, Liu et al. 2006). The quantity and conformation of certain proteins within
adsorbed protein layers can indicate the type and severity of the biological response induced
by a particular material. By developing materials with surfaces that prevent protein
adsorption and techniques to characterize individual proteins within adsorbed protein layers,
1

it may be possible to design more compatible biomaterials and to predict complications that
may occur post-implantation.
This thesis has two main objectives. First, a proteomics-based methodology was
developed capable of assessing materials compatibility in vitro by measuring the composition
and conformation of adsorbed protein layers. The relationship between material surface
properties and thrombogenic potential remains poorly understood (Sarkar, Sales et al. 2007)
and few methods exist for the in vitro assessment of material compatibility. Many
cardiovascular devices, such as artificial heart valves, require the use of anticoagulant drug
therapies to prevent coronary thrombosis. Small diameter implants (diameter <6 mm) are
easily occluded and thus highly susceptible to thrombus formation and neointimal
hyperplasia. Neointimal hyperplasia can be well controlled with antiproliferative agents such
as sirolimus and paclitaxel, but as evidenced by the increased number of late thrombosis
related fatalities in patients with drug-eluting stents, thrombosis is much more difficult to
manage (Axel, Kunert et al. 1997; Parry, Brosius et al. 2005). By characterizing the
adsorption of proteins onto material surfaces, this research may further the understanding of
the link between material properties and thrombosis as well as determine which biological
responses could potentially be elicited by a particular implantable device. We focused on
monitoring the post-adsorptive characteristics of fibrinogen, a blood protein whose quantity
and conformation within adsorbed protein layers is indicative of thrombus formation and
the adhesion and attachment of both leukocytes and platelets (Salzman, Lindon et al. 1987;
Tang and Eaton 1993). A qualitative mass spectrometric mapping technique was devised to
probe the changes in exposure of locations within adsorbed fibrinogen. This methodology
was tested on a clinically relevant model poly(ethylene terephthalate) (PET) surface and
permitted a residue-level analysis of the exposure of cell-adhesion motifs within fibrinogen
2

after adsorption (Scott and Elbert 2007). Results supported the presence of both postadsorptive spreading effects and a thrombogenic potential for PET that were dependent on
the concentration of the adsorbing fibrinogen solution. Additionally, isotopically labeled
internal standards were developed to allow quantification of common blood proteins
expressed by hepatocytes that are known to participate in the surface activation of bloodcontacting devices. The quantification of internal standards were verified using stable
isotope-labeling tandem mass spectrometry (SILT-MS) and reproducibly resulted in relative
errors ranging between 2.9% -9.8% (Elbert, Mawuenyega et al. 2008).
The second, and primary goal of this thesis was to exploit the protein adsorption
resistant properties of poly(ethylene glycol) (PEG) hydrogels to develop methods of
modifying and fabricating materials with improved biocompatibility and specific bioactivity.
Separate strategies were developed to both modify existing cardiovascular biomaterial
surfaces with nanoscale PEG coatings as well as to fabricate modular 100% PEG constructs
for tissue engineering applications. PEG derivatives were synthesized to permit gel
formation with an amine or thiol containing crosslinker, and thus gels could be crosslinked
with or conjugated to any biomolecule containing solution-exposed lysine or cystine
residues. Through the use PEG and/or albumin crosslinkers and careful monitoring of the
kinetics of gel formation, partially crosslinked PEG solutions containing oligomers and
microgels were covalently attached to material surfaces. The grafting of PEG to material
surfaces at the high densities required for effective protein resistance has been attempted
unsuccessfully for many years. These oligomer/microgel solutions were able to provide high
density PEG layers to material surfaces that have low levels of functionalization. Compared
to the surface-grafting of individual PEG chains, these large macromonomers are able to
cover significantly larger portions of surfaces with only a single covalent attachment.
3

Covalent oligomer/microgel coatings were applied to relatively inert PET surfaces using a
practical plasma-etching strategy that could potentially be applied to a variety of different
polymer surfaces. Multiple surface analysis techniques in addition to cell adhesion
assessments confirmed the formation of stable coatings that minimized protein adsorption
and allowed controllable bioactivity.
We additionally used these oligomer/microgel solutions in the fabrication of multiple
types of PEG microspheres with diverse properties and functionalities that were assembled
into modular scaffolds. Partially crosslinked solutions were further reacted after phase
separation into spherical PEG-rich domains by raising the solution temperature above the
cloud point/lower critical solution temperature (LCST), which was lowered to below 37ºC
using aqueous sodium sulfate solutions. The resulting microspheres displayed a porous
structure and were prepared without the use of other monomers, polymers, surfactants or
solvents that could decrease biocompatibility or cell survival. Without surfactants and
emulsifiers, microsphere formation required control over the kinetics of PEG phase
coarsening relative to the rate of gelation. Three separate microsphere types were fabricated:
one type of PEG microsphere provided mechanical support and cell adhesion, a second type
provided controlled delivery of the angiogenesis-promoting molecule, sphingosine 1phosphate (S1P), and a third type served as a slowly dissolving non-toxic porogen. These
microspheres were crosslinked around hepatocytes via serum proteins present in cell media
with a simple centrifugation methodology. The porogenic microspheres dissolved within
two days, producing macropores in the scaffold with >90% viability of the liver cells. This
small library of PEG microspheres permitted for the first time, to the best of our knowledge,
the fabrication of macroporous scaffolds in the presence of living cells. Bioactivity of the
modular scaffolds was demonstrated through conjugation of RGD peptides for the directed
4

infiltration of endothelial cells, and the rate of migration was shown to double in the
presence of S1P-loaded microspheres.

1.2

Protein Films on Biomaterials: Biological Implications
and Characterization of Adsorbed Fibrinogen

1.2.1 Relevance of Protein Films in Biomaterials Science
Proteins are present in all bodily fluids and thus coat materials regardless of the
location of implantation. The dynamics and specificity of protein adsorption is influenced
by the properties of the material surface such as charge, hydrophobicity, and roughness
(Luck, Paulke et al. 1998; Qiu, Sayer et al. 1998; Dufrene, Marchal et al. 1999; McGurk,
Green et al. 1999). Adsorbed biofilms consequently function as a mechanism of recognition
for the direction of biological responses to foreign materials. Proteins are well suited for this
purpose as they contain a wide range of properties incorporated within hydrophobic,
hydrophilic, cationic, and anionic domains. The proteins found in blood alone contain a
diversity of chemical properties extensive enough to interact with all known materials
surfaces. Detailed knowledge of the process of protein adsorption is therefore essential to
the design of implanted devices, and extensive research has been performed in this area.
Proteins are believed to initially adsorb to surfaces in their native state/structure due
to ionic, polar, or van der waals forces (Andrade and Hlady 1986; Norde 1986). During
adsorption, proteins likely go through the following three processes originally proposed by
Soderquist and Walton: 1) rapid and reversible adsorption (up to 50-60% surface coverage)
in the native conformation 2) slow conformational change and unfolding that leads to a
decreasing rate of desorption and increasing surface contact to achieve irreversible binding,
5

and 3) irreversible binding in a denatured state and extremely slow rate of irreversible
desorption (Soderquist and Walton 1980; Norde, MacRitchie et al. 1986; Morton, Myszka et
al. 1995; Engel, Visser et al. 2004). From the simplest perspective, this process is often
represented by two structural states for adsorbed proteins: folded (reversible surface-binding
and folding) and denatured (irreversible surface-binding and denaturation) (Agnihotri and
Siedlecki 2004). The rate of protein unfolding can be estimated from the rate of surfaceinduced spreading and appears to be on the order of the time required to approach the
‘jamming’ limit on surfaces (Ramsden 1993). As a result, proteins do not have adequate time
to reach their maximum spread area if proteins are adsorbed from highly-concentrated
solutions, due to the filling of space required for major conformational changes (Schaaf and
Talbot 1989). Irreversible binding of the more surface-active proteins results in a
heterogeneous biofilm composed of spread and unspread proteins, which is a consequence
of proteins that spread early in the adsorption process decreasing the available spreading area
for proteins that adsorb later (Morrissey 1977; Van Tassel and Viot 1997; Zoungrana,
Findenegg et al. 1997).
The degree of conformational change and the strength of attachment to material
surfaces not only increase with the time allowed for adsorption, but also with the
hydrophobicity of the surface (Bohnert and Horbett 1986; Santore and Wertz 2005). The
Siedlecki group recently used water contact angle measurements and atomic force
microscopy (AFM) to demonstrate a step-like response between surface tension and the
adhesive force of adsorbed proteins (Xu and Siedlecki 2007; Xu and Siedlecki 2009). For all
proteins tested, a sharp increase in adhesive force occurred when the water contact angle
transitioned across the region of ~60-65º, further supporting the proposed definition of
hydrophobic “protein adherent” surfaces (water contact angle >~60-65º) and hydrophilic
6

“protein nonadherent” surfaces (water contact angle <60º) (Vogler 1999; Sethuraman, Han
et al. 2004).
The kinetics of protein adsorption determines the dynamic composition of biological
films. Since 2982 proteins can currently be reproducibly detected in human blood, the
adsorption process is highly competitive (Liu, Valentine et al. 2007). The majority of
theories used to describe this process represent adsorbed protein layers as a two-dimensional
monolayer that can be described in units of surface density (mass or moles per unit area).
Early depictions such as the Random Sequential Adsorption (RSA) model based on the
Langmuir isotherm have progressed into more complex representations that account for
surface exclusion, convection, surface diffusion, and Brownian dynamics (Feder 1980;
Schaaf and Talbot 1989; Ramsden 1993; Magan and Sureshkumar 2006). Diffusion
controlled transport favors the adsorption of higher concentration proteins first (Andrade
and Hlady 1987). Consequently biofilms are initially dominated by “the big twelve”, which
are proteins with blood concentrations higher than 1 mg/mL: albumin (40 mg/mL), IgG
(8-17 mg/mL), α1-antitrypsin (2 mg/mL), transferrin (2.3 mg/mL), haptoglobin (1.2-3.0
mg/mL), LDL (4 mg/mL), HDL (3 mg/mL), IgA (1-4 mg/mL), complement C3 (1.6
mg/mL), fibrinogen (2-3 mg/mL), and α2-macroglobulin (2.7 mg/mL) (Blomback ; Schultze
1966; Andrade and Hlady 1987). Over time, these proteins can desorb form the surface to
be replaced by lower concentration proteins of higher surface activity, and in the case of
fibrinogen, desorption results in selective replacement with proteins involved in contact
activation (Scott 1991).

Leo Vroman is widely regarded as the first to link the dynamics of

this competitive adsorption process with clinically relevant biological responses (Vroman
and Adams 1969). His investigations into the adsorptive and desorptive characteristics of
fibrinogen were essential to unraveling the mechanisms behind coagulation and thrombosis
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(Vroman, Adams et al. 1980). The biological implications of fibrinogen conformation and
competitive adsorption make it a model protein for the general study of protein adsorption
as well as for the verification of the clinical relevance of new materials and analytical
techniques.

1.2.2 Fibrinogen Structure and Surface Activity
Fibrinogen is a 340 kDa dimeric glycoprotein composed of Aα, Bβ, and γ chains
containing globular and α-helical coiled-coil secondary structures held together by 29
disulfide bonds (Figure 2.9). The structure is trinodular, composed of one inner and two
outer globular domains linked by regions of coiled-coils (Hall and Slayter 1959). The inner
domain (E domain) contains the amino termini of the Aα, Bβ, and γ chains, while the two
outer domains (D domains) consist of the carboxyl termini of the Bβ, and γ chains
(Spraggon, Everse et al. 1997; Madrazo, Brown et al. 2001). Extending from the D domains,
beginning near Aα224 in bFg, are the mobile and highly flexible αC domains that associate
non-covalently with the E domain (Veklich, Gorkun et al. 1993). Fibrinogen possesses
several cell adhesion and protein interaction domains in all three of its major chains,
including RGD integrin binding motifs in the Aα chain, a heparin and cadherin binding
domain in the Bβ chain, and a dodecapeptide essential for platelet aggregation in the γ chain
(Kloczewiak, Timmons et al. 1984; Andrieux, Hudry-Clergeon et al. 1989; Bach, Barsigian et
al. 1998; Yakovlev, Gorlatov et al. 2003).
The principle biological responses to adsorbed protein layers are thrombosis,
coagulation, complement activation, and inflammation (Andrade and Hlady 1986; Farrell,
Thiagarajan et al. 1992; Tang and Eaton 1993). Fibrinogen contains binding domains that
contribute to almost all of these responses. In the Aα chain, RGDF and RGDS motifs that
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bind several cell receptors, including GPIIB-IIIa integrins on platelets, are located at Aα9598 and Aα572-575 respectively (Cheresh 1987; Bennett 2001). The Bβ chain contains
domains linked to cadherin binding (Bβ15-42) and heparin binding (Bβ15-57) (Bach,
Barsigian et al. 1998; Yakovlev, Gorlatov et al. 2003). The MAC-1 leukocyte binding sites at
γ190-202 and γ377-395, the RIBS-I epitope at γ373-385, the GPIIb-IIIa platelet binding site
within γ370-385, and the platelet binding dodecapeptide at γ400-411 are all located in the γ
chain, which is highly conserved between different species (Hawiger, Timmons et al. 1982;
Zamarron, Ginsberg et al. 1990; Podolnikova, Yakubenko et al. 2003; Flick, Du et al. 2004).
Antibody and platelet activation/adhesion studies have demonstrated that most of these
sites are not accessible when fibrinogen is in solution, and only become accessible after
adsorption and denaturation on material surfaces (Cierniewski, Plow et al. 1984; Shiba,
Lindon et al. 1991).
The thrombogenicity of materials in contact with blood often correlates with
hydrophobicity and the amount of adsorbed fibrinogen within protein layers on the surface
(Brash 1979). Shiba et al. examined the ability of antibodies specific for integrin binding
domains to bind fibrinogen adsorbed to polymer surfaces, and concluded that surfacedependent conformational changes influenced the exposure of platelet interaction sites
within fibrinogen (Shiba, Lindon et al. 1991). Furthermore, antibodies specific for solution
conformations of fibrinogen were less able to bind the plasma adsorbed fibrinogen on the
more hydrophobic surfaces. Thus extensive spreading on hydrophobic surfaces may allow
fibrinogen to denature and unfold into post-adsorptive conformations that expose peptide
sequences conducive to platelet adhesion and activation (Zucker and Vroman 1969;
Mohammad, Hardison et al. 1974; Shiba, Lindon et al. 1991; Farrell, Thiagarajan et al. 1992).
Due to differences in the conformation and surface expression of the αIIbβ3 receptor, only
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ADP or thrombin-stimulated platelets can bind fibrinogen in solution (Plow and Marguerie
1980; Litvinov, Shuman et al. 2002; Li, Mitra et al. 2003). Surprisingly, both activated and
unactivated platelets can bind to adsorbed fibrinogen (Savage and Ruggeri 1991). This is
particularly striking considering that only activated platelets can bind to other adsorbed
prothrombotic factors such as vitronectin, von Willibrand factor, and fibronectin (Savage
and Ruggeri 1991). Furthermore, platelet adhesion to some material surfaces has been
shown to be greatly reduced in the presence of afibrinogenemic plasma (Tsai, Grunkemeier
et al. 1999). Even surfaces that do not significantly alter the conformation of fibrinogen can
lead to the activation and aggregation of platelets (Lindon, McManama et al. 1986). This is
possibly due to the multivalency of available sites that could enhance binding to platelet
receptors (Ganguly and Gould 1979). The ability of soluble fibrinogen aggregates held
together by anti-E domain F(ab’) fragments to stimulate platelet aggregation and activation
supports this conclusion (McManama, Lindon et al. 1986). The concentration of plateletbinding motifs on fibrinogen-coated surfaces is higher than typically found in solution, and
thus receptor clustering may be responsible for the ability of adsorbed fibrinogen to interact
with unactivated platelets (Litvinov, Shuman et al. 2002).
Initiation of the coagulation cascade is most prominent on hydrophilic surfaces that
weakly adsorb fibrinogen (Vroman and Adams 1969). In the presence of multi-component
solutions such as plasma, fibrinogen can be rapidly replaced on some surfaces by lower
concentration proteins with higher surface activity in a competitive adsorption process
known as the Vroman effect (Brash and ten Hove 1984; Horbett 1984). Similar protein
exchanges on surfaces have been found to occur with other proteins, and have been
attributed to competition for limited adsorption sites and differences in the surface
activation of individual proteins (Brash and ten Hove 1984; Horbett 1984; Slack, Bohnert et
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al. 1987; Slack and Horbett 1995). In systems of competitive adsorption, high concentration
proteins tend to adsorb first, but are gradually replaced over time as these proteins desorb
from the surface and are replaced by proteins with stronger interactions with the surface
(Vroman, Adams et al. 1980; Vroman and Adams 1986). On hydrophilic glass surfaces,
fibrinogen was found to initially adsorb preferentially over albumin and IgG despite their
higher concentrations (Brash, Uniyal et al. 1974). However, fibrinogen was no longer
immunologically detectable on surfaces after 10 min when in the presence of factor XII,
prekallikrein, and high-molecular-weight-kininogen (HK) (Vroman, Adams et al. 1980; Slack
and Horbett 1988). It was later found that fibrinogen was being gradually replaced or
‘converted’ by activated HK, which used factor XII and prekallikrein as cofactors (Schmaier,
Silver et al. 1984; Scott, Silver et al. 1984). The activation of these enzymes is the first step
in the contact activation (intrinsic) pathway of the coagulation cascade.

1.2.3 Post-Adsorptive Conformation of Fibrinogen
Not unlike most proteins, single component adsorption studies have revealed that
the post-adsorptive spreading of fibrinogen increases with hydrophobicity of the surface and
is concentration-dependent (Pitt, Spiegelberg et al. 1987; Lu and Park 1991; Ramsden 1993;
Wertz and Santore 1999). Circular dichroism (CD) and FTIR of adsorbed fibrinogen that
was eluted from hydrophilic, hydrophobic, and charged surfaces revealed extensive postadsorptive conformational changes marked by decreases in alpha-helical content (>50%)
(Soderquist and Walton 1980; Chan and Brash 1981; Roach, Farrar et al. 2005; Steiner, Tunc
et al. 2007). Adsorption to hydrophobic surfaces has additionally been shown by FTIR to
lower the beta-sheet/turn ratio (Steiner, Tunc et al. 2007). The additional unfolding of
fibrinogen on hydrophobic surfaces is indicative of extensive deviation from the solvent11

induced secondary structure of fibrinogen in plasma, and has, therefore, been proposed as a
qualitative test for the assessment of material biocompatibility. On a hydrophobic silicon
dioxide surface, scanning force microscopy revealed two separate structures for dry
fibrinogen: a trinodular form of length 60 nm and a spherical globular shape with a 40 nm
diameter, both of which had a maximum height of 6 nm (Wigren, Elwing et al. 1991). These
measurements were later verified to also be valid for hydrated fibrinogen molecules (Taatjes,
Quinn et al. 1997; Sit and Marchant 1999). The globular shape in combination with the
trinodular shapes suggested the presence of extensive post-adsorptive conformational
changes due to influences from the hydrophobic surface. Sit et al. additionally used AFM to
compare the dimensions of post-adsorptive fibrinogen on surfaces of decreasing
hydrophobicity and demonstrated that significantly less spreading occurred on hydrophilic
surfaces (Sit and Marchant 1999).
Two distinct surface-bound fibrinogen species have been detected on numerous
surfaces, one extremely difficult to elute and one less so. On poly(dimethyl siloxane)
(PDMS), 40% of fibrinogen was found to be irreversibly bound and resistant to elution by
buffer for 100 h (Lok, Cheng et al. 1983). On polystyrene, 10-15% of adsorbed fibrinogen
was highly resistant to elution by sodium dodecyl sulfate and 3-mercaptoethanol and does
not participate in fibrin gelation. The percentage of nondesorbable fibrinogen increases with
increasing availability of area for spreading and conversion to the nondesorbable species
occurs on the same time scale as adsorption (Retzinger, Cook et al. 1994). Fibrinogen
adsorption kinetics have been shown to reach a steady state typically between 10 – 20 h, with
the majority of surface coverage being obtained before 6 h (Weathersby, Horbett et al.
1977). Using the dimensions of 45 x 6 nm, surface densities of 220 ng/cm2 and 1500
ng/cm2 are expected at maximum surface coverage if fibrinogen adsorbs with respectively a
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side-on or end-on orientation. This suggests a theoretical spread surface area of 20.25 nm2
for end-on and 212 nm2 for side-on adsorption (Santore and Wertz 2005). End-on versus
side-on conformations depend heavily on the concentration of the adsorbing fibrinogen
solutions. Less than 10 ng/cm2 of fibrinogen is required in order to elicit a physiological
response, and thus the density of fibrinogen layers as well as the percentage of irreversibly
bound fibrinogen on a variety of surfaces has been examined at different adsorbing
concentrations. Such an analysis by Bohnert et al. verified the aforementioned influences of
surface properties and adsorbing concentration on fibrinogen surface density and elutability:
593 ng/cm2 on Silastic with 20% nonelutable at 1.5 mg/mL; 238 ng/cm2 on Silastic with
26% nonelutable at 5 µg/mL; 539 ng/cm2 on Teflon with 12% nonelutable at 1.5 mg/mL;
176 ng/cm2 on Teflon with 40% nonelutable at 5 µg/mL; 565 ng/cm2 on polyethylene with
25% nonelutable at 1.5 mg/mL; 200 ng/cm2 on polyethylene with 40% nonelutable at 5
µg/mL.
A comprehensive description of the fibrinogen spreading process has remained elusive.
Total internal reflection fluorescence (TIRF) (Wertz and Santore 1999; Santore and Wertz
2005) and atomic force microscopy (AFM) (Agnihotri and Siedlecki 2004) experiments both
demonstrate that after an initial rapid spreading event, only a single mode of fibrinogen
relaxation can be detected due to the presence of only a single exponential decay. The decay
rate of fibrinogen E and D domain heights have been directly measured with AFM and used
to extrapolate the initial heights of fibrinogen domains immediately after adsorption and
prior to surface-induced spreading. The calculated values were much lower than the known
dimensions of fibrinogen, suggesting the presence of a more rapid unfolding rate that
occurred prior to analysis by AFM. TIRF confirmed these results by demonstrating that the
majority of spreading occurs within the first 15 minutes of adsorption, followed by 2 h of
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additional relaxation (Wertz and Santore 1999). The length of the decay was found to be
dependent on the hydrophobicity of the surface, as evidenced by TIRF results showing 1735
s on C16-SAM, 2127 s on hydrophobic graphite, and 6740 s on OH-SAM. These results
suggest that the two-state (folded versus denatured) single energy barrier model of protein
spreading may be inaccurate. Agnihotri et al. proposed a mechanism governed by two
separate spreading regimes: an initial rapid spreading event that lasts seconds to minutes
followed by a gradual exponential spreading event over the course of ~2 h. This initial event
may be due to the initial mechanical impact at the point of contact between amino acids and
the surface, while the second event is due to the obtaining of thermodynamic equilibrium
whereby the entropy is maximized and the energy of the system is minimized through the
increased interaction between hydrophobic domains in fibrinogen and the hydrophobic
surface (Agnihotri and Siedlecki 2004).

1.3

Controlling Protein Adsorption and Bioactivity Via
Surface Treatments of Biomaterials

1.3.1 Progression of Biomaterial Design: Improving the
Biocompatibility of Poly(ethylene terephthalate)
Three separate stages of advancement have been identified for the progression of
biomaterials science over the last 50 years, but the underlying objective has remained
unchanged: to reproducibly control how biological systems interact with a material surface
(Hench and Polak 2002). While the definition has been frequently amended and varies
significantly, a biomaterial can be classified in the broadest sense as a “substance other than
food or drugs contained in therapeutic or diagnostic systems that are in contact with
biological fluids or tissues” (Peppas and Langer 1994). The first stage of polymeric
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biomaterials design focused on biological and chemical inertness and material accessibility.
Inert materials were considered those that minimized immunologic responses and resisted in
vivo degradation. Limited development of polymeric biomaterials initially led to the use of
accessible polymers that were stable in aqueous environments, such as Dacron-based
vascular grafts derived from textiles, poly(methyl methacrylate) originally used in dentistry
and for windshields, or poly(ether urethane) taken from women’s girdles. While these
materials provided temporary solutions to many medical problems, their applications were
limited and eventually resulted in severe post-transplantational complications.

Dacron, or

poly(ethylene terephthalate) (PET), is a classic example of a first-generation biomedical
material. Coronary artery bypass surgery has been a common procedure to treat
atherosclerotic cardiovascular diseases since the 1960’s, but the ideal use of an autologous
saphenous vein is not an option for over 30% of all patients (C. William Hall 1967; Mehta
and Khan 2002). Mechanically flexible, nontoxic, and chemically inert under physiological
conditions, PET was a logical choice for vascular graft design. However, as demonstrated
by a water contact angle of 70.0°, the hydrophobic nature of PET supported extensive
fibrinogen adsorption and spreading, resulting in inflammation, thrombosis and distal
embolization (Roald, Barstad et al. 1994; Chen Jie-Rong 1999). First-generation PET
surfaces possessed the structural integrity to maintain compliance under the required 50
mL/min flow rate, but complications stemming from surface activity prevented the
development of small diameter vascular grafts with <4 mm internal diameters (Callow 1988).
Second generation polymeric biomaterials evolved to additionally elicit controlled
physiological responses, demonstrating degradation or bioactivity that improved the
inertness of the surface. The biodegradeable and resorbable suture is a notable example of
such a material, which by 1984 was used clinically in a variety of procedures. Sutures
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composed of poly(lactic-co-glycolic) polymers degrade by hydrolysis at an adjustable rate to
allow replacement by host tissues as well as to deliver therapeutic agents (Lim, Poh et al.
2009). Numerous modifications of PET have been attempted to impart bioactivity and
inhibit thrombosis and coagulation. For example, PET surfaces have been functionalized
with thiol-containing groups to promote the release of nitric oxide (NO) from naturally
occurring nitrosated compounds found in the body that are known to inhibit platelet
adhesion (Gappa-Fahlenkamp and Lewis 2005). The thrombin-inhibitory activity of
antithrombin III is heightened by the glycosaminoglycan heparin, and Bilsen et al. covalently
attached heparin to PET surfaces that were first grafted with poly(ethylene imine)
(Rosenberg and Damus 1973; Parish 2006). The heparin coatings decreased surface
hydrophobicity, and results demonstrated a reduction in inflammatory cell adhesion due to
minimizing fibrinogen spreading and preventing exposure of the P2 epitope. Since PET is a
“protein adherent” surface, the preadsorption of protein coatings that do not support
platelet and cell adhesion has been frequently attempted. Surfaces that preferentially adsorb
albumin tend to resist platelet adhesion in vitro, and preadsorbed albumin coatings have been
shown to temporarily passivate materials surfaces in vivo (Chang 1969; Imai, Tajima et al.
1971; Kim, Lee et al. 1974). Albumin is a lipid carrier that possess a high affinity for fatty
acids and has demonstrated strong adhesion to alkylated surfaces (Munro, Quattrone et al.
1981). A variety of techniques have been attempted to coat PET with albumin, including
chemical crosslinking, surface alkylation, and heat denaturation (Domurado, Guidoin et al.
1978; Tingey 1983; Rumisek, Wade et al. 1986). Although coatings reduced embolization
and improved endothelial cell attachment, they were found to be rapidly removed in fluid
flow and by protein degradation, and slow tissue incorporation resulted in long-term,
thrombus-related complications (Rumisek, Wade et al. 1986; Ben Slimane, Guidoin et al.
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1988; Jensen, Lindblad et al. 1996). Other protein coatings have been attempted including
collagen, fibronectin, and gelatin without substantial improvement (Drury, Ashton et al.
1987; Noishiki and Chvapil 1987; Callow 1988; Gouny, Hocquet-Cheynel et al. 1995).
Instead of focusing on inertness, third-generation biomaterials actively utilize molecular
interactions to direct cell adhesion, migration, differentiation, or proliferation. As evidenced
by the aforementioned late-term thrombosis on drug-eluting stents, sustained
biocompatibility will likely not be achieved with static polymeric surfaces that solely inhibit
biochemical or cellular interactions, and more biologically based strategies that recruit
dynamic endotheliums in vivo may be more favorable (Axel, Kunert et al. 1997; Hench and
Polak 2002; Parry, Brosius et al. 2005). It has been proposed that such a material should: 1)
have receptor-based recognition reactions optimized through computer modeling, 2) be well
characterized, 3) induce specific healing pathways, 4) not exhibit non-specific interactions, 5)
be sufficiently robust to withstand sterilization, storage, and in vivo conditions, and 6) be
manufacturable (Ratner 1996). Unsuccessful attempts were made in the late 1970’s and
1980’s to seed PET and poly(tetrafluoroethylene) vascular grafts with endothelial cells in vitro
prior to implantation (Herring, Gardner et al. 1984; Fasol, Zilla et al. 1989). These early
experiments achieved marginal if any improvement over unmodified PET surfaces, and
failure was attributed to insufficient cell seeding and formation of unstable endothelium.
Several groups have recently revisited these early experiments and utilized improved cell
culture techniques, only to again produce marginal improvements (Deutsch, Meinhart et al.
2009). Thrombosis was found between 30 days to 3 years and histology revealed inflamed
connective tissue below the endothelium. In all of these prior experiments, cells were
directly applied to unmodified polymer surfaces. Such protocols could be improved through
the incorporation of adhesion peptides to promote cell attachment and spreading.
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Additionally, the delivery of therapeutic agents may be needed to inhibit inflammation and
improve endothelial cell migration while limiting the proliferation of smooth muscle cells.
Adhesion peptide conjugation and the delivery of chemotactic agents are two promising
mechanisms through which material surfaces could exhibit bioactivty and are discussed in
section 1.3.2. An overview of two methods that alone or in conjunction could impart this
bioactivity to a variety of material surfaces are discussed in section 1.3.3 and 1.3.4. This
thesis endeavors to add to the expanding biomaterials literature by presenting a highly
versatile strategy for covalently attaching bioactive coatings to most polymeric surfaces. The
method is described and demonstrated in Chapter 3 for the imparting of third-generation
properties to a first-generation PET surface.

1.3.2 Directing Cell Adhesion and Migration: Integrin-Binding Motifs
and Sphingosine 1-Phosphate Delivery
Cell adhesion and migration in the extracellular matrix is mediated through the
transient binding of cell-surface receptors and the in situ enzymatic degradation of matrix
proteins. Several classes of receptors are responsible for cell-surface contacts, but
biomaterials are most frequently functionalized to incorporate small integrin-binding motifs.
Human integrin receptors are transmembrane heterodimers composed of 24 different
matched pairs from a pool of 18 α and 8 β subunits (Shimaoka and Springer 2003). The
heterodimers have been categorized as RGD-recognizing (α5β1, αVβ1, αVβ3, αVβ5, αVβ6,
αVβ8, αIIbβ3), laminin-binding (α1β1, α2β1, α3β1, α6β1, α7β1, α6β4), collagen-binding (α1β1, α2β1,
α3β1, α10β1, α11β1), and leukocyte integrins (αLβ2, αMβ2, αXβ2, αDβ2) (Takada, Ye et al. 2007).
Inside-out signaling regulates receptor conformation and affinity, which, for example, can
modulate platelet aggregation, neutrophil rolling, and the biphasic endothelial cell adhesion
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that permits migration (DiMilla, Barbee et al. 1991; Farrell, Thiagarajan et al. 1992; Ginsberg,
Partridge et al. 2005; Green, Schaff et al. 2006; Wegener, Partridge et al. 2007). Outside-in
signaling through integrins primarily influences the cell cytoskeleton to modulate cell
adhesion, proliferation, differentiation, gene expression, shape, migration, polarity, and
survival (Takada, Ye et al. 2007). The short peptide sequences present within protein ligands
that bind integrins can be fabricated using solid phase peptide synthesis and have been used
to impart a diverse range of bioactivities onto material surfaces (Pierschbacher and Ruoslahti
1984). Peptides may be synthesized to contain nucleophilic cystine or lysine residues that
can readily react with electrophilic end-groups of functionalized polymers under mild
conditions (Elbert and Hubbell 2001). In addition to promoting cell adhesion, conjugation
and crosslinking of peptides into materials have also been used for cell-mediated degradation
to allow improved integration and replacement of materials by host tissues (Kouvroukoglou,
Dee et al. 2000; Lutolf 2003; Lutolf 2003; Lutolf and Hubbell 2005).
Cell adhesion motifs present in fibrinogen were outlined in section 1.2.2, but many
other extracellular matrix- and serum-based proteins contain adhesion motifs that have been
mimicked by biomaterial surfaces. The most important of these protein ligands include
fibronectin, vitronectin, laminin, collagen, thrombospondin, and von Willebrand factor. As
with fibrinogen, protein conformation and surface adsorption play a significant role in the
presentation of their motifs, and thus the surface properties of materials can be tuned to
preferentially adsorb certain proteins to direct cell adhesion. One example of this is the
adhesion of cells to tissue culture polystyrene (TCPS), which is currently the standard
adhesive surface used in cell culture. TCPS is plasma-treated to possess a highly oxygenated
surface, and both antibody assays and radiolabeling studies have demonstrated that this
surface preferentially adsorbs vitronectin from serum present in the culture medium (Steele,
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Dalton et al. 1993). Adjusting the surface treatment to include equal parts of both nitrogen
and oxygen groups shifts the adsorption preference to fibronectin (Steele, Dalton et al.
1995). Fibronectin uses the sequences RGDS, LDV, and REDV to interact primarily with
the α5β1 integrin, while vitronectin binds the αVβ3 integrin via the RGDV sequence. While
RGD sequences bind integrin receptors such as αVβ3 that are well distributed in various
tissues, some motifs are highly specific to integrins found only on certain cell types
(Pierschbacher and Ruoslahti 1984). Notable examples include αIIbβ3 on platelets, α4β1 and
β2 integrins on leukocytes, and αEβ7 on dendritic, mast and T cells (Andrieux, HudryClergeon et al. 1989; Farstad, Halstensen et al. 1996; Rose, Alon et al. 2007). Thus adjusting
material surface properties to influence the exposure of various integrin motifs within
adsorbed proteins can permit control over the adhesion, migration, and activation of cell
types that influence materials compatibility.
The controlled delivery of growth factors and chemotactic agents may also aid in the
proliferation and recruitment of cells for in situ tissue regeneration on third-generation
material surfaces. For example, the Sakiyama-Elbert group has used the controlled delivery
of neurotrophin-3 and platelet derived growth factor from fibrin matrices to direct the
differentiation of stem cells into specific cells types for neural tissue regeneration (Willerth,
Arendas et al. 2006; Willerth, Rader et al. 2008). Our laboratory has previously
demonstrated that endothelial cell migration rates on bioactive hydrogel surfaces can be
optimized by adjusting the surface concentration of RGD peptide in the presence of
sphingosine 1-phosphate (S1P) (Wacker, Alford et al. 2008). S1P is a signaling lipid that
participates in a broad spectrum of biological responses and is actively researched as a
chemotactic agent in both vascular biology and immunology (Chun and Rosen 2006; Yatomi
2006). Activation of the G protein coupled receptor S1P1 is the primary mechanism for S1P
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manipulation of both lymphocytes and endothelial cells (Van Brocklyn, Lee et al. 1998;
Matloubian, Lo et al. 2004). The effects of S1P on endothelial cells regulates multiple stages
of vasculogenesis, including an initial promotion of endothelial cell migration and
proliferation as well as subsequent endothelial cell entubulation into stable blood vessels
(Lee, Thangada et al. 1999; Bayless and Davis 2003; Langlois, Gingras et al. 2004).
Additionally, smooth muscle cell migration that often results in stenosis of small diameter
vascular devices has been shown to be inhibited in the presence of physiological
concentrations of S1P via binding of the chemorepellant S1P2 receptor (Takuwa 2002; Hla
2004).
S1P levels in blood are regulated by enzymatic, cellular, and protein-based
mechanisms. The enzymes sphingosine kinase and sphingosine lyase respectively mediate
the phosphorylation of sphingosine into S1P and the degradation of S1P into
phosphoethanolamine and fatty aldehyde (Kohama, Olivera et al. 1998; Yatomi, Ozaki et al.
2001). Platelets and red blood cells (RBCs) express sphingosine kinase but not S1P lyase,
and thus store large quantities of S1P (Yatomi, Ozaki et al. 2001; Ito, Anada et al. 2007).
RBCs constitutively release S1P and are thought to be responsible for the basal level plasma
concentrations, while platelets only release S1P upon stimulation by physiological cues such
as shear stress and thrombin activation (Yatomi, Yamamura et al. 1997; Yang, Yatomi et al.
1999; Aoki, Osada et al. 2007). Due to poor water solubility, nearly 100% of S1P in blood is
bound to the lipid-carriers albumin (39.5±7.9%), high density lipoprotein (53.3±6.4%), and
low density lipoprotein (7.2±3.8%) (Aoki, Yatomi et al. 2005). Thus S1P levels in blood are
tightly regulated, and the localized delivery of S1P from biomaterials is a practical option for
the design of vascular devices. The incorporation of albumin as a lipid carrier for the
controlled release of S1P from hydrogels has been achieved, and a variation of this
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methodology is utilized to increase the migration rate of endothelial cells through the thirdgeneration scaffolds discussed in Chapter 4 (Hla 2004; Wacker, Scott et al. 2006).

1.3.3 Layer-by-Layer Methods
Layer-by-layer (LbL) methods generate films on surfaces by alternately adsorbing
different macromolecules possessing complementary and attractive functionalities.
Electrostatic, van der Waals, hydrogen bonding, and covalent interactions have all been
employed to maintain the structural integrity of multi-layered coatings of desired thickness
on material surfaces (Decher 1997; Stockton and Rubner 1997; Serizawa, Hamada et al.
2000; Kim, Wacker et al. 2007). The coatings can function as barriers between material
surfaces and protein solutions, allowing control over protein adsorption and spreading. An
LbL methodology is beneficial in that the protocol is usually simple and performed under
mild aqueous conditions, often requiring only incubation and washing steps that can be
performed on substrates of complex geometries. The films are frequently used in biological
applications, and modifications have been developed to elicit specific cellular interactions for
third-generation biomaterials. Polyelectrolyte multilayer (PEM) films generated by
alternating a cationic poly(allylamine hydrochloride) solution with an anionic poly(sodium 4styrenesulfonate) solution have shown promise in controlling both the amount and
conformation of fibronectin adsorption (Ngankam, Mao et al. 2004). Depending on
whether the outermost polymer layer was positively or negatively charged, the adsorbed
fibronectin shifted from a side-on to an end-on conformation and the bioactivity changed as
evidenced by decreased antibody binding.
A preference for polyelectrolytes in LbL methodologies exists due to the more
stringent requirements of sequential covalent reactions (Decher 1997; Z. Tang 2006).
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Covalent chemistry has a high steric demand, making consistently dense multilayers difficult
to achieve with an LbL strategy that requires high conversion percentages at each step.
Electrostatic interaction have the least steric demand of all chemical bonds and the resulting
charge reversal at each layering step produces monolayers of consistent density. However,
LbL protocols dependent on electrostatic interactions are not well suited for long-term
biological applications due to in vivo flow conditions and exposure to bodily fluids containing
charged molecules and ions that could disrupt the non-covalent bonds between polymer
layers (Dubas and Schlenoff 2001). Richert et al. worked around this issue to produce a
covalently crosslinked biomimetic surface using a polyelectrolyte LbL method. They formed
poly(L-lysine)/hyaluronan multilayers using a standard LbL protocol, but then covalently
crosslinked the coating with a mixture of 1-ethyl-3-(3-dimethyl-aminopropyl) carbodiimide
and N-hydroxysulfo-succinimide. The hyaluronan component in combination with the
increased rigidity of the film due to the crosslinking supported chondrocyte adhesion and
spreading. They later switched to a photo-crosslinkable system using sequential poly(Llysine) and photoreactive vinylbenzene-grafted hyaluronan layers that could produce variable
gel stiffnesses to influence cell adhesion (Vazquez, Boudou et al. 2009). Bioactive LbL
coatings have also been developed using a “click”-type reaction wherein polyamine was
reacted with the azlactone functionality present in poly(2-vinyl-4,4’-dimethylazlactone) to
form covalently attached multilayers (Buck, Breitbach et al. 2009). By reacting the free
azlactone groups on the surface of the coatings with different biomolecules, they could
control the types of proteins that adsorbed to the surface and thus specify cell adhesion.
The simplicity of the protocols and mild reaction conditions make LbL strategies an
attractive option for imparting bioactivity and biocompatibility to material surfaces.
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1.3.4 Radio Frequency Glow Discharge Plasma Treatments
Radio frequency glow discharge (RFGD) plasma may be employed to rapidly modify
the surfaces of polymers to both increase biocompatibility and direct cellular responses.
Electrical discharges in the presence of low pressure gasses can produce a mixture of lowtemperature reactive gaseous species including electrons, free radicals, ions, photons, and
excited molecules (Chan, Ko et al. 1996). These highly reactive gas-phase species permit
surface etching, functionalization, and grafting on surfaces that may normally be considered
chemically inert. As a result, plasma-based protocols can be applied on a variety of different
surfaces that would otherwise require separate and often chemically harsh reaction schemes.
Furthermore, plasma etching allows functionalization of any surface on a device exposed to
the ionized gas, allowing uniform functionalization of materials with complex geometries.
This has proven to be quite useful for the industrial sterilization and modification of medical
devices such as small diameter vascular grafts (Lauer, Shohet et al. 2004).
Plasma treatments can produce third-generation material surfaces by influencing
protein spreading and limiting the exposure of attachment sites within adsorbed proteins
containing cell adhesion motifs. Functionalization of PET surfaces with hydrophilic groups
has been performed via RFGD plasma treatments with the intention of increasing surface
wettability (Ramires, Mirenghi et al. 2000). Ammonia gas treatment was found to be
particularly beneficial for endothelial cell attachment and spreading. Dekker et al. used
nitrogen and oxygen plasma treatments to decrease the water contact angle of
poly(tetrafluoroethylene) from 96° to between 15-58 degrees, which supported the
formation of endothelial cell monolayers in the presence of 20% serum (Dekker, Reitsma et
al. 1991). The utility of nitrogen plasma treatments was further strengthened by Griesser et
al., who found polymer surfaces functionalized with amide groups to support fibroblast and
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endothelial cell adhesion more effectively than oxygen or amine functionalization (Griesser,
Chatelier et al. 1994).
Plasma treatments have additionally been used to functionalize surfaces in
preparation for chemical grafting. This strategy has allowed grafting of proteins and
polysaccarides to polymer surfaces as described in section 1.3.1 to enhance inertness on
second generation material surfaces. The development of biomimetic third-generation
materials via the direct grafting of adhesion peptides onto materials surfaces has been
attempted, but requires complex and often harsh chemistries that are specific to each
polymer surface (Massia and Hubbell 1990; Biltresse, Attolini et al. 2005; Chollet, Chanseau
et al. 2007). Recently, a reaction scheme was developed to graft different densities of RGD
peptides onto PET to promote osteoblast and endothelial cell adhesion (Chollet, Chanseau
et al. 2009). While promising, this protocol cannot be easily adapted for use on other
material surfaces, and it would be extremely beneficial if a universal plasma-based protocol
could be developed to graft peptides and bioactive coatings to multiple types of polymers.
Massia et al. established that a spacing of 440 nm (1 fmol/cm2) between grafted RGD
peptides led to fibroblast spreading via αVβ3 integrin receptors, and a spacing of 140 nm (10
fmol/cm2) led to the formation of focal contacts (Massia and Hubbell 1991). Achievement
of such high densities of surface functionalization is difficult with plasma-based strategies
due to the medley of reactive species present in cold plasmas. Valdes et al. addressed this
issue by using plasma polymerization to apply a tetraethylene glycol dimethyl ether
(tetraglyme) and (2) 2-hydroxyethyl methacrylate (HEMA) coating that was reacted with 1,1′carbonyldiimidazole to allow grafting of adhesion peptides to a Nafion surface. A 2.5%
HEMA/97.5% tetraglyme surface greatly increased the surface concentration of reactive
groups to allow the grafting of approximately 1 nmol/cm2 of adhesion peptide. While
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tetraglyme surfaces are relatively nonfouling, the 2.5% HEMA component may adsorb
protein (Cao, Chang et al. 2007). Furthermore, the peptide-grafted surface has yet to be
tested for cell adhesion, and tetraglyme surfaces have been shown to increase monocyte
adhesion during in vivo tests (Shen, Martinson et al. 2002). As an alternative to using
complex plasma-based strategies to increase the surface concentration of reactive groups, it
may be more practical to instead increase the size and functionality of the grafted molecule.
Grafting large (50-180 nm diameter), highly functionalized, bioactive, hydrated, and
crosslinkable oligomers/microgels to an air or nitrogen plasma-etched surface may allow
extensive covalent surface coverage despite the minimal functionalization that can be
achieved via standard plasma-treatments. This strategy is presented in Chapter 3 of this
thesis, wherein high density bioactive PEG/albumin or 100% PEG coatings were applied to
surfaces following short (10 min) air plasma-treatments.

1.4

Poly(Ethylene Glycol) Hydrogels as Biomaterials

1.4.1 Poly(Ethylene Glycol): Resistance to Protein Adsorption and
Chemical Functionalization
PEG, also referred to as poly(ethylene) oxide at high molecular weights, is a synthetic
FDA-approved polymer composed of ethylene oxide monomers. PEG has a general formula
of HO-(CH2-CH2-O)n-H and is strongly hydrophilic. Raman scattering and NMR analysis
both indicate that three water molecules hydrate each PEG unit, and this extensive hydrogen
bonding results in the formation of a hydration shell that may extend several hundred
angstroms from the PEG backbone (Liu and Parsons 1969; Horne, Almeida et al. 1971;
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Maxfield and Shepherd 1975; Kjellander and Florin 1981; Muller and Rasmussen 1991). The
hydration shell and steric repulsive forces of the polymer chains are both thought to provide
PEG with considerable resistance to non-specific protein adsorption (Jeon, Lee et al. 1991;
McPherson, Shim et al. 1997).

Longer lengths and increased packing of the polymer chains

enhances the effects of these repulsive forces, and accordingly, the resistance of PEG to
protein adsorption is amplified as the molecular weight and density are increased (Jeon and
Andrade 1991). Additionally, PEG has an overall neutral charge, which in combination with
the hydration shell provides very few binding sites for proteins to attach via electrostatic
forces (Harris 1992; Ostuni, Chapman et al. 2001). Studies have demonstrated that reacting
the surfaces of proteins and enzymes with PEG chains prevent immunologic recognition as
well as clearance of these biomolecules when injected into the blood stream (Abuchowski,
McCoy et al. 1977; Abuchowski, van Es et al. 1977). As expected, the covalent attachment
of higher molecular weight PEG chains required lower densities of coupling in order to
obtain immunologic resistance.
PEG is desirable for use as a biomaterial due to its resistance to protein adsorption,
but it does not possess the structural properties of other polymers that are currently used in
the manufacturing of implanted devices. As a result, PEG is frequently grafted or coated
onto the surfaces of other materials (McPherson, Shim et al. 1997; Burchenal, Deible et al.
2002; Ma, Hyun et al. 2004; Heuberger, Drobek et al. 2005) or used in the formation of
hydrogels (Sawhney, Pathak et al. 1993; Zisch, Lutolf et al. 2003; Wacker, Scott et al. 2006).
Since the hydroxyl moiety is not highly reactive, PEG derivatives are commonly used in the
development of PEG-based materials. Harris et al. developed numerous methods for the
highly efficient synthesis of PEG derivatives based on the initial formation of either a PEGtosylate or PEG-mesylate that could be displaced in subsequent reactions with minimal
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chain cleavage (J. Milton Harris 1984). PEG-diisocyanate has been grafted onto Dacron
surfaces and was shown to significantly decrease platelet adhesion and fibrinogen adsorption
(Burchenal, Deible et al. 2002). Graft polymerization has also been applied for the
attachment of PEG to Dacron by generating surface radicals with UV light (Uchida, Uyama
et al. 1994). Four-arm PEG-VS hydrogels have been used in the formation of cell in-growth
matrices by covalently retaining integrin-binding RGD peptides and substrates for matrix
metalloproteinases (Zisch, Lutolf et al. 2003). Despite a plethora of such chemical
modifications and applications, few implanted devices currently utilize PEG-based materials,
primarily due to an inability to graft a sufficiently high density layer of PEG onto surfaces
and partially due to cost restrictions stemming from prohibitively complex chemistries and
strategies (Elbert and Hubbell 1996).
Chemical modification of the hydroxyl end-groups of PEG with vinyl-sulfone
functionality allows crosslinking for hydrogel formation, retention of biological factors, or
covalent attachment to material surfaces under mild physiological conditions (Zisch, Lutolf
et al. 2003; Wacker, Scott et al. 2006) . α,β conjugated compounds undergo Michael-type
nucleophilic addition reactions in the presence of nucleophiles, and vinyl sulfone has been
shown to participate in such reactions in a pH dependent manner (Masri and Friedman
1988). Thus PEG-VS can be readily alkylated by thiol-containing molecules under neutral
conditions and amine-containing molecules under slightly basic conditions, allowing selective
reactivity with either cysteines or lysines within proteins. Since these reactions occur under
mild physiological conditions, biological factors can be crosslinked into or retained within
PEG-VS gels without fear of denaturation or unwanted side-reactions. This ability has
generated a variety of bioactive hydrogel coatings that, for example, allow conjugation of cell
adhesion peptides or crosslinking with enzymatically degradable peptides (Lutolf 2003).
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Furthermore, these mild reaction conditions can be used to incorporate versatile proteins
such as albumin, which is known to passivate material surfaces and function as a lipid carrier
for bioactive lipids such as sphingosine 1-phosphate (Amiji, Park et al. 1992; English, Welch
et al. 2000; Wacker, Scott et al. 2006). RGD-peptide-containing PEG hydrogels crosslinked
with S1P-loaded albumin have been optimized to allow control over the biphasic migration
of endothelial cells across hydrogel surfaces (Wacker, Alford et al. 2008). Thus PEG-VS
functions as an adaptable and convenient synthetic polymer for the fabrication of bioactive
coatings and scaffolds.

1.4.2 Poly(Ethylene Glycol) Coatings
A number of strategies have been explored to produce thin PEG-based coatings.
Glow discharge treatment of surfaces with tetraglyme produces surfaces that exhibit low
amounts of fibrinogen adsorption (Lopez, Ratner et al. 1992; Cao, Sivaprasad et al. 2006).
Surface-initiated free-radical polymerization of hydrophilic monomers promotes
polymerization and crosslinking in a limited region above the substrate (Hill-West,
Chowdhury et al. 1994; Kizilel, Sawardecker et al. 2006). Adsorption of high molecular
weight PEG/polylysine copolymers onto endovascular stents reduces restenosis after
implantation, although long-term stability of the adsorbed copolymers may be a concern
(Billinger, Buddeberg et al. 2006; Lussi, Falconnet et al. 2006). Copolymers of methyl
methacrylate and PEG are also quite effective in reducing non-specific cell adhesion on a
variety of surfaces (Banerjee, Irvine et al. 2000; Irvine, Mayes et al. 2001; Hyun, Ma et al.
2003; Zhang, Ma et al. 2005). A single or very thin crosslinked layer of “star” (multiarm)
PEG reduces non-specific cell adhesion on surfaces (Kuhl and Griffith-Cima 1996; Groll,
Haubensak et al. 2005; Hoffmann, Groll et al. 2006). Covalent layer-by-layer methods have
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also been described, in some cases yielding coatings with resistance to protein adsorption
and cell adhesion (Lackowski, Ghosh et al. 1999; Ghosh, Lackowski et al. 2001). Amirpour
et al. combined micro-contact printing-based lithography and polymer grafting to generate
patterns of poly(acrylic acid) layers coated with PEG on gold surbstrates. The 3D patterns
of polymeric “fences” that resulted could direct cell adhesion and spreading (Amirpour,
Ghosh et al. 2001).
Our research group has previously attempted the covalent LbL assembly of
nanoscale PEG hydrogels by repeatedly alternating surface incubations between PEG-VS
and a dithiothreitol crosslinker. However, these efforts to apply dense coatings of PEG to
surfaces proved to be quite laborious and afforded only a moderate reduction in cell
adhesion (Kim, Wacker et al. 2007). As explained previously, the difficulty in achieving
100% conversion at each reaction step results in progressively inconsistent densities of
polymer within layers. Consequently, gaps exist in the coating through which protein can
migrate to the underlying material surface, and the thickness of the film eventually reaches a
maximum due to decreasing availability of functional groups for further reaction. This
suggested that the use of higher molecular weight polymers or larger polymer aggregates
(oligomers/microgels) may more readily achieve dense PEG coverage, especially on surfaces
with low densities of reactive groups. Such an approach has proven to be quite successful as
demonstrated by data presented in Chapter 3 of this thesis.

1.4.3 Poly(Ethylene Glycol) Scaffolds
Tissue engineering scaffolds are structures designed to promote tissue healing
and/or regeneration by providing the mechanical and biochemical cues required to maintain
cell viability and direct cell proliferation and differentiation (Place, George et al. 2009). The
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recent shift in the general focus of the biomaterials field towards the employment of thirdgeneration biomedical materials has carried over into the design of tissue engineering
scaffolds. Accordingly, advanced scaffolds are composed of biomaterials designed to elicit
specific cellular interactions and responses at the molecular level while minimizing
unfavorable nonspecific biological activity (Hench and Polak 2002). As a result, a variety of
different scaffold strategies have emerged to take advantage of the chemical versatility and
specificity of PEG derivatives and copolymers. Photopolymerizable poly(ethylene glycol)
diacrylate (PEG-DA) is certainly the most utilized PEG derivative. It is particularly
amenable to template-based lithographic methods that can produce hydrogel modules with
well-defined 3D structures for the assembly of larger tissue engineering constructs. For
example, cells encapsulatd within hydrogels formed by crosslinking PEG-DA with
hyaluronic acid within microwells have permitted immense control over 3D scaffold shape
(Yeh, Ling et al. 2006). PEG-DA has also served as an injectable cell-laden scaffold for
adipogenesis and has been particularly successful when crosslinked with peptides containing
LGPA collagenase-degradable and YIGSR cell adhesion motifs (Patel, Gobin et al. 2005).
Halstenberg et al. developed hydrogels composed of PEG-DA that were grafted to artificial
protein prior to photopolymerization. The protein component was able to provide multiple
functions in addition to cell adhesion, including heparin binding and plasmin degradation
(Halstenberg, Panitch et al. 2002). A technique designed for precise control over hydrogel
porosity was developed by Stachowiak et al., who photopolymerized PEG-DA around
poly(methyl methacrylate) microspheres that could be arranged in ordered structures and
dissolved with acetic acid to generate interconnected macroporosity (Stachowiak, Bershteyn
et al. 2005). The vinylsulfone derivative of PEG has been primarily utilized by the Hubbell
group to fabricate PEG hydrogel scaffolds under mild conditions without
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photopolymerization. The group developed cell-laden PEG-VS hydrogels crosslinked with
MMP-degradeable peptides to achieve in situ formation of cell niches as cells migrated and
proliferated within the scaffold (Lutolf 2003). Completely synthetic PEG copolymers have
been utilized to enhance scaffold stiffness, as demonstrated by poly(ethylene glycol)terephthalate fibers used in porous scaffolds that can achieve elastic moduli up to 4.33 MPa
for the engineering of articular cartilage (Malda, Woodfield et al. 2004; Malda, Woodfield et
al. 2005). Thus third-generation scaffolds with a wide range of physical and chemical
properties can be generated through the use of PEG.
From this prior work, a description of the optimal tissue engineering scaffold can be
envisioned. The scaffold composition should contain as high a percentage of PEG as
possible to minimize nonspecific protein adsorption and cell adhesion. A hydrogel structure
is desired to achieve high levels of water content and nutrient transfer. Porosity is needed at
multiple length scales to provide niches for embedded cells and routes of vascularization.
Scaffolds should allow incorporation of biomolecules either at the backbone level or in the
form of end-group conjugation to impart specific bioactivity and/or cell-initiated
mechanisms of degradation. The stiffness should be adjustable to mimic the physical
characteristics of different types of tissues. And finally, scaffolds should be able to
accomplish these goals with a rapid, scalable, and modular fabrication process. What is
missing from this literature is a methodology to form modular, porous scaffolds under mild
conditions that would allow assembly in the presence of cells and not require mobilityimpeding cell encapsulation. The creation of such a process was one objective of this thesis,
and preliminary data towards achieving this goal are discussed in Chapter 4.
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CHAPTER 2†
Mass Spectrometric Mapping of Fibrinogen
Conformations at Poly(Ethylene Terephthalate)
Interfaces
2.1

Abstract
We have characterized the adsorption of bovine fibrinogen onto the biomedical

polymer polyethylene terephthalate (PET) by performing mass spectrometric mapping with
a lysine-reactive biotin label. After digestion with trypsin, MALDI-TOF mass spectrometry
was used to detect peptides from biotinylated bovine fibrinogen, with the goal of identifying
lysines that were more accessible for reaction with the chemical label after adsorption.
Peptides within domains that are believed to contribute to heparin binding, leukocyte
activation, and platelet adhesion were found to be biotin labeled only after bovine fibrinogen
adsorbed to the PET surface. Additionally, the accessibility of lysine residues throughout
the entire molecule was observed to increase as the concentration of the adsorbing bovine
fibrinogen solution decreased, suggesting that the proximity of biologically active motifs to
hydrophilic residues leads to their exposure. The surface area per adsorbed bovine
fibrinogen molecule was quantified on PET using optical waveguide lightmode spectroscopy
(OWLS), which revealed higher surface densities for bovine fibrinogen adsorbed from
higher concentration solutions. Preliminary work towards a quantitative variation of the
†
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mass spectrometric method is additionally presented. A protocol was developed for the
expression of isotopically labeled proteins from HepG2 hepatocaricoma cells. Stable isotope
labeling tandem mass spectrometry (SILT-MS) was utilized to generate standard curves for
the quantification of complement C3, α2-macroglobulin, and human fibrinogen. By
measuring changes in the identity, conformation, and quantity of proteins that adsorb from
complex mixtures such as blood or plasma, the methods presented here may have
applications in fundamental studies of protein adsorption and may allow for more accurate
predictions of the biocompatibility of materials.

2.2

Introduction
The first biological response to the implantation of foreign materials is the

adsorption of a thin layer of proteins onto their surfaces (Baier and Dutton 1969; Brash and
Davidson 1976; Andrade and Hlady 1986). The rate of adsorption and the chemical
properties of the surface influence protein conformations and surface coverage as the
adsorbed proteins denature and unfold at this solid/liquid interface. Some adsorbed
proteins expose previously hidden binding domains that participate in inflammatory,
thrombotic, and immunologic responses (Zucker and Vroman 1969; Mohammad, Hardison
et al. 1974; Kottke-Marchant, Anderson et al. 1987; Anderson, Bonfield et al. 1990; Shen and
Horbett 2001). The post-adsorptive conformations of fibrinogen have been investigated on
surfaces of varying surface energy and these transformations expose sites responsible for
platelet activation and aggregation (Shiba, Lindon et al. 1991; Farrell, Thiagarajan et al. 1992;
Liu, Rooney et al. 1998; Tang, Wu et al. 1998; Sit and Marchant 1999; Bennett 2001). Here,
we introduce mass spectrometric mapping to probe local conformational changes within
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bovine fibrinogen (bFg) following adsorption to the biomedical polymer polyethylene
terephthalate (PET).
When proteins are reacted with a chemical label prior to enzymatic digestion, labeled
peptides with increased masses can be identified by mass spectrometry. Since the rate of
reaction of protein functional groups is dependent on their degree of solution exposure
(Suckau, Mak et al. 1992), mass spectrometry can be used to map changes in protein
conformation by varying the experimental conditions and tracking the accessibility of
specific residues to chemical modification. Mass spectrometric mapping has been previously
utilized to discern protein-protein interactions and protein conformations in solution
(Robinson, Gross et al. 1994; Bennett, Matthiesen et al. 2000; Carven and Stern 2005).
Arginine, lysine, tryptophan, and tyrosine are the most common targets of amino acid
modification (Bennett, Matthiesen et al. 2000; Hager-Braun and Tomer 2002; Carven and
Stern 2005). Since lysines occur frequently throughout proteins, are charged and have a high
degree of solution exposure, amine-specific N-hydroxysuccinimide (NHS) ester labels have
been used in various applications, including isotope-tagging for relative absolute
quantification (ITRAQ) (Ross, Huang et al. 2004; Roesli, Elia et al. 2006). The availability of
water-soluble derivatives of NHS-esters provides an advantage over most other reagents
used for protein labeling, in that the reaction can be performed under physiologic conditions
(Staros 1982).
Techniques such as antibody labeling , atomic force microscopy (AFM), circular
dichroism, sum frequency generation (SFG), total internal reflectance fluorescence (TIRF)
and Fourier transform infrared spectroscopy (FTIR) have demonstrated structural changes
in fibrinogen after adsorption onto surfaces (Lu and Park 1991; Shiba, Lindon et al. 1991;
Buijs, Norde et al. 1996; Sit and Marchant 1999; Cacciafesta, Humphris et al. 2000; Holland
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and Marchant 2000; Lu, Huang et al. 2003; Clarke, Wang et al. 2005; Hylton, Shalaby et al.
2005; Tunc, Maitz et al. 2005; Toscano and Santore 2006). Each of these techniques has
advantages for elucidating protein structural changes, but generally provides information at
the domain-level. Antibody binding can be used to correlate the exposure of cell interaction
motifs to post-adsorptive changes in fibrinogen conformation (Shiba, Lindon et al. 1991).
While antibody binding verifies the exposure of previously inaccessible domains of
fibrinogen, it is dependent on the availability of specific antibodies and can only reveal
changes in protein conformation in areas of the protein complementary to these antibodies.
AFM has provided detailed information on the overall post-adsorptive structure of
fibrinogen by revealing the dimensions of the fibrinogen D and E domains on various
surfaces. However, AFM is not well suited for discerning transitions in dense monolayers of
protein. Detailed studies on the global changes in fibrinogen secondary structure after
adsorption have been performed using SFG, TIRF, and FTIR, also yielding information at
the domain-level (Clarke, Wang et al. 2005; Roach, Farrar et al. 2005; Toscano and Santore
2006). We believe that mass spectrometric mapping may contribute to the study of
adsorbed proteins by providing residue-specific information on surface-dependent
conformational changes under physiologically relevant experimental conditions.
Although protein molecular weights can be routinely determined within ± 0.1 Da,
accurate quantification of protein concentrations by mass spectrometry (MS) has remained
elusive. The intensities of signals observed in MS are influenced not only by the quantity of
the analyte, but also by its ionization efficiency, which is dependent on numerous factors
including charge and composition, and can thus vary significantly between different peptides.
The most accurate methods of quantifying proteins with MS involve the incorporation of
stable isotopes into peptides, usually 13C, 2H, or 15N. Isotopic labeling does not affect the
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chromatographic properties of molecules, and thus permits the direct comparison between
the intensities of the heavy and light versions of peptides as they coelute during liquid
chromatography. Stable isotopes can be incorporated into peptides with either chemical or
metabolic strategies. Chemical strategies have primarily focused on the mass tagging of
amino-acid side chains within proteins. The most widely used techniques are the cysteinespecific isotope-encoded affinity tags (ICAT), and the lysine-specific isobaric tags for
iTRAQ mentioned earlier (Gygi, Rist et al. 1999; Ross, Huang et al. 2004). Metabolic
strategies use the efficient biological machinery of cultured cells to achieve 99%-100%
labeling of all expressed proteins. Originally, entire proteomes of cell lines were
metabolically labeled by carefully removing all sources of nitrogen except for 15N-substituted
food (Oda, Huang et al. 1999). Current metabolic strategies have shifted towards stable
isotope labeling by amino acids in cell culture (SILAC), in which specific amino-acids in the
cell culture medium are replaced by their heavy counterparts. Since SILAC labels only select
amino acid throughout the proteome, the data analysis is greatly simplified (Ong, Blagoev et
al. 2002; Mann 2006).
Stable isotope labeling tandem mass spectrometry (SILT-MS) is a metabolic labeling
technique that improves upon previous methodology by utilizing LC-ESI-MS/MS in a
manner that significantly increases the accuracy of peptide quantification (Bateman, Munsell
et al. 2006; Bateman, Munsell et al. 2007; Elbert, Mawuenyega et al. 2008). The technique is
similar to SILAC, in that it requires the metabolic labeling of proteins with stable isotopes.
In SILAC, the integrated intensities of parent ions of the MS1 scan are compared for
quantification, which introduces significant error from background noise stemming from
peptides that coelute with the peptides of interest. SILT-MS takes advantage of the MS2
scan, which is performed after the rf-field of the ion-trap is adjusted to eject all peptides
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from the trap except for peptides with a specific mass to charge ratio. The mass
spectrometer can be programmed to follow the MS2 scan of each parent ion with a second
MS2 scan in which the same parent ion mass is increased by the mass of one isotope-labeled
amino acid. For each parent ion and their heavy counterpart, the ratio of the sum of the
intensities of b-ions (N-terminus fragments) and y-ions (C-terminus fragments) in the MS2
spectra may be calculated. This ratio can be used to calculate the quantity of the sample
protein based on the known quantity of an internal standard within ±1% error. Previous
quantitative MS methods that used MS1 precursor ions instead of MS2 tandem ions could
only quantify protein levels within ±30-50% error.
We have developed a proteomics-based strategy to analyze the adsorption of bFg
onto PET, which supplements our earlier proteomic studies on the adsorption of serum and
plasma proteins on biomaterials (Kim, Scott et al. 2005). The conformational changes that
occur upon fibrinogen adsorption were examined by comparing the mass spectra of bFg that
was biotin-labeled in solution to bFg that was labeled after adsorption to the surfaces of
PET particles. We hypothesized that there was a tendency for sections of bFg to be exposed
to solution during the adsorption process, and that peptides at these locations would be
biotinylated at higher rates. We targeted primary amines with a chemical label due to their
reactive properties and presence at 107 sites throughout the bFg molecule, which could be
analyzed with respect to their location in three dimensional space due to the availability of
the nearly complete bFg crystal structure. The reactions were performed under physiological
conditions with an NHS-ester label. These residue-specific mass spectrometric mapping
experiments correlated well with optical waveguide lightmode spectroscopy (OWLS) results,
both of which demonstrated concentration-dependent changes in fibrinogen spreading on
PET surfaces. Our data support previous findings that large scale changes in fibrinogen
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conformation occur upon adsorption from dilute solutions, evidenced by enhanced exposure
of hydrophilic lysine groups throughout the protein. Furthermore, post-adsorptive
increases in lysine exposure were detected for several residues localized within biologically
relevant fibrinogen motifs. Thus this method may be useful in localizing adsorption-induced
conformational changes to specific sites within proteins with a residue-level resolution.
Finally, a strategy was developed for the MS-based quantification of plasma proteins
expressed by HepG2 hepatocellular carcinoma cells. SILT-MS was used to generate
standard curves that demonstrated the quantification of human fibrinogen, complement C3,
and α2-macroglobulin. This technique may prove to be a safe and non-radioactive method
of quantifying protein within adsorbed protein layers.

2.3

Materials and Methods

2.3.1 Spin Coating
Unless otherwise noted, all reagents were purchased from Sigma. Glass OWLS chips
coated with a Si/Ti/O2 waveguide layer (48 x 16 x 0.5 mm, MicroVacuum Ltd.) and silicon
wafers (48 x 16 x 0.5 mm) were cleaned by immersion in piranha solution (3:1 H2SO4 and
H2O2) for 5 min followed by rinsing in deionized (DI) water. Polyethylene terephthalate
(PET, 0.05 mm thick, McMaster Carr, Chicago, IL) sheets were dissolved in chloroform with
5% (w/v) trifluoroacetic acid (TFA) to make 0.8% solutions of PET. The PET solution
(100 µL) was applied to the surfaces of either the wafers or OWLS chips and spun at 4500
RPM for 50 s with a model KW-4A spin coater (CHEMAT Technology). PET layer
thicknesses on the silicon wafers were confirmed with a variable angle Stokes ellipsometer
(Gaertner Scientific Corporation). X-ray photoelectron spectroscopy (XPS, Kratos
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Analytical Axis 165 spectrometer, University of Missouri Rolla) was performed to verify the
composition of the layers.

2.3.2 OWLS Analysis
PET coated waveguide chips were placed inside the flow chamber of a
MicroVacuum OWLS 110 optical waveguide lightmode spectrometer. The adsorption of
bFg from 1, 0.5 and 0.1 mg/mL solutions in phosphate buffered saline (PBS; 0.2 g/L KCl,
0.2 g/L KH2PO4, 8 g/L NaCl, 1.15 g/L anhydrous Na2HPO4, pH 7.4) was monitored with a
time step of 30 sec. PBS was flowed over the surface of the chips for at least 1 h, or until a
baseline with a transverse magnetic mode refractive index variation less that 1 x 10-6 was
obtained. Solutions of bFg (0.1, 0.5, or 1 mg/mL) were allowed to flow over the surface for
4 h at 0.15 mL/min. The surface was then washed with PBS at 0.15 mL/min until a steady
baseline was again reached. The thickness and density of the adsorbed layers were
determined for each time point using MicroVacuum BioSense software.

2.3.3 Analysis of OWLS Results
The density and the change in density with time (dM/dt) were fit to a random
sequential adsorption (RSA) model of the protein adsorption process (Ramsden 1993), using
MathWorks MATLAB version 6.1. The OWLS data was fit to the equation:
dθ
= K aCbϕ (θ )
dt

(1)

where θ is the fractional surface coverage, Ka is the deposition rate constant, Cb is the bulk
solution protein concentration, and φ is a surface coverage dependent function that
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represents exclusion effects due to previously adsorbed proteins. The fractional surface
coverage is defined by:

θ=

Ma
m

(2)

where M is the adsorbed surface density, m is the mass of a single fibrinogen molecule, and a
is the surface area covered by one fibrinogen molecule. The dM/dt data were fit to the RSA
equation previously derived using statistical mechanics of hard sphere adsorption to a two
dimensional surface (Schaaf and Talbot 1989):

 6 3  2  40 176  3 
dM
θ + 
= K 1 − 4θ + 
− 2 θ 

dt
π
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(3)

The maximum θ, or jamming limit, resulting from the adsorption process for spheres is
0.547 (Hinrichsen, Feder et al. 1986). By substituting this maximum coverage into equation
(2), the protein surface density at the jamming limit, M∞, was calculated for each adsorption
experiment. M∞ was used to directly convert OWLS surface density measurements into
fractional surface coverages. Statistical significance (p-value < 0.05) between the fibrinogen
concentrations was determined by ANOVA followed by a Scheffe post-hoc test.

2.3.4 PET Particle Fabrication
PET solutions (1%) were obtained by dissolving polymer sheets in dichloromethane
with 5% (v/v) TFA. Each sample was filtered with a 0.5 µm PTFE filter (Millipore) and
poured into 1 L of DI water while stirring. Emulsions were stirred overnight and PET
particles were removed by filtration. The particles were washed in ethanol and DI water and
stored under vacuum until use. The surface area per gram of particles was determined for
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three separate fabrications using BET (Micrometrics Brunauer Emmett Teller model Gemini
2375).

2.3.5 Biotinylation
PET particles were placed in 1.5 mL silicone-coated polypropylene Eppendorf tubes
and washed 3X in ethanol and 3X in PBS. Disposable polystyrene columns (Fisher
Scientific) with 2 mL bed volumes were filled with the PET particles (150 mg) in PBS and
allowed to settle for 30 min. PBS (3 mL) was added to the columns for washing, followed
by 2 mL of 1, 0.5, or 0.1 mg/mL bFg in PBS. The PET surfaces were incubated with the
bFg solutions for 2 h and then washed with 5 mL of PBS. The PBS washes were collected
in 1 mL samples for analysis with a GENESYS 10 spectrophotometer (Spectronic) at 280
nm to monitor the decrease in protein concentration and to ensure that the non-adsorbed
bFg solution was completely removed. A 10 mg/mL solution of Sulfo-NHS-LC-Biotin
(Pierce) in PBS was added to the column and incubated for 1 h to allow reaction with the
adsorbed bFg. PBS (5 mL) was then flowed through the column to remove excess NHS
solution. The adsorbed protein was eluted from the column with 500 µL of an elution
buffer (4% SDS, 40 mM Tris, 8M urea, pH 8.5). The elution buffer was allowed to incubate
in the column overnight. Protein was collected by acetone precipitation and dried in an
Eppendorf Vacufuge concentrator. Adsorption experiments were performed in triplicate for
each concentration.
SDS-PAGE was used to monitor the extent of labeling in biotinylated samples. To
maintain a similar degree of labeling between solution-labeled and surface-labeled samples,
0.5 mg/mL of bFg was biotinylated in solution with 1 mg/mL of Sulfo-NHS-LC-Biotin for
1 h at room temperature. The labeled bFg was concentrated and desalted by acetone
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precipitation. The solution-labeled samples were not exposed to PET surfaces nor the
elution buffer. Solution-labeling experiments were performed in triplicate.
Each surface-labeled and solution-labeled fibrinogen precipitation was resuspended
in DI water and separated into 3 samples. The samples were reduced with 100 mM DTT,
alkylated with 100 mM iodoacetamide and separated by SDS-PAGE using Tris-HCl linear
gradient 8-16% gels (Pierce). Fibrinogen Aα, Bβ, and γ chains were stained with SYPRO
Ruby stain and excised from the gels. In-gel trypsin digestions were performed overnight for
16 h at 37°C. The peptides were purified for MALDI-TOF analysis using ZipTips (Fisher
Scientific) with elution by 15 mg/mL α-cyano-4-hydroxycinnamic acid matrix solution in
0.1% TFA/50% acetonitrile.

2.3.6 MALDI-TOF Analysis
Mass spectrometry was performed with an Applied Biosystems Voyager System 4254
MALDI-TOF in positive-ion reflectron mode to produce centroided spectra. Each bFg
sample was divided into three separate aliquots prior to in-gel trypsin digestion and thus each
sample was analyzed with MALDI-TOF three times (see workflow diagram, Figure 2.4).
The three spectra obtained for each sample were normalized to each other using internal
bFg peptide standards. Peptides common to each trypsin digest that did not contain lysines
were selected as standards. Trypsin-digested bFg peptide masses were predicted using the
ExPASy proteomics server (Gasteiger, Gattiker et al. 2003). Peptides with up to three
missed cleavages ranging in size from 700 – 4000 Da were found in MALDI-TOF spectra
with in-house Perl scripts that identified peaks consistent with tryptic bFg peptides. A
tolerance of ± 0.1% was utilized with a maximum upper deviation of 2 Da and a maximum
lower deviation of 1 Da was utilized. Biotin-labeled peptides were identified by the
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following criteria: 1) the peptide contained at least one missed cleavage, 2) the peptide mass
increased by the size of the Sulfo-NHS-LC-Biotin label (+339.452 Da), and, 3) the peptide
contained at least one lysine residue that was not located at the carboxyl terminus, since
trypsin cleavage after labeled lysines should be unfavorable. If two separate peaks
corresponded to different peptides that contained the same labeled lysine location due to
incomplete trypsin digestion, the normalized intensities were summed. The summed
normalized intensities of peptides containing each lysine residue were averaged across the
three trypsin digests. These average lysine intensities were then averaged across three
separate experiments for each of the tested conditions. Non-parametric Mann-Whitney
pairwise comparisons were used to identify statistically significant (p-value < 0.05) changes
in intensity. Labeled bFg locations were visualized using PDB file 1DEQ (Brown,
Volkmann et al. 2000) with Visual Molecular Dynamics version 1.8.3 (Humphrey, Dalke et
al. 1996). A sequence comparison between human and bovine fibrinogen was performed
using CLUSTAL W version 1.83 (Thompson, Higgins et al. 1994).

2.3.7 Liquid Chromatography Electrospray-Ionization Ion Trap
Tandem Mass Spectrometry
The reliability of labeled peptide detection was confirmed by processing some
solution-labeled samples with liquid chromatography electrospray-ionization ion trap tandem
mass spectrometry (LC-ESI-MS/MS). After biotinylation, PBS solutions of bFg were buffer
exchanged using microcentrifuge filters (NMWL 10,000, PLGC cellulosic membrane,
Millipore Corp.) into 25 mM ammonium bicarbonate and digested with sequence grade
trypsin overnight at 37˚C. The ammonium bicarbonate was evaporated in a Vacufuge and
samples were stored at -20˚C. Tryptic peptides were dissolved in 25 µL of 5%
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acetonitrile/0.02% N-heptafluorobutyric acid (HFBA). The peptide solutions (4 µL) were
injected into a nano-HPLC system (Agilent 1100 capillary pump) connected to a Picoview
nanoelectrospray head (New Objective, Woburn, MA) attached to an ion trap mass
spectrometer (LCQ DECA, ThermoFinnigan, San Jose, CA). The peptides in the mixture
were separated at a flow rate of 300 nL/min. A gradient of 5% acetonitrile/0.02% HFBA to
80% acetonitrile/0.02% HFBA was run over 60 min, with peptides separated on a 75 µm ×
5 cm C18 Biobasic column (New Objective). The LCQ-DECA was operated in positive ion
mode using a capillary voltage of 12 V, a capillary temperature of 150˚C, and a spray voltage
of 2.2 kV. Each experiment was immediately followed by a blank injection to ensure that
proteins were not carried over from previous injections. Data were collected in full MS/MS
mode and biotin-labeled peptides were identified using an in-house program as described
previously (Kim, Scott et al. 2005).

2.3.8 Expression of HepG2 Proteins
HepG2 cells were cultured in lysine-free medium (Washington University School of
Medicine Tissue Culture Support Center) containing either 105 µg/mL of L-lysine or
13

C6,15N2- L-lysine hydrochloride . Cells were initially grown in medium supplemented with

10% dialyzed fetal calf serum and 1 µM all-trans retinoic acid until reaching 50-60%
confluency. The culture medium was then switched to serum free medium containing
primary hepatocyte growth supplements (Lonza), 1µM all-trans retinoic acid, and 1 µg/mL
aprotinin. Medium was collected every 2 days, supplemented with protease inhibitor cocktail
(Roche) and filtered through a 0.22 µM filter (Millipore). The filtered media was
concentrated to about 1 mL using 10K MWCO centrifuge filters and stored at -80°C.
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2.3.9 Quantification of 13C6,15N2-Fibrinogen Concentrations in Media
The concentration of 13C6,15N2-fibrinogen in the HepG2 media was determined with
an ELISA kit (AssayMax Human Fibrinogen ELISA Kit). Media was added to a 96-well
plate that were pre-coated with a murine anti-human fibrinogen antibody and allowed to
incubate for 2 h. After washing, each well was incubated with a biotinylated fibrinogen
standard. A streptavidin-peroxidase conjugate was then added to each well to report the
amount of bound biotinylated fibrinogen standard. The absorbance was then be read at a
wavelength of 450 nm. Lower absorbances indicate higher concentrations of bound
13

C6,15N2-fibrinogen. According to the manufacturer, the minimum detectable dose of

fibrinogen for the ELISA kit is 100 ng/mL.

2.3.10 13C6,15N2-Fibrinogen Purification
13

C6,15N2-fibrinogen in HepG2 media was immunoprecipitated with fibrinogen

polyclonal rabbit anti-human IgG (Dako North America, Inc.) that were covalently attached
to sepharose beads (Amersham Biosciences). Antibody beads were prepared according to
the manufacturer’s protocol and stored at 4°C in a 50% slurry of PBS and 0.02% sodium
azide. Media (1 mL) was incubated with the antibody beads overnight at 4°C in an
Eppendorf micro-centrifuge tube and then rinsed 3X with radioimmuno precipitation assay
(RIPA) buffer containing protease inhibitors. The bound 13C6,15N2-fibrinogen was eluted
from the beads by boiling in SDS-PAGE loading buffer without a reducing agent at 100°C.
Separate fibrinogen purifications in SDS-PAGE loading buffer were pooled together and
stored at -20°C.
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2.3.11 Preparation of 13C6,15N2-HepG2 Protein Standards
Concentrated isotope-labeled and unlabeled media or fibrinogen in SDS-PAGE
loading buffer were mixed into 10 µL volumes at various ratios. Media samples were
additionally mixed with 10 µL of 2X SDS-PAGE loading buffer, boiled for 5 min at 100°C.
Samples were separated by SDS-PAGE, and individual bands were excised, reduced with 50
mM TCEP, and alkylated with 100 mM iodoacetamide. Additionally, an extra 1 h incubation
step in a 10 mg/mL sulfo-NHS acetate (Pierce) or 100 mM acetic anhydride was performed
for some fibrinogen samples to achieve extensive acetylation of the reduced protein prior to
digestion. In-gel digestion was performed with 250 ng of sequence-grade trypsin (Princeton
Separations) for 16 h at 37°C. The trypsin reaction was stopped by the addition of 0.1%
TFA in DI water and the peptide solutions were evaporated to dryness in an Eppendorf
Vacuufuge. Dried samples were stored at -20°C until analysis by mass spectrometry. The
percentage of labeled peptide was determined using the SILT-MS software assuming a mass
difference of 8 amu between labeled and unlabeled peptides (Elbert, Mawuenyega et al.
2008). Acetylated peptides were detected assuming mass increases of amu after the reaction.

2.4

Results

2.4.1 Characterization of PET Films
The spin coating of PET layers was initially characterized on silicon wafers.
Ellipsometry showed consistent thicknesses of between 45 and 50 nm across the surfaces of
the silicon wafers (Figure 2.1). XPS analysis verified the composition of these layers (Table
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Figure 2.1: Ellipsometry measurements of polyethylene terephthalate (PET) layer thickness
and uniformity on silicon wafers. PET coatings were applied to surfaces using spin coating,
and ellipsometry was used to determine the layer thickness at 2 mm increments across a
wafer. Error bars represent standard deviations of four samples.
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Table 2.1: XPS analysis of PET coated silicon wafers.
Peak
O
Ti
N
C
S
Si
Cl

Position BE (eV)
530.5
464
397
283
167
100.5
99.5
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Atomic Conc. %
24.80
0.02
0.19
71.48
0.12
3.05
0.00

2.1). Peaks at 283.5 eV for carbon and 530.5 eV for oxygen revealed their respective atomic
compositions to be approximately 71.0% and 24.8%, which corresponded well with the
expected amounts for a PET layer of 72% for carbon and 28% for oxygen. OWLS
waveguide chips were coated using the protocol developed for the silicon wafers and the
changes in thickness were verified by OWLS to be between 50 and 75 nm.

2.4.2 OWLS Analysis of Fibrinogen Adsorption onto PET
A random sequential adsorption model was used to determine the average surface
area of individual bFg molecules on PET-coated OWLS chips at the jamming limit (Table
2.2). Changes in protein surface density over time for the bulk solution concentrations of
0.1, 0.5 and 1 mg/mL were non-linear least-squares fit to equation (3) by adjusting the a/m
and K parameters. Statistically significant differences in surface density were found when
comparing the 1 mg/mL samples to either the 0.5 mg/mL or the 0.1 mg/mL samples. The
0.5 mg/mL and 0.1 mg/mL samples were not significantly different.

2.4.3 MALDI-TOF Sequence Coverage
The bFg peptides identified in the MALDI-TOF spectra of the solution-labeled
samples revealed the sequence coverages of the Aα, Bβ, and γ chains to be 69%, 68%, and
61%, respectively (Figure 2.2). Within these regions, 81 of the 107 lysine locations in bFg
were identified. Due to the lack of lysines present in certain sections (e.g. a 128 amino acid
span between Aα272-400), several large segments of bFg were neither available for MALDITOF detection after trypsin digestion nor accessible for labeling with biotin.
To determine whether the sequences spanned by the recovered peptides included
areas of the protein that were complementary to binding motifs previously studied in human
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Table 2.2: Summary of bFg m/a values estimated from OWLS and AFM experiments.
OWLS analysis of PET coated waveguide chips was performed under flowing bFg solutions
in PBS. A random sequential adsorption model was used to determine the m/a from
measured changes in surface density during the adsorption process. Statistically significant
differences were determined by ANOVA with a Scheffe post-hoc test. OWLS samples that
are significantly different (p-value < 0.05) from the 1 mg/mL samples are marked with an
(*). AFM Calculations were made using fibrinogen volume and height measurements
obtained from Sit et al. (Sit and Marchant 1999).

PET

Bovine
fibrinogen
Concentration
1 mg/ml

PET

0.5 mg/ml

PET
Mica
APTES
OTS

0.1 mg/ml
50 ng/ml
50 ng/ml
50 ng/ml

Instrument Material

OWLS

AFM
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m/a (ng/cm2)
275.48 ± 4.34
*129.68 ±
51.73
*119.63 ±
22.82
162.31 ± 19.28
124 ± 17.96
79.82 ± 13.19

MAC -1 (P2)/ RIBS-I/
GPIIb-IIIa
GPIIb-IIIa
γ370-395
(HHLGGAKQ AGDV)
γ400-411

MAC-1 (P1)
γ190-202

γ Chain
E Domain

D Domain

He parin/C adherin
Bβ21-64

Bβ Chain
D Domain

E Domain
GPIIB-IIIa
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GPIIb-IIIa
(RGDS)
Aα255-258
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E Domain

0

D Domain

100

αC Domain
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300
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500
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Residue Number

Figure 2.2: Sequence coverage obtained for Aα, Bβ, and γ chain in-gel trypsin digests of
biotinylated bFg. Residues that were found in peptides recovered after the trypsin digests
are represented with thick lines, while residues that were not found are represented with thin
lines. Locations of important binding motifs are indicated. Sequence coverages of 69%,
68%, and 61% were obtained for the Aα, Bβ, and γ chains, respectively.
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fibrinogen, the sequences of human and bovine fibrinogen were compared using multiple
sequence alignments with CLUSTAL W. Although only approximately 66% of the entire
bFg molecule was observable by MALDI-TOF, identified regions included several locations
of interest, which are labeled in Figure 2.2. In the Aα chain, an RGDF platelet binding
domain for αIIbβ3 integrins at Aα98-101 was found to be complementary to Aα95-98 in
human fibrinogen and was found in the MALDI-TOF sequence coverage. A region
containing an RGGS motif at Aα541-544 in bFg that was not found in the sequence
coverage had high sequence complementarity to a region in human fibrinogen containing an
RGDS (Aα572-575). An RGDS motif is present in bFg at Aα255-258 and was within the
sequence coverage, but an RGDS is not present in human fibrinogen at the complementary
site. The Bβ chain of human fibrinogen contains domains linked to cadherin binding (Bβ1542) and heparin binding (Bβ15-57), which were respectively located in bFg at Bβ21-49 and
Bβ21-64. Both sequences were identified in bFg by MALDI-TOF after trypsin digestion.
The binding domains of the γ chain are highly conserved between species. The MAC-1
leukocyte binding sites at γ190-202 and γ377-395, the RIBS-I epitope at γ373-385, the αIIbβ3
platelet-binding site within γ370-385, and the platelet-binding dodecapeptide at γ400-411
were in similar locations for human and bovine fibrinogen. The biologically-active γ chain
binding domains were within the sequence coverage except for the MAC-1 leukocyte motif.

2.4.4 PET Particle Fabrication
SEM analysis revealed mostly spherical particles with diameters ranging from 1 - 200
µm that tended to aggregate in PBS solution (Figure 2.3). Higher percentages of spherical
particles were obtained when the surface tension was adjusted with surfactant during
formation, but this step was not performed to eliminate the possibility of unwanted
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a)

b)

15.0 µm

100 µm

Figure 2.3: Scanning electron microscopy (SEM) of fabricated PET particles. (a) An
individual PET particle at 2000x magnification. (b)) SEM image of an aggregate of PET
particles at 300x magnification. Particle sizes ranged from 1 to 200 µm.
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influences of surfactant on protein adsorption. BET analysis determined the surface area of
the particles to be 20.1 ± 2.9 cm2/mg.

2.4.5 Biotinylation of Surface-Adsorbed Fibrinogen
The biotinylation protocol used for labeling and analyzing bFg after adsorption to
PET surfaces is outlined in Figure 2.4. Plastic disposable chromatography columns were
packed with 150 mg of PET particles to provide approximately 3000 cm2 of surface area.
Based on OWLS measurements of adsorbed bFg surface density, this surface area was
estimated to adsorb between 0.3 – 0.9 mg of bFg as the solution concentration increased
from 0.1 mg/mL to 1mg/mL. Decreased reaction between surface-adsorbed bFg and the
biotin label was expected when compared to the reaction of bFg in solution with the biotin
label. Therefore, a 10-fold higher concentration of Sulfo-NHS-LC-Biotin was used for the
surface adsorption experiments to maintain similar levels of biotin labeling between surface
and solution samples (Figure 2.5a). SDS-PAGE of bFg eluted from the PET columns
revealed differences in molecular weights between labeled and unlabeled bFg chains. The
changes in mass of solution-labeled and surface-labeled samples were compared to verify
similar levels of biotin incorporation. The size of each band was determined via the linear
relationship between the mobility of proteins in SDS-PAGE gels and the logarithms of their
molecular weights (Weber and Osborn 1969). Using the molecular weight standards to
produce a standard curve, the Aα, Bβ, and γ chains were found to correlate well with their
expected molecular weights of 63.5 kDa, 56 kDa, and 47 kDa (Fig 5b). The changes in
molecular weight of the bFg chains in the solution-labeled samples corresponded to the
binding of approximately 68.4% ± 17.0%, 53.8% ± 11.0%, and 52.1% ± 17.1% of the
lysines in each respective chain. For the surface-labeled samples, the respective changes in
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Figure 2.4: Workflow diagram for bFg surface adsorption experiments. Diagram is labeled
as follows: (1) Adsorption of bFg onto PET beads packed in a column from 0.1, 0.5, or 1
mg/mL solutions. Each concentration was tested in triplicate, (2) Incubation of adsorbed
bFg with Sulfo-NHS-LC-Biotin for 1 h, (3) Elution of adsorbed bFg with 4% SDS, 100 mM
DTT and 8 M urea elution buffer. Elutions were separated into three samples for separate
trypsin digestion, (4) bFg purification by acetone precipitation, (5) bFg chain separation by
SDS-PAGE, (6) In-gel trypsin digestion, (7) Peptide purification with ZipTips, (8) MALDITOF analysis, (each PET column yielded three separate samples, and bFg Aα, Bβ, and γ
chains were analyzed for each sample), (9) Intensities of peptides containing labeled lysine
residues were averaged across the three separate digests.
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63.5

56

47

64.8 ± 2.9

57.5 ± 3.3

50.9 ± 3.3

9.1 ± 2.3

6.9 ± 1.4

5.3 ± 1.7

9.1 ± 1.7

7.0 ±1.8

4.9 ± 2.2

Figure 2.5: SDS-PAGE gel of bFg before and after reaction with the Sulfo-NHS-LC-Biotin
label. The concentration of the label was adjusted to achieve the same degree of labeling for
both bFg in solution and bFg adsorbed to PET. (a) Aα, Bβ, and γ chains were separated by
SDS-PAGE and stained with SYPRO Ruby stain to compare the increases in molecular
weight due to labeling. Lanes are labeled as follows: Unlabeled bFg in solution (lane 1);
labeled bFg eluted from the surfaces of PET particles after adsorption from 1 mg/mL (lane
2), 0.5 mg/mL (lane 3), and 0.1 mg/mL (lane 4); unlabeled bFg eluted from PET surfaces
(lane 5); and bFg labeled in solution (lane 6). (b) The increases in molecular weight due to
labeling were determined from the changes in migration the distances of the protein bands.
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molecular weight of the Aα, Bβ, and γ chains corresponded to the reaction of approximately
68.7% ± 12.8%, 50.6% ± 14.0%, and 41.6% ± 21.5% of the lysines. An ANOVA revealed
no statistically significant differences in the extent of biotinylation between the solutionlabeled and surface-labeled fibrinogen chains.

2.4.6 Identification of Biotinylated Residues
After excision from SDS-PAGE gels and digestion with trypsin, the labeled and
unlabeled fibrinogen chains were analyzed with MALDI-TOF and fibrinogen peptides were
identified based on the expected molecular weights of tryptic fragments. Figure 2.6
demonstrates the detection of labeled and unlabeled peptides for fibrinogen biotinylated in
solution and fibrinogen biotinylated after adsorption onto a PET surface. Trypsin should
not cleave after lysines that have been labeled, and thus all Sulfo-NHS-LC-Biotin labeled
peptides contained at least one missed cleavage. As a result, the average peptide mass
increased as the number of biotinylated peptides increased, and the majority of labeled
peptides had molecular weights above 2000 Da.
The ability to discern labeled from unlabeled peptides based on peptide molecular
weight was verified with LC-ESI-MS/MS sequence analysis after an in-solution trypsin
digestion. Table 2.3 lists the peptide sequences that were detected and the locations of the
labeled lysines within them. These lysine locations and peptide masses were used to verify
solution-labeled peptides that were identified with MALDI-TOF (Figure 2.7 (
)). A total of
19 of the 81 lysine residues spanned by the MALDI-TOF sequence coverage were identified
as biotin-labeled, and 11 of these lysines were also detected as labeled by LC-ESI-MS/MS.
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Figure 2.6: Centroided MALDI spectra corresponding to bFg trypsin digest fragment
masses from the 0.5 mg/mL adsorption experiments. Open circles indicate the
identification of masses that correspond to unlabeled bFg trypsin fragments. Black squares
mark peaks that match an expected peptide after the Sulfo-NHS-LC-Biotin label was added
to the mass. Spectra are shown for: (a) Unlabeled bFg Aα chain, (b) Aα chain labeled with
biotin, (c) Aα chain labeled with biotin after adsorption onto PET, (d) Unlabeled Bβ chain,
(e) Bβ chain labeled with biotin, (f) Bβ chain labeled with biotin after adsorption onto PET,
(g) Unlabeled γ chain, (h) γ chain labeled with biotin, (i) γ chain labeled with biotin after
adsorption onto PET.
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Table 2.3: Biotin-labeled bFg peptides identified by liquid chromatography electrospray-ionization
ion trap tandem mass spectrometry. bFg was labeled with biotin while in a 0.5 mg/mL solution.
Collision-induced dissociation fragmentation spectra of tryptic bFg peptides were compared to the
predicted spectra of tryptic peptides from a database of 1x106 proteins. Only peptides that matched
bFg peptides with p-values < 1x10-7 were considered significant. Labeled lysine locations are
displayed in lowercase italics.
Peptide Sequence
Lysine Location
MkGLIDEVDQDFTSR
Aα55
GDFAkANNNDNTFK
Aα103
ANNNDNTFkQISEDLR
Aα112
kVIEQVQR
Aα128
LEVDIDIkIR
Aα160
ALEHkVDLEDYK
Aα175
NQQkQLEQVIAINLLPSR
Aα186
EFkSQLQEAPLEWK
Aα222
ALLEMQQTkMVLETFGGDGHAR
Aα242
SCSkVITkTVTNADGR
Aα438
VITkTVTNADGR
Aα442
TETTkEVVK
Aα455
DkDDFFTR
Aα491
kPPDADGCLHADPDLGVLCPTGCK
Bβ65
kSIEDLR
Bβ102
VYCDMkTEK
Bβ250
VYCDMkTEkGGWTVIQNR
Bβ250, Bβ253
TEkGGWTVIQNR
Bβ253
QGFGNIATNAEGkK
Bβ290
ISQLTNMGPTkLLIEMEDWK
Bβ316
DNDGWkTTDPR
Bβ393
kQCSkEDGGGWWYNR
Bβ399, Bβ403
NSkSMMEEIMK
γ87
DkVVQLEANCQEPCQDTVkIHDVTGR
γ127, γ144
DCQDVANkGAK
γ159
LDGSLDFkK
γ205
LAIGEGQQHQLGGAkQAGDV
γ406
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Mol. Wt. (Da) p-value of match
2093.63
1x10-15
1895.43
2.45x10-12
2218.23
6.66x10-11
1339.54
2.32x10-09
1554.08
8.49x10-12
1799.48
4.14x10-12
2432.49
2.6x10-14
2072.62
1.21x10-12
2772.7
1.98x10-10
2415.95
6.73x10-10
1614.47
2.21x10-12
1374.64
2.69x10-09
1383.43
5.06x10-09
2933.07
1.91x10-11
1200.23
5.38x10-10
1513.58
6.69x10-11
2865.09
3.8x10-09
1727.93
7.66x10-13
1774.73
4.34x10-08
2687.71
3.64x10-13
1644.27
4.96x10-11
2550.37
5.22x10-15
1667.27
3.57x10-11
3719.16
1.62x10-08
1544.92
8.48x10-13
1362.57
2.57x10-10
2316.76
3.77x10-09
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112 160 186 242 412 442 524 566

Aα Chain Lysine Residues
-------------------GPRLVERQQSACKET
GWPFCSDEDWNTKCPSGCRMKGLIDEV
DQDFTSRINKLRDSLFNYQKNSKDSNTL
TKNIVELMR-----ANNNDNTFKQINEDL
RSRIEILRRKVIEQVQRINLLQKNVRDQ
LVDMKRLEVDIDIKIRSCKGSCSRALEH
KVDLEDYKNQQKQLEQVIAINLLPSRDI
QYLPILKMSTITGPVPR---SQLQEAPLE
WKALLEMQQTKMVLETFGGDGHARGD
SVSQGTGLAPGSPR--------------------------------------------------------------------------------------------------------------------EEGSVSSGTKQEFHTGKLVT
TKGDKELLIDNEKVTSGHTTTTRRSCSK
VITKTVTNADGRTETTKEVVKSEDGSD
CGDADFDWHHTFPSRGNLDDFFHRDKD
DFFTRSSHEFDGRTGLAPEFAALGESGS
SSSK------QFVSSSTTVNR-----------ME
DEAESLEDLGFKGAHGTQKGHTK------------------

15

60

102 165 216 253 291 344 399 456

Bβ Chain Lysine Residues
---------------------GHRPYDKKKEEAP
SLRPVPPPISGGGYRARPATATVGQKK
VER------------------------LQDTLVRQ
ERPIRKSIEDLRNTVDSVSRTSSSTFQY
ITLLKNMWKGRQNQVQDNENVVNEYS
SHLEKHQLYIDETVKNNIPTKLRVLRSI
LENLRSKIQKLESDVSTQMEYCRTPCT
VTCNIPVVSGKECEKIIR--------------------VYCDMKTEKGGWTVIQNRQDGS
VDFGRKWDPYKQGFGNIATNAEGKKY
CGVPGEYWLGNDR----------------------VTALYEGFTVQNEANKYQLSVSK-----------------------------------DNDGWK
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Figure 2.7: Normalized MALDI-TOF spectral peaks corresponding to biotinylated lysine
residues within bFg Aα, Bβ, and γ chains, labeled while in a 0.5 mg/mL solution. A
cumulative sum of the intensities of all the labeled peptides that contained the listed lysine
residues was determined, normalized relative to the highest intensity obtained, and averaged
across three separate experiments. Error bars represent one standard deviation. Peaks that
were also found to be labeled by the more accurate LC-ESI-MS/MS sequence analysis are
marked with a (). The MALDI-TOF sequence coverages for each chain are displayed
below each graph. Labeled lysine locations are in italics.
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The lysine residues that were labeled after bFg was adsorbed onto PET from 1, 0.5,
and 0.1 mg/mL solutions are displayed in Figure 2.8. The exposure of lysine residues was
higher for the 0.5 mg/mL and 0.1 mg/mL samples when compared to the 1 mg/mL
samples. Both the degree of label incorporation and the surface coverage of the MALDITOF spectra increased after adsorption onto PET (Table 2.4). A statistical comparison
between solution-labeled and the 1 mg/mL surface-labeled samples revealed a significant
decrease in the relative intensity of Aα128 and a significant increase in exposure of Aα438
and Aα442 following adsorption. Several biotin-labeled locations found for the 1 mg/mL
surface sample were within the sequence coverage of the solution-labeled samples, yet were
not found labeled in solution. Overall, 7 labeled lysines were found in the Aα chain only in
the adsorbed protein, along with 10 in the Bβ chain, and 9 in the γ chain. Two of theses
residues were Bβ60, which is located within a heparin/cadherin binding domain, and γ196,
which is located within a MAC-1 binding motif.
After adsorption from 0.5 mg/mL solutions, there were 17 biotinylated locations
each in the Aα and γ chains and 21 locations in the Bβ chain that were within the sequence
coverage of the solution samples, but were not labeled while in solution. When the 0.5
mg/mL samples were compared to the solution samples, statistically significant decreases in
intensity were found for Aα55, Aα71, Aα128 and Aα165, while Aα141 increased in intensity.
In addition to Bβ60 and γ196, a multitude of previously inaccessible lysine residues were
found labeled, including γ380, γ381, γ385, and γ406 which all contained binding motifs
essential for platelet adhesion.
For adsorption from 0.1 mg/mL solutions, statistically significant decreases in lysine
exposure were seen for Aα71, and Aα128, and an increase in ranked intensity was observed
for Aα141. As seen in the 0.5 mg/mL samples, previously inaccessible locations were
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Figure 2.8: Normalized MALDI-TOF spectral peak intensities of lysine residues within bFg Aα, Bβ,
and γ chains that were biotinylated after adsorption to a PET surface from 1, 0.5 and 0.1 mg/mL
solutions. Error bars represent one standard deviation. Locations that were labeled both in solution
and after adsorption to a PET surface are represented by grey bars. Locations that were labeled only
after adsorption to a PET surface are represented by black bars. Pairwise Mann-Whitney comparisons
were used to determine statistically significant differences in intensity (p-value <0.05) between
solution-labeled samples and surface-labeled samples (*) and between the high concentration (1
mg/mL) surface-labeled samples and the low concentration (0.5 mg/mL, 0.1 mg/mL) surface-labeled
samples (†).
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Table 2.4: Sequence coverage and percentage of labeled lysines observed after MALDITOF analysis of tryptic bFg peptides. Peptides originated from bFg that was labeled with
Sulfo-NHS-LC-Biotin while in solution or after adsorption onto PET from different
solution concentrations.
Sequence
Coverage
Solution
1 mg/mL
0.5 mg/mL
0.1 mg/mL

66%
74%
89%
84%

Lysines
Labeled in
Aα Chain
28%
51%
77%
69%
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Lysines
Labeled in
Bβ Chain
13%
39%
92%
84%

Lysines
Labeled in γ
Chain
10%
53%
93%
50%

labeled in all three chains, with notable exposures of γ380, γ381, and γ385. Increased
labeling in the Aα chain was mainly localized at the carboxyl terminus, while residues
throughout the Bβ chain increased in exposure. Within these locations, a total of 12 residues
in the Aα chain, 18 in the Bβ chain, and 9 in the γ chain were found to have reacted with
biotin exclusively in the surface-labeled samples.
Protein visualization software was utilized to display the three-dimensional locations
of biotinylation sites (Figure 2.9). Lysines labeled while in solution were found primarily
within the coiled coils of the Aα chain and the globular domains of the Bβ and γ chains.
Several locations in the αC domain and in the coiled coil regions of the Bβ chain were biotin
labeled as well, but these residues were not present in the bFg crystal structure. After
adsorption, lysines throughout both the globular and coiled regions of the Bβ and γ chains
were labeled, including several locations within the protein interior that are not normally
solution-exposed.

2.4.7 Quantification of Complement C3, α2-Macroglobulin, and
Fibrinogen
To test the quantitative ability of our SILT-MS technique, we cultured HepG2 cells
in lysine-free, serum free-media to which we added either carbon-13 labeled lysine or
standard carbon-12 lysine. The initial protocol used HepG2 media consisting of lysine-free
DMEM containing 10% FCS, 1 uM all-trans retinoic acid, and 105 ug/mL.

13

C6,15N2-

fibrinogen expression was unaffected under these culture conditions and was improved by
the addition of aprotinin to the culture media. ELISA results demonstrated 13C6,15N2fibrinogen concentrations after two days of incubation during which cells typically grew
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Figure 2.9: 3D image of bFg displaying the locations of labeled lysines after adsorption to a
PET surface from a 0.1 mg/mL solution. The image is labeled as follows: Aα chain, red; Bβ
chain, blue; γ chain, green; residues not included in sequence coverage, black; labeled lysine
residues, yellow spheres; lysine residues with statistically significant changes in relative
intensity after adsorption to PET surface, orange spheres. Image was generated using the
bFg PDB file 1DEQ and Visual Molecular Dynamics version 1.8.3.

66

from 50-75% confluency to be 0.8+/- 0.6 ug/mL, 5.1+/- 3.1 ug/mL, and 10.8 +/- 7.5
ug/mL respectively for lysine-free MEM with 10% FCS, serum free media with all-trans
retinoic acid, and serum free media with all-trans retinoic acid and aprotinin. These levels of
13

C6,15N2-fibrinogen were too low for SDS-PAGE isolation, and fibrinogen was thus

immunoprecipitated with CNBr sepharose beads with conjugated anti-human fibrinogen
IgG.
Complement C3 and α2-macroglobulin were expressed at much higher levels than
fibrinogen and were purified solely through SDS-PAGE. This allowed concentrated stocks
of media to be directly stored and to serve as internal standards for these proteins.

13

C6,15N2-

fibrinogen stored in the nonreducing SDS-PAGE buffer used for elution from CNBr resin
served as the labeled fibrinogen stocks. Bands corresponding to 13C6,15N2-lyisine-labeled and
unlabeled complement C3 and α2-macroglobulin were excised from SDS-PAGE gels after
separation from other media proteins under reducing conditions (Fig 10). Fibrinogen bands
were excised after separation under nonreducing conditions, which allowed better
purification from small amounts of IgG that coeluted from the CNBr resin (Fig 11).
The protocol for quantifying proteins using isopically labeled HepG2 protein internal
standards is outlined in Figure 2.12. For quantification of complement C3 and α2macroglobulin, small aliquots of labeled and unlabeled stocks were mixed at varios ratios and
separated using SDS-PAGE. Quantification via fibrinogen internal standards was tested by
adding known amounts of unlabeled commercially available fibrinogen to aliquots of the
13

C6,15N2-fibrinogen stock prior to separation by SDS-PAGE. After LC-ESI-MS/MS

analysis of excised and digested bands, 13C6,15N2-lyisine-labeled and acetylated fibrinogen
peptides corresponding to the fibrinogen gamma chain peptide were detectible (Figure 2.13
& 2.14). Standard curves for complement C3, α2-macroglobulin, and 13C6,15N2-fibrinogen
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Figure 2.10: SDS-PAGE gel displaying proteins expressed by HepG2 cells grown in serumfree media. HepG2 cells were grown in lysine-free MEM supplemented with 10% dialyzed
FCS and 1 uM all-trans retinoic acid. After reaching 50%-60% confluency, the media was
replace with lysine-free MEM containing primary hepatocyte growth supplements (Lonza),
105 ug/mL L-lysine-13C6,15N2 hydrochloride, 1uM all-trans retinoic acid, and 1 ug/mL
aprotinin. Media was collected every 2 days and concentrated with 10K MWCO centrifuge
filters prior to protein separation with SDS-PAGE. Marked bands were analyzed for
identity and carbon-13 incorporation using ion-trap mass spectrometry. [A] Molecular
weight marker, [B] control containing 5 ug of hFg under reducing conditions, [C] 10 ug of
HepG2 media proteins, [a] alpha-2 macroglobulin (100% labeled), [b] complement C3
(100% labeled), [c] inter-alpha-trypsin inhibitor (100% labeled), [d] bovine serum albumin
(0% labeled), [e] heat shock protein hsp84 (100% labeled), [f] transferrin (0% labeled), [g]
alpha-1-antitrypsin (100% labeled).
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Figure 2.11: SDS-PAGE gel demonstrating the purification of carbon-13 labeled hFg from
HepG2 media by immunoprecipitation. [A] Molecular weight marker, [B] control containing
5 ug each of hFg and bovine serum albumin under nonreducing conditions, [C] elution of
hFg from CNBr IgG beads with SDS-PAGE sample buffer under reducing conditions, [D]
elution of hFg from CNBr IgG beads with 5mM EDTA under nonreducing conditions.
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Figure 2.12: Workflow diagram for fibrinogen peptide quantification using 13C6,15N2labeled fibrinogen internal standards. Diagram is labeled as follows: (1) Culture of HepG2
cells in serum-free
free medium supplemented with L
L-lysine-13C6,15N2 hydrochloride, all-trans
all
retinoic acid, and aprotinin. (2) Immunoprecipitation, (3)) Spiking of unlabeled fibrinogen
sample with internal standard of known concentration, (4) SDS-PAGE
PAGE and trypsin digestion
diges
of fibrinogen bands, (5)) Liquid chromatography followed by mass spectrometry to generate
parent ions, (6)) Collision induced dissociation of selected peptides and corresponding
13
C6,15N2-labeled variants, ((7) Analysis of tandem ions by SILT-MS for sequencing and
quantification.
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Figure 2.13: Tandem spectra of unlabeled ((top) and 13C6,15N2-labeled (bottom
bottom) fibrinogen
gamma chain dodecaptide. The amino
amino-terminal
terminal amino acid of the fibrinogen dodecapeptide
is a lysine, and thus all y-ions
ions (underline
(underlined)
d) of the peptide increased in mass by 8 amu.
Doubly charged ions increased in mass by 4 amu. Arrows point from the unlabeled
dodecapeptide y-ions
ions the corresponding 13C6,15N2-labeled
labeled dodecapeptide ions.
ion Spectra was
generated by the SILT-MS
MS software pa
package.
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Figure 2.14: Tandem spectra of untagged ((top) and acetylated (bottom)) fibrinogen gamma
chain dodecaptide. The amino
amino-terminal
terminal amino acid of the fibrinogen dodecapeptide is a
lysine, and thus all y-ions
ions (underlined) of the peptide increased in mass by 42 amu after
reaction with sulfo-NHS-acetate.
acetate. Doubly charged ions increased in mass by 21 amu.
Arrows point from the untagged dodecapeptide yy-ions
ions to the corresponding acetylated
dodecapeptide ions.. Spectra was generated by the SILT
SILT-MS softwaree package.
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Figure 2.15: Standard curves for isotopically labeled HepG2 proteins generated using SILTSILT
MS. An experimental protocol similar to SILAC was followed using proteins secreted by
HepG2 cells, mixing a 13C6,15N2-labeled -labeled
labeled protein with an unlabeled protein
p
in
different ratios. Complement C3 ((a) and alpha-2 macroglobulin (b) are secreted in large
amounts by HepG2 cells and are readily purified using SDS
SDS-PAGE
PAGE alone. Fibrinogen (c)
was purified by immunoprec
immunoprecipitation.
ipitation. HepG2 cells were incubated with unlabeled medium
or medium containing 13C6,15N2-lysine.
lysine. Cell lysates were mixed and purified by SDS-PAGE.
SDS
13
C6,15N2-fibrinogen
fibrinogen was mixed with unlabeled commercially available fibrinogen at different
ratios prior to SDS-PAGE.
PAGE. The bands were excised and analyzed by data dependent mass
spectrometry. Error bars (standard deviations) are present on all datapoints, with n = 3.
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were generated by comparing the known ratios of labeled and unlabeled protein with the
measured ratios as determined by the SILT-MS software (Figure 2.15) (Elbert, Mawuenyega
et al. 2008). Relative errors ranged from 2.9%- 9.5%, and the linear fit of the standard curve
had a slope of 0.988 and an R2 value of 0.986.

2.5

Discussion
Conformational changes can occur in proteins after adsorption to biomaterial

surfaces. These changes can influence protein surface coverage with time and expose
binding sites that are responsible for eliciting biological responses (Zucker and Vroman
1969; Mohammad, Hardison et al. 1974; Kottke-Marchant, Anderson et al. 1987; Anderson,
Bonfield et al. 1990; Shen and Horbett 2001). Since fibrinogen adsorbed on biomaterials
directs numerous cellular and thrombotic responses (Weisel 2005), a better understanding of
fibrinogen conformational changes at the molecular level may provide information useful in
the development of devices with enhanced biocompatibility. We are developing methods to
allow a more complete analysis of the fibrinogen structure-function relationship at
solid/liquid interfaces by using mass spectrometric mapping to probe changes in the
exposure of individual residues. These methods may be beneficial for studying
conformation changes in proteins adsorbed from complex mixtures, such as blood or
plasma.
Prior to performing the chemical labeling experiments, we used optical waveguide
lightmode spectroscopy (OWLS) to measure the extent of bFg spreading on PET as a
function of solution protein concentration. OWLS has the ability to measure the surface
density of protein layers in situ with a 30 s time-step, which permits the determination of
parameters in kinetic models of molecular interactions with surfaces (Ramsden 1993; Voros,
74

Ramsden et al. 2002). Since our interest lies in the interactions of proteins at the solid/liquid
interface between blood and biomaterial surfaces, we modified the surfaces of OWLS
waveguide chips by spin coating to study the frequently used biomaterial PET.
OWLS results for bFg adsorbed onto PET demonstrated the post-adsorptive
spreading of the protein in a concentration-dependent manner, consistent with previous
results on other surfaces (Ramsden 1993; Wertz and Santore 1999). During protein
adsorption, the rate of protein unfolding appears to be on the order of the time required to
approach the RSA jamming limit on surfaces (Ramsden 1993). Proteins thus will not have
adequate time to reach their maximum spread area when adsorbed from highly-concentrated
solutions, due to the filling of adjacent spaces required for major conformational changes
(Schaaf and Talbot 1989). Statistical analysis of OWLS results showed that the 0.5 and 0.1
mg/mL samples were not different from each other, while both were significantly different
from the 1 mg/mL samples. The RSA model does not account for the kinetics of spreading,
diffusion or hydrodynamic effects on the adsorption process. However, diffusion and
hydrodynamic influences have been shown to be counteractive (Bafaluy, Senger et al. 1993).
A model that incorporates multiple states of protein denaturation may improve the
measurement of protein unfolding kinetics on surfaces, but would require the curve-fitting
of additional parameters to the OWLS surface density measurements, which may introduce
additional inaccuracies.
Atomic force microscopy (AFM) has previously provided a detailed picture of
fibrinogen’s post-adsorptive conformations. We compared our OWLS results with
published AFM experiments, estimating fibrinogen m/a values from reported volume
measurements (Sit and Marchant 1999) (Table 2.2). The m/a estimates were calculated based
on dimensions of fibrinogen obtained by Sit et al, who used AFM to study the structure of
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fibrinogen adsorbed onto hydrophobic (octadecyltrichlorosilane, OTS), negatively charged
(mica), and positively charged (3-aminopropyltriethoxysilane, APTES) surfaces. Their
results were obtained under experimental conditions that differed from ours, allowing
spreading to occur only over a 1 h period, while our studies allowed 4 h of spreading. We
monitored adsorption only on PET, a surface with a higher surface energy than OTS and
lower surface energy than mica and APTES (Baier, Shafrin et al. 1968). Moreover, Sit et al.
used a much lower fibrinogen concentration (50 ng/mL), so that the jamming limit would
not be reached. The OTS surface resulted in a lower m/a in the AFM experiments than the
PET used in our OWLS experiments, which was expected due to the higher surface energy
of PET and the more concentrated fibrinogen solutions that we tested. PET in the presence
of 0.5 and 0.1 mg/mL fibrinogen solutions showed larger spread areas than the hydrophilic
mica surfaces exposed to a 50 ng/mL bulk concentration. Wertz et al. showed that the
majority of post-adsorptive conformational changes occurred within the first 15 minutes
after adsorption (Wertz and Santore 1999), and thus the measurements of Sit et al. may
represent the maximum obtainable surface coverage for individual fibrinogen molecules on
the surfaces tested. Assuming that bFg has a rod-shaped geometry with dimensions of 6.0 x
6.0 x 45 nm, the theoretical unspread end-on and side-on close packing densities for
adsorbed bFg at complete surface coverage are 1.57 and 0.21 µg/cm2 (Lassen and Malmsten
1996). Thus, even at the highest concentration tested, bFg adsorption levels were in the
vicinity of a side-on molecular packing arrangement. These adsorption densities were even
lower than the 0.4 – 0.5 µg/cm2 achieved on low energy methylated surfaces (Wojciechowski
and Brash 1993; Malmsten 1994; Lassen and Malmsten 1996), which may reflect extensive
spreading of fibrinogen on the PET surface.
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Our OWLS experiments revealed increases in the average area per bFg molecule as
the solution concentration decreased from 1 mg/mL to 0.1 mg/mL, indicating that different
degrees of conformational change occurred between these concentrations. By proteomic
methods, we were then able to determine the specific residues within bFg that were
susceptible to biotinylation after adsorption to the surfaces of PET particles. These small
PET particles were fabricated with high surface areas using emulsion chemistry to increase
the amount of adsorbed protein for the labeling experiments. Our hypothesis was that if a
predisposition existed for certain biologically active domains within bFg to be exposed upon
adsorption, then lysine residues found near these sites would have a higher tendency to react
with the chemical label and could be detected by changes in MALDI-TOF peak intensities.
Based on the OWLS results, we expected to observe differences in labeling between higher
concentration, 1 mg/mL, and lower concentration, 0.5 and 0.1 mg/mL, samples. While only
a few statistically significant changes in intensities were found, large differences in the
number of biotin labeled lysines were observed. These qualitative results suggest that
conformational changes influenced by the energetically more favorable interactions of
hydrophilic residues with the solution over the PET surface may be driving the exposure of
biologically active motifs. This is evidenced by the drastic increase in accessibility of lysines
within the highly interspecies conserved γ chain, which coincides with the exposure of
several cell interaction motifs essential to thrombosis and inflammation. Overall, our results
are consistent with previous experiments examining the interactions of proteins with low
energy surfaces, but at a higher level of resolution and revealing additional complexity.
Although SDS-PAGE showed equivalent increases in molecular weight between
solution-labeled and surface-labeled samples, mass spectrometric analysis may have revealed
considerable differences in the distribution of the label throughout the bFg molecule.
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MALDI-TOF has a strong bias for higher concentration peptides (Knochenmuss, Stortelder
et al. 2000), and, consequently, many solution-labeled peptides originating from stericallyhindered locations may have been overshadowed by highly labeled locations. However, the
non-linear nature of MALDI-TOF intensity may have amplified the differences in labeling
between solution and surface biotinylated samples. LC-ESI-MS/MS demonstrated the
presence of several labeled peptides that were never detected in the MALDI-TOF spectra of
solution-labeled samples. More quantitative mass spectrometric methods will be required to
definitively show that such differences between surface and solution labeled fibrinogen exist.
Increases in lysine exposure within the Aα chain appeared to occur most
prominently in the αC domain. Previous immunochemical studies of the human fibrinogen
Aα chain performed by Cierniewski et al. revealed that in solution, the majority of the
immunogenic surface resided between Aα1-238, with moderate immunogenicity between
239-476 and minimal antibody binding at the C-terminus between Aα518-584 (Cierniewski,
Plow et al. 1984). Since the inaccessible areas of the αC domain were readily bound by
antibody after plasmin cleavage, they concluded that this region was integrated into the
native fibrinogen molecule in a manner that influenced epitope exposure. Mass
spectrometric mapping of the bFg Aα chain displayed similar distributions of accessibility to
the biotin label. Of the 11 lysines biotinylated to a high degree in the Aα chain, only one
location was found labeled near the carboxyl terminus in the solution-labeled samples. The
surface-labeled samples showed that post-adsorptive conformational changes readily
exposed these minimally accessible carboxyl-terminal domains, possibly due to decreased
interaction between the αC domain and the E domain.
Binding of an antibody that recognizes human Aα572-575 has been correlated with
platelet adhesion to adsorbed human fibrinogen (Tsai and Horbett 1999). A region within
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the bFg αC domain containing an RGGS site (Aα541-544) has high sequence homology with
a region in the human fibrinogen sequence that contains an RGDS motif (Aα572-575). A
lysine (Aα549) near this site was shown to increase in exposure after adsorption to PET
from the lower concentration solutions. Similarly, a lysine (Aα103) in close proximity to the
Aα98-101 RGDF site in the bovine fibrinogen, which is synonymous to RGDF Aα95-98 in
human fibrinogen, was found to increase in exposure upon adsorption to PET as the
solution concentration decreased. While biotinylated Aα103 was detected in the LC-ESIMS/MS analysis of solution-labeled samples, Aα549 was only found to be biotinylated in the
surface-labeled samples by MALDI-TOF.
Although similar percentages of labeled lysines was found in the γ chain when
comparing the high concentration and low concentration adsorption experiments (Table
2.4), the labeling in the low concentration samples shifted towards the carboxyl terminus. In
the 0.5 and the 0.1 mg/mL samples, residues were labeled within the sequence γ370-383,
which has been shown to have an essential role in platelet adhesion (Podolnikova,
Yakubenko et al. 2003). Sites located in the γ377-395 sequence, thought to bind the
αMβ2/Mac-1 leukocyte integrin and participate in inflammation, were also found labeled
(Flick, Du et al. 2004). LC-ESI-MS/MS analysis revealed that γ406 within the platelet
adhesion dodecapeptide (400-411) was accessible while in solution. This lysine was not
found labeled in MALDI-TOF analysis of solution samples nor the 1 and 0.1 mg/mL
surface-labeled samples. However, this residue was detected as labeled after adsorption to
PET from the 0.5 mg/mL solutions (Bennett 2001). These results suggest that the peptide
containing this lysine either does not ionize well in MALDI-TOF or is present at very low
amounts.
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It has been shown that nonactivated platelets bind less to human fibrinogen
fragments containing only γ400-411, only Aα95-98, or without Aα572-575 (Savage and
Ruggeri 1991). These previous findings are supported by our data that suggest a postadsorptive exposure of the locations in bFg that are synonymous to these platelet binding
human fibrinogen sites. Furthermore, a lysine near the bovine complement to Aα572-575 in
human fibrinogen was only found exposed after adsorption, while a lysine near the bovine
complement to Aα95-98 in human fibrinogen was accessible both in solution and on the
surface. Thus our data also supports previously performed experiments that suggest that
Aα572-575 may be more specific to post-adsorptive platelet binding than Aα95-98.
MALDI-TOF was selected for our initial mass spectrometric mapping experiments
because of the quickness and ease of sample preparation and analysis. Unlike MALDI-TOF,
more sensitive electrospray ion-trap and Fourier transform mass spectrometry can take
advantage of quantitative techniques such as SILAC or ITRAQ, as well as provide more
reliable peptide identification by MS2. With mass spectrometry coupled to liquid
chromatography, adsorption from multicomponent protein solutions or even whole blood
could potentially be analyzed, which would have novel applications in the study of postadsorptive processes such as the Vroman effect (Vroman and Adams 1969; Slack and
Horbett 1989). Since the majority of the highest concentration plasma proteins are
produced in the liver, we developed a metabolic labeling strategy to express 13C6,15N2-lyisinelabeled fibrinogen from HepG2 cells. HepG2 cells express a variety of proteins other than
fibrinogen that participate in coagulation and innate immunity, including α2-macroglobulin,
fibronectin, and complement C3 (Knowles, Howe et al. 1980; Borth 1992). We thought that
it would be advantageous to use proteomic methods to isolate these proteins as well, without
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the need for immunoprecipitation. Thus we developed a protocol for culturing HepG2 cells
in serum-free media to minimize albumin interference during protein purification.
SILAC-based strategies typically quantify protein by comparing the ratios of the parent
ions of isotopically labeled and unlabeled protein (Ong, Blagoev et al. 2002). Experiments
are simultaneously performed on cells cultured in media with and without isotopically
labeled amino acids and specific proteins are immunoprecipitated from each culture for
comparison. Here, we have demonstrated that stocks of internal standards can be stored
and utilized for the repeated and accurate quantification of multiple proteins within
individual samples purified either with immunoprecipitation or SDS-PAGE. From a
multicomponent protein sample, we were able to excise and quantify individual protein
brands containing less than 1 µg of protein after separation by electrophoresis. Considering
the microgram levels of protein that were eluted previously from the PET beads, this
method may be quite useful in the quantification of proteins within adsorbed protein layers.
The SILT-MS software also permitted the identification of acetylated locations within the
gamma chain dodecapeptide of fibrinogen, suggesting that this method may also be useful to
probe the exposure of fibrinogen cell-adhesion motifs.

2.5

Conclusion
In summary, we have applied OWLS and mass spectrometric mapping in the study of proteins

at solid/liquid interfaces. We have shown that OWLS waveguide chips can be coated with PET and
that substantial differences in protein spread area are found between bFg adsorbed at 1 and 0.1
mg/mL. Using chemical labeling and proteomic methods, we compared the differences in exposure
of lysines between bFg in solution and bFg adsorbed to PET. Our results suggested extensive
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conformational changes in all three chains and specific increases in the exposure of biologically
relevant residues in the Aα and γ chains during the unfolding process on PET.
Based on these results, we pursued a more quantitative adaptation of this methodology by
expressing isotopically labeled fibrinogen from HepG2 cells. The inclusion of aprotinin and all-trans
retinoic acid was found to more than double fibrinogen expression. While immunoprecipitation was
still required to purify labeled fibrinogen internal standards, the HepG2 media itself proved to be a
suitable stock of internal standards for quantification of both complement C3 and α2-macroglobulin.
The SILT-MS software package was able to both identify the locations of the 13C6,15N2-lyisine-labels as
well as sites of acetylation within proteins. Together, these results suggest that with further
development, it may be possible to simultaneously monitor the conformation and abundance of
individual proteins within adsorbed protein layers on material surfaces.
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CHAPTER 3†
Protein Adsorption and Cell Adhesion on
Nanoscale Bioactive Coatings Formed from
Poly(Ethylene Glycol) and Albumin Microgels
3.1

Abstract
Late-term thrombosis on drug-eluting stents is an emerging problem that might be

addressed using extremely thin, biologically-active hydrogel coatings. We report a dipcoating strategy to covalently link poly(ethylene glycol) (PEG) to substrates, producing
coatings with <≈100 nm thickness. Gelation of PEG-octavinylsulfone with amines in either
bovine serum albumin (BSA) or PEG-octaamine was monitored by dynamic light scattering
(DLS), revealing the presence of microgels before macrogelation. NMR suggested extremely
high end-group conversions prior to macrogelation, which was supported by gel permeation
chromatography (GPC) results that revealed that only 12% of the monomer remained
unreacted after approximately 90% of the gelation time had passed. Before macrogelation,
the reacting solutions were diluted and incubated with nucleophile-functionalized surfaces.
Using optical waveguide lightmode spectroscopy (OWLS) and quartz crystal microbalance
with dissipation (QCM-D), we identified a highly hydrated, protein-resistant layer with a
thickness of approximately 75 nm. Atomic force microscopy in buffered water revealed the
presence of coalesced spheres of various sizes but with diameters less than about 100 nm.
Microgel-coated glass or poly(ethylene terephthalate) exhibited reduced protein adsorption
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and cell adhesion. Cellular interactions with the surface could be controlled by using
different proteins to cap unreacted vinylsulfone groups within the coating.

3.2

Introduction
Thin hydrogel coatings may prove to be useful for reducing coagulation and

thrombosis on blood-contacting devices with complex geometries, such as endovascular
stents. However, the density of poly(ethylene glycol) (PEG) in the coating must be quite
high to achieve a substantial reduction in protein adsorption (Jeon, Lee et al. 1991; Elbert
and Hubbell 1996). We have found that single layers or even multiple layers of PEG coated
on a surface do not provide the required cell adhesion resistance for long-term effectiveness
(Kim, Wacker et al. 2007). This suggested to us that the use of relatively large aggregates
containing high densities of PEG to form the thin coatings may ensure adequate surface
coverage even with a limited number of attachment sites on the material.
Microgels have been used extensively to produce or enhance surface coatings (e.g.
latex paints) (Funke, Okay et al. 1998). The definition of microgel by IUPAC has evolved
from “a network of microscopic dimensions”(Metanomski 1991) to the more recent
recommendation: “particle of gel of any shape with an equivalent diameter of approximately
0.1 to 100 µm” (Aleman, Chadwick et al. 2007). ‘Nanogel’ is now “a gel with an equivalent
diameter in the range of 1-100 nm”. For simplicity, microgel will herein refer to both the
nano- and microscale regimes. Microgels can be readily produced by emulsion
polymerization, in which macrogel formation is hindered by the segregation of initiator,
monomer and/or polymer in the heterogeneous solution (Smith and Ewart 1948; Baker
1949; Funke, Okay et al. 1998). However, many examples exist in which microgels form in
homogenous solutions. For example, polymerization of N-isopropylacrylamide in water at
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high temperatures leads to microgel formation due to precipitation (Gan and Lyon 2002;
Nolan, Reyes et al. 2005; Singh, Bridges et al. 2007). Other examples exist where microgels
form during polymerization, likely due to steric or electrostatic stabilization rather than
precipitation (Graham and Mao 1996; Graham, Mao et al. 1996; Graham and Cameron 1998;
de Groot, Zurutuza et al. 2001). By manipulating solvent quality, some systems can produce
stable microgels without gelation even after complete reaction of end-groups (Graham and
Cameron 1998).
Using PEG-octavinylsulfone (PEG-OVS) and either bovine serum albumin (BSA) or
PEG-octaamine (PEG-OA) as crosslinkers, we found evidence for substantial microgel
formation before macrogelation. The reaction between amines and vinylsulfones is
somewhat sluggish, allowing us to maintain a well-mixed system with reproducible sizes of
microgels observed by dynamic light scattering (DLS). The crosslinking reaction could be
further slowed by dilution or freezing. Taking advantage of the higher reactivity of
vinylsulfones with thiols, the crosslinking-solutions containing PEG microgels could be
reacted with thiol-functionalized surfaces without macrogelation. Optical waveguide
lightmode spectroscopy (OWLS) and quartz crystal microbalance with dissipation (QCM-D)
measurements demonstrated the presence of thin hydrogel layers that were extremely
resistant to fibrinogen adsorption. A single incubation of the surface with a microgel
solution reduced non-specific cell adhesion to an extent that was much greater than 20 layers
of PEG applied via a covalent layer-by-layer method (Kim, Wacker et al. 2007). Overall, the
resistance to cell adhesion indicates that partially crosslinked multi-arm PEG may be useful
in producing thin, but dense, PEG films on a variety of surfaces.
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3.3

Materials and Methods

3.3.1 Synthesis of Poly(ethylene glycol) Vinylsulfone
Poly(ethylene glycol) vinylsulfone (PEG-OVS) was synthesized from PEG-OH using
a variation of a previously described synthesis (Morpurgo, Veronese et al. 1996). The fourstep synthesis began with the preparation of a PEG mesylate. A 10% (w/v) solution of 8arm PEG MW 10,000 was obtained in toluene. The solution was dried by azeotropic
distillation and after cooling to room temperature, dichloromethane was added to 20%
(v/v). Methane sulfonyl chloride (4 equiv.) and triethylamine (4 equiv.) were added after
cooling in an ice bath while stirring. After 24 hours, the cloudy white product was filtered
using a vacuum flask and filter paper to remove the almost completely clear and transparent
PEG solution from the solid salt byproduct. The solution volume was then reduced to
approximately 20 ml with a roto-evaporator and the polymer was precipitated with the
addition of dry diethyl ether after cooling to near 0°C. The final PEG mesylate product was
dried overnight in vacuo. The mesylate was then dissolved at 10% (w/v) in deionized (DI)
water after which 1M NaOH solution (4 equiv.) and β-mercaptoethanol (4 equiv.) were
added. The reaction was carried out at reflux for 3 hours while stirring. The product was
cooled in an ice bath and extracted twice with dichloromethane and dried over anhydrous
sodium sulfate. The sodium sulfate was removed by filtration and the polymer solution was
reduced to 20 ml with a rotoevaporator. The PEG was precipitated with the addition of dry
diethyl ether after cooling to near 0°C. The final PEG hydroxyethyl sulfide product was
dried overnight in vacuo. The hydroxyethyl sulfone was completely dissolved at 25% (w/v) in
0.123 M sodium tungstate in distilled water. The solution was cooled to 0°C in an ice bath
and 30% hydrogen peroxide (2 equiv.) was added. The reaction continued overnight while
stirring, and the product was extracted twice with dichloromethane. After drying over
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anhydrous sodium sulfate, the solution was filtered and reduced to 20 ml with a
rotoevaporator. The PEG was precipitated with the addition of dry diethyl ether after
cooling to near 0°C. The final PEG hydroxyethyl sulfone product was dried overnight in
vacuo. The hydroxyethyle sulfone was dissolved at 10% (w/v) in tolune and dried through
azeotropic distillation. After cooling, dichloromethane was added to 20% (v/v) mesyl
chloride (1.5 equiv.) and triethylamine (3 equiv.) were added. The reaction was carried out
overnight in an ice bath after which mesyl chloride (1.5 equiv.) and triethylamine (3 equiv.)
were again added. After another 24 hours, the solution was filtered and reduced to 20 ml
with a rotoevaporator. The PEG was precipitated with the addition of dry diethyl ether after
cooling to near 0°C. The final PEG vinylsulfone product was dried overnight in vacuo.
Before NMR analysis was performed, the product was purified twice by dissolving in
dichloromethane followed by filtration and precipitation with diethyl ether. The final
product was recovered at 30% with an overall PEG-OVS composition of 96%.

3.3.2 Microgel Syntheses
Unless otherwise noted, all reagents were purchased from Sigma Aldrich. PEGoctaamine (PEG-OA, 91% end-group conversion) were synthesized from 8-arm PEG-OH
(mol wt 10,000, Shearwater Polymers, Huntsville, AL) as described previously (Elbert and
Hubbell 2001; Wacker, Scott et al. 2006). PEG-OVS, PEG-OA, and bovine serum albumin
(BSA) solutions were prepared at 200 mg/mL in phosphate buffered saline (PBS; 0.2 g/L
KCl, 0.2 g/L KH2PO4, 8 g/L NaCl, 1.15 g/L anhydrous Na2HPO4, pH 7.4) and sterile
filtered with 0.22 µm sterile syringe tip filters (Millipore). PEG-OVS/BSA or PEGOVS/PEG-OA microgel solutions were formed through Michael-type conjugate addition
reactions by respectively mixing PEG-OVS with either BSA or PEG-OA solutions at 0.4:1
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or 1:1 ratios of amine to vinylsulfone groups. Ratios were prepared assuming that 8 moles
of accessible functional groups per mole of PEG-OVS or PEG-OA were available and that
bovine serum albumin had approximately 36 lysines sterically accessible for reaction
(Wacker, Scott et al. 2006). Microgel solutions were maintained at 37°C and rotated at 40
RPM until the desired mean effective diameters were reached, as recorded by DLS.

3.3.3 Characterization of Microgel Formation
Mean effective hydrodynamic diameters (dPCS) were determined by dynamic light
scattering/photon correlation spectroscopy (DLS/PCS; 90Plus Particle Size Analyzer,
Brookhaven Instruments, Holtsville, NY) at a scattering angle of 90° and wavelength of 658
nm. Disposable polystyrene cuvettes (Brookhaven Instruments) were cleaned 1x with 95%
ethanol and 2x with DI water prior to use. Polymerizing samples (30 µL) were collected at
regular intervals and diluted with PBS (3 mL) in cleaned cuvettes and analyzed at 25°C.
Data presented represent the average results of 3 measurements for each microgel synthesis
with acquisition times of 1 min. Calculation of dPCS and statistical analysis of the results were
performed using Brookhaven Instruments Particle Sizing Software (version 2.34,
Brookhaven Instruments), which uses an intensity-weighted model assuming a log-normal
distribution of particle sizes. We also used the software to calculate volume-weighted mean
effective diameters.
Increases in BSA molecular weight over the time course of gelation was monitored
with SDS-PAGE. BSA and PEG-OVS were mixed at amine to vinylsulfone ratios of 0.4:1
and aliquots (20 µg) were collected every hour and mixed with Laemmli sample buffer
(0.01% bromophenol blue, 2% sodium dodecyl sulfate, 25% glycerol, 62.5 mM Tris-HCl, pH
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6.8) and separated by gel electrophoresis using standard protocols. ImageJ software (NIH)
was used to quantify the relative intensities of 66 kD unreacted BSA monomer bands stained
with Coomassie Blue (Bio-Rad Laboratories, Inc.), which were in turn used to calculate the
fraction of reacted BSA. 2nd-order kinetic analysis was performed to determine the rate of
free BSA monomer consumption (Laidler 1987). Equation 2, valid for a 2nd order reaction,
was evaluated and plotted against corresponding time points.
kA t =

 b (a − x)
1
ln o o

ao − bo  ao (bo − x)

[2]

Parameters ao and bo represent the initial concentrations of BSA and PEG-OVS, and x
represents the amount of consumed BSA. A linear best-fit determined kA from the slope,
which is the rate of reaction for free BSA monomer.
Nuclear magnetic resonance spectroscopy (NMR) was used to determine the
percentage of reacted vinylsulfone groups while PEG-OVS was crosslinked with PEG-OA.
The PEG-OVS/PEG-OA microgels are well-suited for 1H NMR analysis due to the
simplicity of the signal from the PEG backbone. PEG-OVS and PEG-OA solutions (200
mg/mL) were prepared in 20 mM potassium phosphate in D2O and mixed at a 1:1 (v/v)
ratio. At various timepoints before gelation, samples of the microgel solution (10 mg of
total polymer) were collected and dissolved in deuterated chloroform containing 0.71%
N,N-dimethylformamide (DMF; used as an internal standard) prior to analysis on a 300
MHZ Varian Mercury-300 NMR. Integrated vinylsulfone peaks at 6.27 ppm (d, 2H, =CH2)
and 6.16 ppm (d, 2H, =CH2) were normalized against the integrated DMF peak at 7.76 ppm
(s,1H, -OCH ) in each NMR spectra.
For gel permeation chromatography, PEG8-VS was reacted with PEG8-amine to a
dPCS ≅ 100. The reaction was stopped by incubation with 2-mercaptoethanol for 1 h at 37°C
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at a thiol:vinylsulfone ratio of 2:1. After reaction with 2-mercaptoethanol, the dPCS was
unchanged. GPC was performed by PolyAnalytik (London, ON, Canada) using a Viscotek
Model 302-050 detector (detecting light scattering, viscosity and refractive index). Samples
(0.5 mg PEG) were dissolved in 0.05 M sodium nitrate. Three columns were used in series
(PolyAnalytik High Resolution Aqueous Columns: PAA-202.5, exclusion limit 10 kDa; PAA203, exclusion limit 100 kDa; PAA-206M, exclusion limit 20 MDa) calibrated with
poly(ethylene oxide) standards.

3.3.4 Reaction with Surfaces
Round glass coverslips (12 mm dia., Ted Pella Inc.) were functionalized with
mercaptopropyltrimethoxysilane (MPTS) for covalent reaction with unreacted vinylsulfone
groups in microgel solutions. Coverslips were cleaned by washing 3x in DI water and 3x in
ethanol prior to oxygen-plasma etching, which was performed at 50% power for 10 min with
a 40 kHz, 100 W plasma etcher (Diener Electronic, Femto model). The hydroxylated
coverslips were then washed 3x in acetone and reacted for 1 h at 25°C with a 5% (v/v)
solution of MPTS in acetone. Surfaces were washed 3x in acetone and cured for 1 h at
100°C under nitrogen. MPTS coverslips were incubated for 1 h with microgel solutions
(dPCS =100-120 nm), washed 3x in PBS, and incubated overnight with PBS, BSA (50
mg/mL), or bovine fibrinogen (bFg, 2.5 mg/mL) at 37°C to respectively form uncapped,
BSA-capped, or fibrinogen-capped microgel-coated surfaces.
Oxygen-plasma treated OWLS waveguide chips (MicroVacuum Ltd.) were vapor
silanized with MPTS in preparation for covalent reaction with microgel solutions. After
hydroxylation with oxygen plasma for 10 min at 50% power, the waveguide chips were
placed on a polyethylene rack within a 100 mL Pyrex bottle attached to a Liebig condenser
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(Figure 1). A 5% solution of MPTS in acetone was boiled at reflux for 24 h to provide a
continuous silane vapor for reaction with the hydroxylated Si/Ti/O2 waveguide chip surface.
Silanized waveguide chips were cured for 20 min at 100°C under nitrogen, and PEGOVS/BSA microgel coatings were applied to surfaces as described above for MPTSsilanized coverslips.
QCM-D crystals with silicon dioxide coatings (Q-Sense, QSX 303, Gothenburg,
Sweden) were O3-cleaned for 15 min in a homemade O3 chamber and immersed in an
initially-boiling solution of 5:1:1 DI water:ammonium hydroxide:hydrogen peroxide for 30
min while the solution cooled to remove organics from the substrate surfaces. Cleaned
crystals were immediately silanized by placement into 5% (v/v) MPTS in acetone for 1 h at
room temperature and subsequently baked at 100 °C for 1 h. Silanized crystals were stored
under nitrogen until use, which was always within 24 h.
Poly(ethylene terephthalate) films (PET, 0.05 mm thick, McMaster Carr, Chicago,
IL) were functionalized with air-plasma prior to coating with microgel solutions. Circular
sections (12 mm dia.) were cut from PET sheets and washed 3x in DI water and ethanol
prior to radio frequency glow discharge air plasma (RFGD) treatments for 10 min at 50%
power. Air-plasma etched PET (RFGD-PET) surfaces were incubated with 1:3 dilutions of
microgels (dPCS=40-50 nm) in PBS for 12 h. Coated RFGD-PET was washed and stored in
PBS until use in cell adhesion assays.
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Figure 3.1: Vapor-silanization
silanization procedure: ((a)) Samples within a covered polyethylene rack
were placed inside a glass chamber containing 20 mL of 5% MPTS in acetone that was
heated under reflux. (b)) Photomicrograph of vapor
vapor-silanized MPTS glass reacted
eacted with
microgels and seeded with CHO cells. No significant differences in resistance to cell
adhesion were observed with vapor and solution
solution-silanized glass.
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3.3.5 Cell Culture and Adhesion Experiments
Chinese hamster ovary (CHO) cells (ATCC, Manassas, VA) were cultured in F-12
Kaighn’s medium (Gibco) supplemented with 10% fetal bovine serum (FBS) and 1%
antibiotic-antimycotic (ABAM). Human aortic endothelial cells (HAEC; Lonza,
Walkersville, MD) were cultured in endothelial growth medium (EGM, MCDB 131 medium)
supplemented with 10 ng/ml epidermal growth factor, 10 µg/mL heparin, 1.0 µg/mL
hydrocortisone, 1% penicillin-streptomycin, 5% FBS, and 12 µg/mL bovine brain extract
(Clonetics). 3T3 fibroblasts were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM,
Gibco) supplemented with 4.5 g/L D-glucose, L-glutamine, 110 mg/L sodium pyruvate,
10% FBS and 1% penicillin-streptomycin. Microgel-coated coverslips were placed into 24well plates of tissue-culture polystyrene (Becton Dickinson Labware, Franklin Lakes, NJ) and
washed 3x with PBS and 1x with the appropriate cell media. Wells were seeded with cells
and incubated for 12 h at 37 °C. CHO cells and fibroblasts were seeded at 2.5 x 105
cells/cm2, while endothelial cells were seeded at the lower surface concentration of 3.5 x 104
cells/cm2. After incubation, surfaces were washed 3x with media and cell adhesion was
assessed by phase contrast microscopy. Photomicrographs were taken at 10X magnification
and the number of attached cells was counted manually. The cell adhesion experiments were
modified slightly for the long-term fibroblast reseeding experiments. Surfaces were washed
and seeded with cells at 2.5 x 105 cells/cm2 every 48 h and observed by microscopy every 24
h. Microscopy was performed on unwashed surfaces to observe the aggregation of nonadherent fibroblasts in solution.
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3.3.6 OWLS Measurements and Analysis
Si/Ti/O2, MPTS-silanized, and BSA-capped PEG-OVS/BSA microgel-coated
OWLS waveguide chips were analyzed inside the flow chamber of a MicroVacuum OWLS
110 optical waveguide lightmode spectrometer (MicroVacuum Ltd). All experiments were
performed at a flow rate of 0.1 mL/min at 37°C and with a time step of 30 s. Waveguide
surfaces were first equilibrated under DI water until a transverse magnetic mode refractive
index variation of < 1 x 10-6 was obtained. For microgel characterization at each step of the
coating process, MPTS-silanized waveguide chips were coated with microgels in situ and
tested for fibrinogen adsorption using the following sequence of flowing solutions: 1) DI
water, 2) PBS, 3) 2 h incubation with PEG-OVS/BSA microgel solutions (dPCS = 100-120
nm) in PBS, 4) PBS wash/equilibration, 5) overnight incubation with BSA in PBS, 6) PBS
wash/equilibration, 7) 2 h incubation with 2.5 mg/mL bFg in PBS, 8) PBS
wash/equilibration, and 9) DI water wash/equilibration. Waveguide chips precoated with
BSA-capped PEG-OVS/BSA microgels were analyzed specifically for fibrinogen adsorption
using the following series of solutions: 1) DI water, 2) PBS, 3) 2 h incubation with 2.5
mg/mL or 20 mg/mL bFg in PBS, 4) PBS wash/equilibration, and 5) DI water
wash/equilibration.
Measured effective refractive indices were analyzed with MicroVacuum BioSense
Software (MicroVacuum Ltd), which calculated mass on the waveguide surfaces using de
Feijter’s formula (de Feijter, Benjamins et al. 1978):
M = dA

n A − nc
dn / dc

[3]

where M is the adsorbed mass, dA is the thickness of the adsorbed layer, dn/dc is the
refractive index increment of the adsorbate, nA is the refractive index of the adsorbed layer,
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and nC is the refractive index of the cover medium. To calculate the amount of attached
microgels on the waveguide surfaces, a refractometer was used to determine the value of the
refractive index increment for PEG-OVS/BSA microgel solutions (dn/dc = 0.150 g/cm3). A
value of dn/dc = 0.182 for g/cm3 was used for the analysis of adsorbed fibrinogen (de
Feijter, Benjamins et al. 1978).

3.3.7 QCM-D Measurements and Analysis1
A quartz crystal microbalance with dissipation monitoring (QCM-D, model Q-Sense
D300) was used to monitor mass deposition on quartz crystals. Frequency (F) and
dissipation (D) were recorded at the fundamental frequency (f = 5 MHz) and the 3rd, 5th, and
7th overtones (f = 15, 25, and 35 MHz) as functions of time. During all experiments,
incubation solutions and the crystal were preheated to and maintained at 37 °C.
After F and D reached steady state in PBS, 0.5 mL PEG-OVS/BSA microgels (dPCS
= 100-120 nm) were diluted by 50% with PBS and incubated with the crystal for 1 h. The
crystal was then thoroughly washed with 30 mL PBS. After F and D again reached steady
state, the crystal was incubated with 0.5 mL 100 mg/mL BSA (0.22 µm-filtered) for
approximately 2 h. Following another 30 mL PBS wash, the crystal was incubated with 0.5
mL 2.5 mg/mL bFg (0.22 µm-filtered) for 90 min. A final wash with 30 mL PBS was
conducted until steady state. Control experiments were conducted similarly, with 100
mg/mL BSA substituted for microgels. Between all experiments, the instrument was
thoroughly cleaned with a 1% SDS solution and DI water to remove any residual material.

1

QCM data was gathered by Michael D. Nichols using equipment located at Duke
University in the laboratory of Ashutosh Chilkoti.
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F and D results corresponding to the 3rd, 5th, and 7th overtones were analyzed using
Q-Tools software (version 2.1.6.134, Q-Sense) using a single-layer Voight (viscoelastic)
model. Fluid density (1000 kg/m3) and fluid viscosity (6.915 x 10-4 kg/m-s), corresponding
to PBS at 37°C, were kept fixed. Using optical densities obtained from OWLS (mOWLS)
analysis in conjunction with modeled Voight masses (mQCM),(Hook, Kasemo et al. 2001;
Voros 2004) corresponding layer densities were estimated as:

ρ layer =

mOWLS

ρ macrogel

mQCM
mQCM − mOWLS
+

[4]

ρ water

Our previous measurement of the volume fraction solid for PEG-OVS/BSA
macrogels was used to estimate ρ macrogel = 1.0335 g/cm3. Initially assuming layer densities of
1100 kg/m3, thickness, shear modulus, viscosity, and Voight mass of a deposited layer were
modeled. In an iterative fashion, a new effective density was calculated from the Voight
mass using equation 4 and used in the model to update parameters until solutions converged.
Atomic force microscopy (AFM, Nanoscope V multimode SPM, Veeco
Instruments) was utilized in tapping mode in PBS. PEG-OVS/BSA coatings were applied
to MPTS glass surfaces as described, with and without BSA capping. In situ surface imaging
was performed using silicon nitride tips (Nanoprobe, Veeco) with drive frequencies of 7.5 ±
0.4 kHz, a nominal spring constant of 0.06 N m-1, and scan rates of 1-1.2 Hz.
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3.4

Results

3.4.1 PEG Synthesis
We developed a four-step synthesis of 10,000 MW eight-arm PEG-VS that did
not require the use of highly toxic divinylsulfone. The reaction scheme was a modification
of a method developed by Morpurgo et al (Morpurgo, Veronese et al. 1996). The first stage
of the synthesis required the reaction of PEG with methane sulfonyl chloride (4 eq) and
triethylamine (4 eq). The second step produces PEG hydroxyethyl sulfide from the reaction
between PEG mesylate and β-mercaptoethanol (4 eq). The desired product of the third step
was PEG hydroxyethyl sulfone, resulting from the oxidation of PEG hydroxyethyl sulfide
with 30% hydrogen peroxide in a sodium tungstic solution. The fourth and final step
produced PEG vinylsulfone by reacting the hydroxyethyl sulfone with methane sulfonyl
chloride in the presence of excess triethylamine. This step of the synthesis utilized an
optimized procedure requiring the addition of 1.5 equivalents of methane sulfonyl chloride
in the presence of 3 equivalents of triethylamine in an ice bath followed by the addition of
these same volumes of reagent again after 24 hours. Thus the total reaction time for this
step was 48 hours and resulted in a final product that was 96% PEG-VS after purification.
Essential NMR peaks for vinylsulfone were seen at 5.96 ppm (d, 2H, =CH2), 6.25 ppm (d,
2H, =CH2), 6.73 ppm (t, 1H, =CHSO2-), and 3.47 ppm (s, PEG backbone, -OCH2-) (Figure
3.2).
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Figure 3.2: NMR spectra of PEG-OVS. A four-step synthesis was used to derivatize PEGOH with vinylsulfone functionality. The final product was recovered at 30% with an overall
conversion to PEG-OVS of 96%. (A) Location of PEG backbone peak. (B-D) Location of
vinylsulfone peaks.
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3.4.2 Characterization of Microgel Formation
Amines within BSA or PEG-OA were crosslinked with vinylsulfone end-groups of
PEG-OVS through a Michael-type conjugate addition reaction, forming PEG-OVS/BSA or
PEG-OVS/PEG-OA microgel solutions, respectively. The protocol for microgel formation
and covalent attachment to glass surfaces is outlined in Figure 3.3. Microgels were formed
by combining 200 mg/mL solutions of either BSA or PEG-OA with 200 mg/mL PEGOVS at an amine to vinylsulfone ratio of 1:1. Additionally, some PEG-OVS/BSA microgels
were formed at an amine to vinylsulfone ratio of 0.4:1. When rotated at 37°C, the 0.4:1 and
the 1:1 ratio PEG-OVS/BSA solutions reached the gel point after 44.6 ± 0.6 h and 7.0 ± 0.5
h, respectively. PEG-OVS/PEG-OA solutions mixed at a 1:1 ratio formed gels in 6.7 ± 0.3
h. The longer gelation time of the 0.4:1 ratio was beneficial for microgel characterization,
while the 1:1 ratio was employed for a more rapid microgel formation protocol. Regardless
of the ratio used, an exponential increase in PEG-OVS/BSA microgel mean effective
diameter with time was observed by dynamic light scattering (DLS) until gelation (Figure
3.4a,b). PEG-OVS/BSA microgels were not detected by DLS until reaching a dPCS of 31.6±
4.5 nm, which occurred after approximately 50% of the total gelation time. The largest
detectable PEG-OVS/BSA dPCS prior to gelation was 159.3 ± 16.5 nm. Note that the
measured mean effective diameters (dPCS) are intensity-weighted and thus monomers, dimers
and other small aggregates will contribute very little to this average. The intensity-weighted
measurement was a highly reproducible measure of microgel formation, but the dPCS should
not be confused with the more physically meaningful number-weighted or volume-weighted
mean particle sizes. Characterization of a dPCS ≅ 100 nm solution by GPC revealed that
PEG microgels with >10 nm hydrodynamic radius constituted 46.6 wt% of the PEG
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Figure 3.3: Crosslinking of bovine serum albumin (BSA) an
and
d poly(ethylene glycol)glycol)
octavinylsulfone (PEG-OVS,
OVS, MW 10,000) may lead to microgel formation if the principle of
equal end-group
group reactivity does not apply. Vinylsulfone groups on PEG molecules undergo
a Michael-type
type addition with solvent
solvent-exposed and sterically
cally accessible lysines on BSA,
forming covalent linkages at neutral pH. If the crosslinking reaction is slowed before the gel
point by dilution, microgel
microgel-containing
containing solutions can be rapidly reacted with nucleophilenucleophile
derivatized surfaces, such as thiol
thiol-silanized glass.
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Figure 3.4: Evidence for formation of microgels during the crosslinking reaction: (a)
Dynamic light scattering (DLS) with intensity
intensity-weighted (dPCS) and volume-weighted
weighted mean
effective diameters of reacting PEG
PEG-OVS/BSA
OVS/BSA solutions (0.4:1 ratio of BSA amine groups
to PEG vinylsulfone groups, 44 h gel time). (b)) NMR was used to measure the kinetics of
end-group
group conversion during the reaction of PEG
PEG-OVS with PEG-octaamine
octaamine (both MW
10,000; 1:1 ratio of PEG-OA
OA to PEG
PEG-OVS,
OVS, 6.5 h gel time). The time scales of both (a) and
(b) were normalized relative to their respective gel times and error bars display the standard
deviations for 4 separate reactions.
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a)

b)

Figure 3.5: Gel permeation chromotography of PEG8-VS and PEG8-amine
amine pre-reacted
pre
to
dPCS ≅ 100 nm. The reaction was halted by capping remaining vinylsulfone groups with 22
mercaptoethanol. The absolute molecular weight was determined by triple detection of light
scattering, viscosity and refractive index. (a)) Molecular weight (black) and refractive
refr
index
(gray) of eluted polymers. The peak at 37.4 min was confirmed to be monomeric
vinylsulfone in a separate run. (b)) Intensity of right angle light scattering (black) plotted
against hydrodynamic radius. Refractive index (gray) is shown for co
comparison.
mparison.
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(Figure 3.5). Monomeric (i.e. unreacted) PEG comprised 12.0 wt% of the PEG, with the
remainder of solution being oligomers of PEG8-VS and PEG8-amine.
An exponential increase in the percentage of reacted vinylsulfone groups was
observed by NMR during the formation of PEG-OVS/PEG-OA microgels (Figure 3.4a,b).
Only 4.6% ± 3.3% of available vinylsulfone groups had reacted after reaching 50% of the
gelation time, while 64.0% ± 2.4% was the highest detectable end-group conversion prior to
gelation. The rate of reaction of BSA with PEG-OVS was calculated from SDS-PAGE.
BSA was reacted with PEG-OVS at the 0.4:1 amine to vinylsulfone ratio, and samples were
collected at various timepoints for separation by SDS-PAGE. Crosslinking of BSA with
PEG-OVS was apparent within 1 min of the start of the reaction, while unreacted BSA was
no longer evident after 20 h, corresponding to the time at which correlograms became
reliable by DLS (Figure 3.6a). After 84% of the gelation time had passed (38 h), there was
no detectable BSA with a molecular weight below 131 kD. This timepoint corresponded to
a dPCS of about 100 nm, a degree of crosslinking that was used in most subsequent
experiments. Concentrations of unreacted BSA were estimated from the SDS-PAGE gels
and analyzed using the method of integration for second-order reactions with different
stoichiometries (Laidler 1987), revealing a reaction rate constant of 3.15 ± 0.11 x 10-3 M-1s-1
for the reaction of free BSA with PEG-OVS (Figure 3.6b).

3.4.3 Covalent Attachment of Microgels to Glass Surfaces
The following steps were utilized to covalently attach microgel coatings to glass: 1) oxygenplasma etching, 2) silanization with mercaptopropyltrimethoxysilane (MPTS), 3) 1 h
incubation with a dilute microgel suspensions in PBS pH 7.4 at 37°C, and 4) overnight
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a)

b)

Figure 3.6: Kinetics of the crosslinking reaction between PEG
PEG-OVS
OVS and BSA. (a) SDSPAGE of BSA during the crosslinking reaction with PEG
PEG-OVS. (b)) Analysis of the 2nd
order reaction kinetics for part ((a) for two separate experiments (circles: first experiment;
squares: second experiment; ordinate units: L/molh).
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incubation with 50 mg/mL BSA. Microgels with dPCS between 100-120 nm were the largest
microgels capable of reacting with the MPTS functionalized surfaces at a 1:1 dilution within
1 h without a noticeable increase in size as measured by DLS at the end of the reaction.
This dPCS was chosen to maximize the amount of PEG attached to the surface while
minimizing the risk of macrogelation on the surface. The presence of microgel coatings on
the glass surfaces was verified by XPS (Table 3.1). After application of the microgel coating,
the Si atomic concentration of the surfaces decreased from 27.4% to 1.03%, and the N/Si
ratio of the surfaces increased by over 600-fold. The microgel-coated surfaces contained
more nitrogen than anticipated for PEG alone (theoretical atomic composition of PEG:
66.7% C, 33.3% O, 0% N,) and more carbon than anticipated for BSA alone (theoretical
atomic composition of BSA: 63.6% C, 19.4% O, 16.9 % N). Using the measured C/N
atomic ratio, a BSA-capped microgel layer was estimated to be 71.4% BSA and 28.6% PEG.
The nature of the microgel coating on the surfaces of MPTS functionalized glass was also
studied by atomic force microscopy (AFM) in PBS. By AFM, the uncapped PEGOVS/BSA microgel coatings appeared to consist of coalesced spheres with diameters
smaller than 100 nm (Figure 3.7B & 3.7D). Although some areas on the microgel-coated
surfaces appear to be uncovered, these areas are only a few nanometers lower than the rest
of the surface. After addition of the BSA capping layer, the resolution of the images
decreased dramatically, perhaps due to the excess of negative charges on BSA (Figure 3.7C).
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Table 3.1: Elemental composition of treated glass surfaces, as determined by XPS.
Surface

Atomic Conc. (%)

Atomic Ratios

O

N

C

S

Si

C/N

C/O

N/Si

O2 Plasma

59.16

0.59

10.34

0.47

26.52

17.53

0.17

0.02

MPTS

54.00

0.88

15.47

1.11

27.43

17.58

0.29

0.03

Microgel

18.02

12.62

67.37

0.7

1.03

5.34

3.74

12.25

106

Figure 3.7: AFM analysis of: (A) MPTS glass, 10 x 10 microns, (B) PEG-OVS/BSA
microgel-coated MPTS glass, 10 x 10 microns , (C) PEG-OVS/BSA microgel-coated MPTS
glass with BSA capping step, 10 x 10 microns, (D) PEG-OVS/BSA microgel-coated MPTS
glass, 3 x 3 microns with height profiles. The height data scales are 20 nm for (A), 30 nm for
(B) and (D), and 120 nm for (C).

107

3.4.4 Properties and protein adsorption resistance of PEG-OVS/BSA
microgel coatings
The optical mass and protein adsorption resistance of microgel coatings was quantified with
OWLS. Since OWLS has an upper limit of sensitivity above the waveguide surface (Picart,
Gergely et al. 2004), vapor silanization was employed instead of solution silanization, to limit
silane aggregation. Solutions of PEG-OVS/BSA microgels (dPCS = 100-120 nm) were
flowed over Si/Ti/O2 or MPTS waveguide surfaces, resulting in surface mass densities of
115.0±0.7 ng/cm2 and 267.38±8.58 ng/cm2, respectively. Resistance to protein adsorption
was tested by comparing the adsorption of bovine fibrinogen (bFg) on MPTS surfaces to
BSA-capped PEG-OVS/BSA microgel surfaces. While bFg readily adsorbed to the MPTS
surface at 201.9 ± 1.2 ng/cm2, no detectable change in refractive index was observed for the
microgel surface when switching from the PBS solution to the 2.5 mg/mL bFg solution in
PBS (Figure 3.8a). To verify that the microgel coated OWLS waveguide chip was still
sensitive to refractive index changes above the microgel surface, the adsorption experiment
was repeated with an 8-fold higher concentration of bFg (a thick coating, e.g. > 200 nm,
could prevent detection of protein on or above the coating) (Lukosz 1991). The refractive
index of the 20 mg/mL bFg solution was 0.0042 higher than PBS alone, and this difference
in refractive index was detected by OWLS when switching from PBS to 20 mg/mL bFg in
PBS on the microgel surface, indicating that the coating was thin enough to detect changes
on the surface (Figure 3.8b). After switching the solution back to PBS and DI water for
washing, only 4.1 ± 0.9 ng/cm2 of bFg was detected in comparison to 192 ± 3.3 ng/cm2 on
the MPTS surface under the same conditions.
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Figure 3.8: OWLS analysis
sis of fibrinogen adsorption to microgel
microgel-coated
coated surfaces. Si/Ti/O2
surfaces of OWLS waveguide chips were oxygen
oxygen-plasma etched, vapor-silanized
silanized with MPTS,
and incubated with PEG-OVS/BSA
OVS/BSA microgels (dPCS = 100-120
120 nm). The adsorption of
bovine fibrinogen (bFg)
Fg) from: (a) 2.5 mg/mL, or (b)) 20 mg/mL solutions onto microgelmicrogel
coated surfaces was monitored. All surfaces were exposed to the same series of solutions
flowing at 0.1 mL/min at 37°C: (1) DI water, (2) PBS pH 7.4, (3) 2.5 mg/mL or 20 mg/mL
bovine fibrinogen
gen in PBS pH 7.4, (4) wash with PBS, pH 7.4, and (4) wash with DI water.
The higher concentration of bovine fibrinogen in part b demonstrated that the microgel
layer was thin enough to detect protein above the microgel coating.
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QCM-D was used to monitor microgel coatings on MPTS surfaces. Quartz sensors
were silanized in solution with MPTS prior to QCM-D analysis. Microgel coatings were
formed on the surfaces using the same protocol as for glass slides, including the final
capping step with BSA. Incubations with microgel solutions (dPCS = 100-120 nm), BSA
solutions, and bFg solutions were all performed within the QCM-D itself (Figure 3.9). By
combining OWLS-measured optical masses with QCM-D frequency and dissipation
measurements, the thickness, Voight mass, shear viscosity, and elastic modulus of the
coatings were calculated (Table 2). Comparison between the optical mass and Voight mass
for PEG-OVS/BSA microgels revealed the presence of a highly hydrated coating ( ~97%
water). Measurements of protein adsorption on the microgel-coated surfaces correlated well
between OWLS and QCM analysis, revealing negligible changes in effective refractive index
or frequency, respectively, after incubation with fibrinogen solutions. None of the
differences in the calculated parameters were found to be statistically significant when
comparing BSA-capped PEG-OVS/BSA microgels before and after incubation with
fibrinogen.

3.4.5 Resistance of Microgel-Coated Glass to Cell Adhesion
Glass slides were coated with microgel solutions and incubated with CHO, fibroblast
and endothelial cells to test for resistance to cell adhesion and spreading. CHO cells and
fibroblasts readily adhere to materials, while endothelial cells are relevant to use of the
coatings on a blood-contacting materials. Phase contrast photomicrographs of cells
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Figure 3.9: QCM-D
D frequency and dissipation changes illustrating the attachment of
microgels to the MPTS-silanized
silanized crystal and subsequent resistance to non
non-specific
specific protein
adsorption. The following solutions were flowed over the crystal: (1) 0.5 mL of BSA/PEGBSA/PEG
OVS microgels (dPCS = 100
100-120
120 nm) flowed onto the crystal and then incubated for 60 min.
(2) 30 mL wash with PBS and incubation with PBS until readings stabilized. (3) 0.5 mL of
100 mg/mL BSA flowed over the crystal and incubated for about 90 minutes. (4) 30 mL
wash with PBS and incubation with PBS until readings stabilized. (5) 0.5 mg/mL of 2.5
mg/mL bovine fibrinogen flowed over crystal and incubated for 2 h. (6) 30 mL wash and
incubation with PBS until readings stabilized.
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Table 3.2: Physical properties of PEG-OVS/ BSA microgels measured with OWLS and
QCM.

Optical mass (ng/cm2)
Density

(kg/m3)

PEG-OVS/BSA
Microgels

PEG-OVS/BSA
Microgels (BSA cap)

267.3±8.5

532.6±77.0

PEG-OVS/BSA
Microgels (BSA
cap) + bFg
579.4±5.9

1001.2±0.1

1002.6±0.2

1002.7±0.5

Thickness (nm)

75.2±8.6

65.7±5.4

71.0±12.0

Voight mass (ng/cm2)

7523.7±855.6

6582.3±544.5

7122.3±1197.1

Elastic Shear Modulus (kPa)

16.1±11.5

16.3±8.8

15.9±10.1

Shear Viscosity (cP)

1.1±0.2

1.2±0.2

1.2±0.2
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adhered to PEG-OVS/BSA microgel coatings capped with BSA are displayed in Figure 7.
All cell types adhered to and spread on MPTS surfaces and BSA-coated MPTS surfaces
during the 24 h incubation period. While fewer cells adhered to the PEG-OVS grafted
surfaces, no spread cells and few adhered cells were found on the microgel-coated surfaces
(Figure 3.10). Long-term resistance to fibroblast adhesion was tested on BSA-capped PEGOVS/BSA microgel-coated surfaces by reseeding cells onto surfaces every 2 days. Nonadherent fibroblasts were observed to clump into aggregates above the surfaces and the
BSA-capped PEG-OVS/BSA microgels resisted cell adhesion for 19 days (Figure 3.11). In
contrast, extensive fibroblast adhesion was observed on non-silanized glass surfaces after the
first day of incubation (Figure 3.11, insets).
Cell adhesion and spreading was quantified on the treated surfaces (Figure 3.12a, b).
Although fibroblasts tended to spread more on the surfaces than CHO cells, no spread cells
of any type were found on the microgel-coated slides. Capping the microgel surfaces with
BSA resulted in a small, but insignificant decrease in cell adhesion compared to uncapped
microgel coatings (Figure 3.13, Figure 3.14b). PEG-OVS/PEG-OA microgel coatings
capped with BSA displayed slightly more cell adhesion than PEG-OVS/BSA gels capped
with BSA, but the difference was also not statistically significant (Figure 3.13, Figure 3.14c).
The resistance of BSA-capped PEG-OVS/BSA microgel coatings to CHO and fibroblast
adhesion was not influenced by preincubation with fibrinogen immediately prior to cell
seeding (Figure 3.12a,b, Fig 3.14e). BSA-capped PEG-OVS/PEG-OA microgel coatings
were less resistant to cell adhesion after incubation with fibrinogen solutions (Figure 3.14f).
Cell adhesion to PEG-OVS/BSA microgel coatings was
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Figure 3.10: Cell adhesion on microgel-coated glass at 10X magnification after a 24 h
incubation with endothelial (3.5 x 104 cells/cm2), CHO (2.5 x 105 cells/cm2), or fibroblast
(2.5 x 105 cells/cm2) cells. MPTS-silanized glass coverslips were incubated at 37°C with one
of the following solutions: PBS for 12 h, 100 mg/mL BSA for 12 h, 100 mg/mL PEG-OVS
for 12 h, or PEG-OVS/BSA microgels (dPCS = 100-120 nm) for 1 h followed by capping
with 50 mg/mL BSA for 12 h.
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Figure 3.11: Cell adhesion to microgel-coated glass at 10X magnification after repeated
seedings with fibroblasts after: (a) 1 day, (b) 5 days, and (c) 19 days. MPTS surfaces coated
with BSA-capped BSA/PEG-OVS microgels were washed and reseeded with fibroblasts
every 2 days at 2.5 x 105 cells/cm2. Cell spreading was not observed until 19 days, at which
time aggregates of fibroblasts spread. Controls consisting of non-silanized glass incubated
with BSA-capped BSA/PEG-OVS microgels are displayed in the lower right corner of each
image at 10X magnification, showing complete cell spreading.
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Figure 3.12: Cell counting results for CHO and fibroblast adhesion to microgel surfaces.
(a)) Comparison of CHO cell adhesion to MPTS
MPTS-silanized
silanized glass incubated overnight with (in
order from left to right): (1) PBS pH 7.4; (2) 50 mg/mL bovine serum albumin (BSA) in
PBS; (3) 100 mg/mL PEG
PEG-OVS in PBS; (4-5) PEG-OVS/BSA
OVS/BSA microgels (dPCS = 100-120
nm),, capped with (4) BSA or (5) bovine fibrinogen (bFg), and (6) PEG
PEG-OVS/BSA
OVS/BSA
microgels (dPCS = 100-120
120 nm), capped with BSA then incubated with 2.5 mg/mL bFg in
PBS for 2 h at 37°C. (b)) Fibroblast adhesion after the same surface treatments described in
part a. CHO and fibroblast cells were seeded at a density of 2.5 x 105 cells/cm2 and
incubated with the surfaces for 24 h at 37°C.
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Figure 3.13: CHO cell adhesion to MPTS-silanized glass reacted with: (in order from top to
bottom): (1) 100 mg/mL PEG-OVS in PBS; (2) 20 PEG-OVS layers alternating with DTT
applied using a layer-by-layer method; (3-4) PEG-OVS/PEG-OA microgels (dPCS = 100-120
nm) capped with (3) BSA; (4) BSA then incubated with bFg for 2 h; (5-8) PEG-OVS/BSA
microgels (dPCS = 100-120 nm) that were capped with: (5) PEG-OVS, (6) BSA, (7) BSA, then
incubated with bFg for 2 h, or (8) bFg. CHO cells were seeded at a density of 2.5 x 105
cells/cm2 and incubated with the surfaces for 24 h at 37°C.
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adhesion
sion on glass slides for 24 h
Figure 3.14: 10X magnification of CHO cell adhe
demonstrating the effects of the crosslinker and final capping step. MPTS
MPTS-silanized
silanized glass
was incubated with: (a)) 2.5 mg/mL bovine fibrinogen in PBS at pH 7.4 for 2 h, (b) PEGOVS/BSA microgels overnight in PBS pH 7.4 at 37°C
37°C, (c) PEG-OVS/PEG
OVS/PEG-OA microgels
capped overnight with 50 mg/mL BSA in PBS pH 7.4 at 37°C, (d) PEG-OVS/BSA
OVS/BSA
microgels capped overnight at 37°C with 2.5 mg/mL bovine fibrinogen in PBS pH 7.4, (e)
PEG-OVS/BSA
OVS/BSA microgels capped overnight with 50 mg/mL BSA and subsequently
sub
incubated for 2 h at 37°C with a 2.5 mg/mL bovine fibrinogen. (f) PEG-OVS/PEG
OVS/PEG-OA
microgels capped overnight with 50 mg/mL BSA and subsequently incubated for 2 h at
37°C with 2.5 mg/mL bovine fibrinogen.
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promoted when a bovine fibrinogen cap was used instead of a BSA cap, suggesting the
presence of reactive vinylsulfone groups in the coating before the capping step but not after
(Figure 3.13, 3.14, & 3.15d). Compared to our previous results with a covalent layer-by-layer
method,(Kim, Wacker et al. 2007) the microgel coatings were far superior in preventing cell
adhesion (Figure 14c).

3.4.6 Application of Microgel Coating to PET surfaces
Microgel coatings were applied to PET surfaces by a 2-step process and tested for
cell adhesion. The first step was etching of the surface with air-plasma to provide a low
surface density of amine groups (Riccardi, Barni et al. 2003). The second step was
incubation with a 1:3 dilution of PEG-OVS/BSA microgel solutions (dPCS =40.1 ± 0.99 nm)
for 12 h. A longer incubation time was utilized compared to the coating of thiolfunctionalized surfaces due to the slower reaction between vinylsulfone and primary
amines.(Friedman 1965) A diluted, smaller dPCS microgel solution was used to limit microgel
growth over the 12 h incubation. Mean effective diameters were found to still be below 100
nm after the longer incubation period. Even without a capping step, microgel coatings on
RFGD-PET demonstrated considerable resistance to CHO cell adhesion (2.3 ± 3.2 adhered
cells/mm2) compared to RFGD-PET (1100 ± 216 cells/mm2), BSA-adsorbed RFGD-PET
(850 ± 129 cells/mm2) and PEG-OVS grafted RFGD-PET (975 ± 95cells/mm2) (Figure
3.15).
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a)

b)

c)

d)

0.4 mm

Figure 3.15: CHO cell adhesion at 24 h to air RFGD-treated PET films that were incubated
with: (a) PBS, (b) BSA, (c) PEG-OVS, or (d) PEG-OVS/BSA microgels. 10X
magnification.
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3.5

Discussion
We have previously demonstrated that delivery of a signaling lipid from macroscopic

PEG-OVS/BSA gels increased the migration rate of endothelial cells attached to the
hydrogel surface via cell adhesion peptides (Wacker, Scott et al. 2006; Wacker, Alford et al.
2008). Here, we present a nanoscale version of this gel that can be covalently attached to
biomaterials as a thin coating. The coatings were generated on surfaces by covalently
attaching PEG-containing microgels under physiological conditions. This was achieved
using a dip-coating methodology wherein thiol-functionalized glass was incubated with dilute
microgel solutions to permit rapid attachment to surfaces within a timeframe that permitted
minimal growth in microgel mean effective diameters. Compared with strategies that require
spin coating, the dip-coating methodology may be useful for coating devices of varying size,
shape and geometry. Because the microgels were attached to surfaces during the process of
gelation, unreacted VS-groups remained available for additional crosslinking with a capping
molecule. Capping of unreacted VS-groups with BSA or PEG-OA may increase the
crosslink density within the coating and add a passivating surface layer. Using bioactive
capping molecules, cellular responses may also be controlled.
The presence of a very broad distribution of polymer sizes during crosslinking is
expected, but the distribution is likely different from that described by Flory and
Stockmayer. This was particularly evident from the high end-group conversion measured by
NMR, which indicates significant intramolecular crosslinking (i.e. ramification) during
crosslinking. The presence of particles with diameters greater than about 30 nm as
observed by DLS and the spherical structures with diameters <≈100 nm observed by AFM
also support the presence of microgels in the crosslinking solutions.
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NMR indicated that the rate of reaction actually increased as reactive groups were
consumed. The exponential increase in the rate of reaction was correlated with the
exponential increase in mean effective diameter measured by DLS. Furthermore, DLS
revealed that a dPCS ≈ 100 nm was reached after approximately 90% of the gelation time had
passed, and GPC analysis demonstrated that only 12.0% of the monomer remained
unreacted at this timepoint. While the number of crosslink sites in similar condensation gels
has been determined by swelling measurements (Metters and Hubbell 2005), detailed
knowledge of the kinetics of crosslinking and microgel formation is sparse. However, NMR
should be a useful tool in such studies. Additionally, if solvent conditions could be found
such that all of the reactive groups within a microgel could be entirely consumed before
gelation occurred, this would enhance the study of microgel size distributions.
We characterized microgel coatings by combining results from OWLS and QCM,
which respectively measure the solid and liquid components of highly hydrated layers (Voros
2004; Wittmer, Phelps et al. 2007). Additionally, OWLS provided an independent
measurement of optical masses that was used to increase confidence in viscoelastic QCM
models (Hook, Kasemo et al. 2001; Voros 2004). PEG-OVS/BSA hydrogel coatings were
found to have a higher water content than hydrated protein layers, and the resulting density
was much closer to that of water (Voros 2004). In comparison to hydrated laminin films
that were previously characterized using the Voight model, the microgel coatings possessed a
comparable thickness, but had a higher shear modulus and a slightly lower viscosity
(Malmstrom, Agheli et al. 2007). The increased shear modulus likely reflected the effects of
covalent crosslinks within the hydrogel coatings versus non-covalent interactions in the
multi-domain protein. AFM revealed the presence of coalesced spheres that were consistent
with the size range of particles detected by DLS.
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The relative role of BSA versus PEG in the resistance of the microgel coatings to cell
adhesion is unknown. BSA-capped coatings were similar to PEG-OA-capped coatings in
initial cell adhesion (Figure 9c), but BSA-capped PEG-OVS/PEG-OA surfaces that were
incubated with fibrinogen before cell seeding displayed some cell adhesion (Figure 10f). The
BSA-capped PEG-OVS/BSA microgels were the most robust, but it is possible that with
further optimization an all-PEG system could perform equally well. The temporary nonfouling properties of adsorbed albumin films are well-documented in both in vitro and in vivo
studies, (Chang 1969; Imai, Tajima et al. 1971; Eberhart, Munro et al. 1987) so it may emerge
that PEG/albumin microgel coatings perform better than all-PEG systems. However, the
albumin films may be subject to degradation by proteases and potential immunological
responses. Switching the capping protein from BSA to fibrinogen led to cell adhesion,
similar to Almany et al. who developed hydrogel scaffolds from PEGylated fibrinogen
fragments to support smooth muscle cell and endothelial cell ingrowth (Almany and Seliktar
2005). In the current study, the entire fibrinogen protein was coupled without reduction of
disulfide bonds. The use of whole proteins versus cell adhesion peptides may be
advantageous in promoting specific cell adhesion and presents a multitude of options for
new bioactive coatings.
Strong evidence has emerged for the advantages of high molecular weight, covalently
attached PEG-containing polymers, lattices or microgels for producing thin layers that
reduce cell adhesion. High molecular weight poly(L-lysine)-graft-poly(ethylene glycol) (PLLg-PEG) adsorbed on surfaces reduces initial cell adhesion, but cell adhesion is observed over
a period of two weeks (Lussi, Falconnet et al. 2006). Covalent linkage of PLL-g-PEG to
aldehyde-functionalized PET may lead to more stable coatings (Blattler, Pasche et al. 2006).
Banerjee et al. used a comb copolymer of methyl methacrylate (MMA) and PEG123

methacrylate (PEGMA)/methyl PEGMA, as well as a coalesced PMMA latex, to coat glass
substrates to a thickness of 225 nm, which completely inhibited N46 fibroblast adhesion for
24 h (Banerjee, Irvine et al. 2000). More similar to the current study, Groll et al. tested starPEG molecules with six isocyanate-terminated arms in which crosslinking was initiated just
prior to spin-coating on substrates to a thickness of 30 nm. Both osteogenic sarcoma
(SaOS) cells and human fibroblasts did not adhere to either of the coated substrates at 24 h
(Groll, Fiedler et al. 2005). Crosslinking of star PEG during attachment to surfaces is
expected to result in higher coating densities and surface coverage (Gasteier, Reska et al.
2007). Nolan et al. fabricated theromoresponsive microgel particles that were about 200 nm
in diameter at 37°C and comprised of poly(N-isopropylacrylamide-co-acrylic acid) (pNIPAmco-AAc) internally-crosslinked with PEG-diacrylate. When spin coated on
aminofunctionalized glass, microgels with 5 mol% PEG 700 significantly reduced 3T3
fibroblast adhesion over 72 h (Nolan, Reyes et al. 2005). More recently, similar microgels
were reacted onto benzophenone-functionalized PET discs, which successfully inhibited IC21 macrophage adhesion over 48 h (Singh, Bridges et al. 2007). Although synthesis and
characterization is challenging, the potential for such nanoscale coatings to enhance cell and
protein resistance seems particularly promising. However, as improvements in coatings
emerge, more challenging cell culture models may be warranted for evaluation prior to in vivo
testing.
In testing the long-term resistance to cell adhesion in vitro, cell reseeding is
advantageous. Drumheller et al. demonstrated that semi-interpenetrating network (semiIPN) thin films containing a PEG-acrylate/acrylic acid copolymer, resisted fibroblasts cell
adhesion for over two-weeks with reseeding every three days (Drumheller, Elbert et al.
1994). Additionally, semi-IPN films containing high MW PEG-acrylate or PEG-diol
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completely resisted fibroblast adhesion for up to 30 days with weekly reseeding (Drumheller
and Hubbell 1995). The microgel coatings presented here, when capped with BSA,
exhibited a resistance to cell adhesion for almost three weeks, with reseeding every two days.
As more effective PEG coating strategies are developed, it would be advantageous if such
reseeding protocols became standard for assessing cell adhesion resistance, as a first step
towards in vivo testing.

3.6

Conclusion
We have fabricated and characterized PEG-OVS-based microgel solutions for use as

protein and cell-resistant bioactive coatings. The microgel solutions were covalently reacted
with biomaterial surfaces uaing a dip-coating methodology. The difference in nucleophilicity
of thiols and primary amines was exploited to achieve the slow growth in microgel size and
rapid attachment to surfaces. OWLS and QCM analysis demonstrated minimal protein
adsorption on the capped films, while DLS, NMR and GPC were used to begin to elucidate
the mechanism for microgel formation. Cell adhesion and spreading were inhibited on
microgel-coated glass and PET, but cell adhesion was promoted by a fibrinogen-capped
coating. If the resistance to cell adhesion translates to blood compatibility, PEG-based
microgels could be useful to produce bioactive barriers between blood and vascular devices.
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CHAPTER 4†
Modular Scaffolds Assembled Around Living Cells
Using Poly(Ethylene Glycol) Microspheres with
Macroporation Via a Non-Cytotoxic Porogen
4.1

Abstract
The LCST behavior of poly(ethylene glycol) (PEG) in aqueous sodium sulfate

solutions was exploited to fabricate microspheres without the use of other monomers,
polymers, surfactants or organic solvents. Reactive PEG derivatives underwent thermally
induced phase separation to produce spherical PEG-rich domains that coarsened in size
pending gelation, resulting in stable hydrogel microspheres between ≈1-100 microns in size.
The time required to reach the gel point during the coarsening process influenced the final
microsphere size and morphology. The gel point could be varied by pre-reaction of the
PEG derivatives below the cloud point, or by controlling reaction conditions above the
cloud point. Pre-reaction brought the PEG derivatives closer to the gel point prior to phase
separation, while the temperature influenced the rate of reaction. Dynamic light scattering
indicated a percolation-to-cluster transition about 3-5 minutes following phase separation.
Three types of PEG microspheres with different functionalities were used to form scaffolds,
allowing control over macroporosity and bioactivity. Scaffolds were formed by centrifuging
microspheres in the presence of HepG2 hepatoma cells, resulting in a homogenous
†

Chapter 4 has been adapted from the following unpublished manuscripts:
Scott EA, Nichols MD, Willits RK, Elbert DL. Modular scaffolds assembled around living cells using
poly(ethylene glycol) microspheres with macroporation via a non-cytotoxic porogen. Acta Biomat. (Under
review).
Nichols MD, Scott EA, Elbert DL. Factors affecting size and swelling of poly(ethylene glycol) microspheres
formed in aqueous sodium sulfate solutions without surfactants. Biomaterials. (Under review).
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distribution of cells. Macropores were formed using porogenic PEG microspheres that
dissolved within two days without affecting cell viability. Gradients in porosity were
produced by varying the density of the porogenic microspheres. Bioactivity was introduced
via cell adhesion peptides and delivery of sphingosine 1-phosphate, promoting endothelial
cell infiltration through macropores in the scaffolds.

4.2

Introduction
Hydrogels made from synthetic polymers are promising as scaffolds for tissue

engineering (Drury and Mooney 2003; Tessmar and Göpferich 2007). PEG-based scaffolds
exhibit a high resistance to non-specific protein adsorption and are easily modified with
peptides and proteins to impart biological functions such as cell adhesion or cell-initiated
degradability (Jeon, Lee et al. 1991; Lutolf and Hubbell 2005). Growth factors and
chemotactic factors may also be incorporated within hydrogels to promote cell proliferation,
migration or vascularization (Richardson, Peters et al. 2001; DeLong, Moon et al. 2005).
However, bulk PEG hydrogels effectively encapsulate the cells in polymer, potentially
impacting cell survival, proliferation and migration (Lutolf and Hubbell 2005; Varghese and
Elisseeff 2006). Porosity at multiple length scales may thus be desirable, with smaller pores
providing a niche for functional cells and larger pores permitting vascularization (Hill,
Boontheekul et al. 2006). Such multi-scale porous hydrogels can be formed with a variety of
porogens, but a need exists for porogens that dissolve without compromising cell viability
(Asnaghi, Giglio et al. 1995; Shapiro and Cohen 1997; Lévesque, Lim et al. 2005; Stachowiak,
Bershteyn et al. 2005; Ford, Bertram et al. 2006; Sannino, Netti et al. 2006; Bryant, Cuy et al.
2007; Osathanon, Linnes et al. 2008). A non-cytotoxic porogen would permit incorporation
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of cells at the time of scaffold formation, potentially leading to a more homogenous
distribution of cells compared to cell seeding after scaffold formation.
Modular assembly of different types of microparticles is also desirable to allow
versatility in engineering the properties of the scaffold (McGuigan and Sefton 2006; Yeh,
Ling et al. 2006; Rivest, Morrison et al. 2007; Du, Lo et al. 2008; Pautot, Wyart et al. 2008;
Serban and Prestwich 2008). Scaffolds for cell transplantation can be formed in a modular
manner by assembling microparticles with different functionalites (Rivest, Morrison et al.
2007; Serban and Prestwich 2008). For example, modular scaffolds have been assembled
from short tubes of collagen gels containing HepG2 hepatoma cells. The tubes were
assembled into a highly porous structure and seeded with endothelial cells to produce a nonthrombogenic scaffold (McGuigan and Sefton 2006). Modular scaffolds may also be
assembled from PEG microparticles formed in wells on a silicon wafer or by microfluidics
(Yeh, Ling et al. 2006; Du, Lo et al. 2008). However, the scalability of many microparticle
production techniques (e.g. micromolding, microfluidics, 3D printing) may be a concern due
to the large number of microparticles required to form scaffolds of sufficient size for
practical applications (Tsang and Bhatia 2004; Boland, Xu et al. 2006; Lu, Mapili et al. 2006;
Yeh, Ling et al. 2006; Kim, Utada et al. 2007; Tan and Takeuchi 2007; Um, Lee et al. 2008).
Formation of hydrogel microspheres in solution addresses the issue of scalability but
typically requires the use of organic solvents and surfactants in a two-phase system. These
additives stabilize the size of the polymer-rich phases but may be difficult to remove from
the formed microspheres, potentially affecting biocompatibility. Hennink and colleagues
previously demonstrated that the phase separation of dextran and PEG in water may be used
to produce crosslinked dextran or PEG microspheres without a surfactant (Franssen and
Hennink 1998; Van Thienen, Demeester et al. 2008; Van Tomme, Mens et al. 2008). In this
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system, the phase separated solutions were vigorously shaken before free-radical
polymerization was initiated. Alternatively, hydrogel microspheres have been formed in
water by copolymerizing PEG with a polymer that exhibits a lower critical solution
temperature (LCST) near room temperature. For example, N-isopropylacrylamide monomer
has been used to form microspheres that are about 60% PEG by mass via free-radical
precipitation polymerization at 70°C (Nolan, Reyes et al. 2005). However, poly(Nisopropylacrylamide) itself is known to promote the adsorption of proteins at physiological
temperature and thus maximizing the concentration of PEG in the scaffold is desirable
(Kawaguchi, Fujimoto et al. 1992).
The LCST of low molecular weight PEG (up to 100 kDa) is above the boiling point
of water but is greatly decreased in the presence of kosmotropic salts (e.g. sulfate,
bicarbonate or phosphate anions) (Bailey and Callard 1959; Bae, Lambert et al. 1991). An
advantage of using a salt for the formation of microspheres is that salts may be easily
removed by washing, particularly when compared to polymers, organic solvents or
surfactants. This ability allows the microspheres to be used in a variety of downstream
biological applications that are extremely sensitive to hyperosmotic environments. Hennick
and colleagues found that vigorous mixing of phase separated PEG/sodium sulfate solutions
led to the formation of large aggregates of PEG microspheres upon polymerization, which
was ascribed to the low viscosity of the solution (Franssen and Hennink 1998). Here, we
report that 100% PEG microspheres can be formed in aqueous solutions without surfactants
in the absence of mixing and by timing the gel point to occur prior to extensive coarsening
of the phase-separated PEG-rich domains.
Phase separation occurs by nucleation and growth or by spinodal decomposition,
dependent upon if the spinodal line is crossed. The binodal and spinodal lines are affected
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by the molecular weight of the PEG, such that no single LCST may be associated with a
PEG solution undergoing crosslinking. Furthermore, away from the critical concentration,
single-phase
phase solutions exist between the LCST and the binodal line. For simplicity, a cloud
point temperature corresponding to the binodal line is often reported rather than an LCST
(Bae, Lambert et al. 1991).. Phase separation by nucleation or spinodal decomposition in a
two-phase
phase system results in a polydisperse mixture of phase
phase-separated
ated minority domains
within the majority phase (J.D. Gunton 1983)
1983). Interfacial instability compels
pels the minority
phase droplets to minimize interfacial tension and area by reducing droplet curvature
(Lifshitz and Slyozov 1961)
1961).. Consequently, the minority phase domains grow in size over
time, and this coarsening primarily occurs through the mechanisms of coalescence and/or
Ostwald ripening (Friedlander 1977; Ratke and Voorhees 2002)
2002).. In coalescence, droplets
grow as they collide and merge while moving through the majority phase due to
hydrodynamic flow and Brownian motion (Friedlander and Wang 1966).. Ostwald ripening
reduces the interfacial area of minority phase domains via the diffusional mass transfer of
molecules from regions of high interfacial curvature to regions of low interfacial curvature
(Ostwald 1900; Lifshitz and Slyozov 1961; Voorhees 1992)
1992).. The growth of phase-separated
phase
domains through either or both coalescence and Ostwald ripening displays the same time
dependence of

, where

is the average droplet radius (Lifshitz and Slyozov 1961;

Friedlander and Wang 1966; Crist and Nesarikar 1995)
1995). Given enough
ough time, the phase
domains will coarsen into a single homogenous layer, which in colloidal systems is referred
to as a coacervate layer (Bungenberg de Jong 1949)
1949).
We have formed PEG hydrogel microspheres in aqueous sodium sulfate solutions
by crosslinking PEG derivatives while above the cloud point and during the early stages of
coarsening. Gelation was achieved via conjugate addition reactions between electrophilic
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vinylsulfone or acrylate groups on eight-arm PEG (PEG8-vinylsulfone or PEG8-acrylate,
mol. wt. 10 kDa) and nucleophilc amines on eight-arm PEG (PEG8-amine, mol. wt. 10 kDa)
or bovine serum albumin (BSA) (Figure 1a) (Elbert, Pratt et al. 2001; Wacker, Scott et al.
2006). We utilized this reaction to produce three types of microspheres: 1) PEG8vinylsulfone/PEG8-amine microspheres containing RGD peptides for structural support,
biocompatibility, and cell adhesion, 2) PEG8-acrylate/PEG8-amine microsphere containing
hydrolyzable ester bonds to provide porosity, 3) PEG8-vinylsulfone/BSA microspheres for
the delivery of sphingosine 1-phosphate (S1P), a bioactive lipid that enhances endothelial cell
migration and is released from PEG/BSA hydrogels in controlled manner due to affinity
interactions with BSA (English, Welch et al. 2000; Wacker, Scott et al. 2006) (Figure 4.1).
Unreacted vinylsulfone moieties on the surfaces of these microspheres were further
crosslinked with serum proteins to form three-dimensional scaffolds in the presence of
HepG2 hepatoma cells (Figure 4.2). Within 48 h, the PEG8-acrylate/ PEG8-amine
microspheres dissolved, producing a porous scaffold capable of supporting endothelial cell
infiltration. Furthermore, degradable 100% PEG microspheres were shown to be noncytotoxic, permitting macropore formation in the presence of living cells.
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Figure 4.1: Production of PEG microspheres in aqueous sodium sulfate solutions. Eightarm PEG-vinylsulfone (PEG8-VS) was reacted with eight-arm PEG-amine (PEG8-amine) in
PBS. The Michael-type reaction was followed by dynamic light scattering to detect the
formation of PEG oligomers/microgels during crosslinking. At a certain mean effective
diameter (dPCS), sodium sulfate was added and the solution was heated above the cloud point.
A similar strategy was followed with eight arm PEG-acrylate (PEG8-acrylate) and PEG8amine to produce porogenic microspheres. Microspheres were produced for the delivery of
sphingosine 1-phosphate (S1P) to promote endothelial cell migration by reacting PEG8-VS
with bovine serum albumin (BSA).
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Figure 4.2: Assembly of microspheres into bioactive modular scaffolds in the presence of
living cells. Microspheres with different functionalities were mixed with HepG2 hepatoma
cells in medium containing 2% serum and centrifuged for 10 min at 1000g and allowed to
crosslink overnight at 37°C. Within 48 h, PEG8-acrylate/PEG8-amine microspheres
dissolved to form macroporous scaffolds. Endothelial cells seeded on the scaffolds adhered
via RGD peptide incorporated in the non-degradable microspheres.

133

4.3

Materials and Methods

4.3.1 PEG Derivatives
Unless otherwise noted, all reagents were purchased from Sigma-Aldrich. Eight-arm
PEG-OH (PEG8-OH; mol. wt. 10,000; Shearwater Polymers, Huntsville, AL) was used to
synthesize PEG8-vinylsulfone (PEG8-VS), PEG8-amine, and PEG8-acrylate as previously
described (Elbert and Hubbell 2001; Scott, Nichols et al. 2008). Stock solutions of PEG8VS, PEG8-amine, PEG8-acrylate, and fatty acid-free bovine serum albumin (BSA) solutions
were prepared at 20%(w/v) in Dulbecco’s phosphate buffered saline (Pierce) and sterile
filtered with 0.22 µm syringe filters. For fluorescent labeling, stock solutions of PEG8-amine
or BSA in PBS were reacted with a 10 mg/mL solution of Dylight-488 or Dylight-633
(Pierce) in dimethylformamide at a 100:1 molar ratio of PEG:dye or BSA:dye overnight at
room temperature.

4.3.2 Dynamic Light Scattering
Dynamic light scattering/photon correlation spectroscopy (DLS/PCS; 90Plus
Particle Size Analyzer, Brookhaven Instruments, Holtsville, NY) was performed at a
scattering angle of 90° and wavelength of 658 nm. Calculation of dPCS and statistical analysis
of the results were performed using Brookhaven Instruments Particle Sizing Software
(version 2.34, Brookhaven Instruments).

4.3.3 Microsphere Fabrication and Characterization
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PEG8-VS/PEG8-amine microspheres were fabricated from pre-reacted solutions of
PEG8-VS and PEG8-amine (20%(w/v) PEG in PBS, 37°C, reacted to dPCS ≅ 100 nm unless
otherwise stated; pre-reacted solutions could be stored at -80°C for at least five months).
Pre-reacted solutions were diluted to 2%(w/v) PEG at room temperature with PBS and PBS
+ 1.5 M sodium sulfate to achieve a final sodium sulfate concentration of 0.6 M and volume
of 50 µL. The solutions were then heated above the cloud point to 37°C for 45 min unless
otherwise stated. Suspensions of microspheres were buffer exchanged into PBS 2x to
remove the sodium sulfate, diluting the microsphere solution 3:1 with PBS and titurating and
centrifuging at 14,100g for 2 min. For zeta potential measurements, PEG8-VS and PEG8amine microspheres were formed as described above. PEG8-VS /BSA microspheres were
formed by pre-reaction of PEG8-VS and BSA (12%(w/v) BSA + 8%(w/v) PEG in PBS,
37°C, reacted to dPCS ≅ 100 nm), dilution10x at room temperature to obtain PBS + 0.65 M
sodium sulfate and reaction for 25 min at 37°C. The number of reactive amines per BSA
was assumed to be 36.(Wacker, Scott et al. 2006) PEG8-acrylate and PEG8-amine were prereacted (20%(w/v) PEG in PBS, 37°C, reacted to dPCS ≅ 100 nm), diluted 10x at room
temperature to obtain PBS + 0.45 M sodium sulfate and reacted for 10 min at 95°C. For
confocal microscopy, microspheres were formed as described above, except in PBS + 0.8 M
sodium sulfate to cause phase separation at room temperature. Samples were held above the
cloud point at room temperature for 5 min prior to reaction at the temperature and time
stated above.

4.3.4 Microsphere Fabrication for Scaffolds
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S1P was dissolved in methanol at 0.5 mg/mL and divided into 287 nmol aliquots in
Eppendorf tubes. The methanol solutions were dried under nitrogen. The tubes were filled with
20% (w/v) BSA in PBS (1 nmol S1P/mg BSA) and rotated at 37°C until completely solubilized.
Pre-reacted solutions of PEG8-VS/PEG8-amine (2:1 VS:amine, dPCS ≅ 50 nm, 20%(w/v) PEG) or
PEG8-VS/BSA/S1P (2:1 VS:amine, dPCS ≅ 50 nm, 8.5%(w/v) BSA + 11.5%(w/v) PEG ) were
reacted for 30 min at 37°C with RGD peptide (sequence: GCGYGRGDSPG, Genscript Corp.) at an
RGD concentration of 5.5 mM.(Wacker, Scott et al. 2006) Pre-reacted PEG8-VS/PEG8-amine
solutions (25 µL) were diluted 10x to obtain PBS + 0.6 M sodium sulfate. PEG8-VS/PEG8-amine
microspheres were formed by incubation of this solution for 45 min at 37°C. Pre-reacted PEG8VS/BSA/S1P solutions (25 µL) were diluted 10x to obtain PBS + 0.65 mM sodium sulfate. PEG8VS/BSA/S1P microspheres were formed by incubation of this solution for 25 min at 37°C. Prereacted PEG8-acrylate/PEG8-amine solutions (1:1 acrylate:amine, dPCS ≅ 100 nm, 20%(w/v) PEG, 25
µL) were diluted 10x to obtain PBS + 0.45 mM sodium sulfate. PEG8-acrylate/PEG8-amine
microspheres with low, medium, or high densities were formed by incubation of this solution at 95°C
for 3 min, 5 min, or 10 min, respectively. Microsphere suspensions were buffer exchanged first into
PBS and then into endothelial growth medium (EGM; MCDB 131 medium supplemented with 10
ng/mL epidermal growth factor, 10 mg/mL heparin,1.0 mg/mL hydrocortisone, 1% penicillin–
streptomycin, 2% FBS, and 12 mg/mL bovine brain extract; Clonetics).

4.3.5 Scaffold Assembly and Cell Seeding
PEG8-VS/PEG8-amine microspheres, PEG8-VS/BSA microspheres and PEG8acrylate/PEG8-amine microspheres (1:1:1 of washed microsphere solutions) were combined
and briefly mixed by tituration with 5x105 HepG2 cells in EGM in UV/vis cuvettes
(Brookhaven Instruments Corporation) to a final volume of 1 mL. Microspheres and cells
were centrifuged for 10 min at 1000g. Scaffolds were incubated for 48 h at 37°C followed by
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replacement of the medium with fresh EGM containing 5x105 endothelial cells. Live/dead
assays were performed by incubating scaffolds for 30 min at 37°C with EGM containing 12
µM fluorescein diacetate (Sigma) and 250 µM ethidium bromide (Pierce).

4.3.6 Confocal Microscopy
Fluorescence microscopy was performed with a Nikon Eclipse C1/80i confocal
microscope. Suspensions of fluorescently-labeled microspheres were imaged on glass
microscope slides (Corning Inc.) with a 20X objective (0.45 DIC L WD 7.4). Scaffolds were
imaged in EGM and within UV/vis cuvettes with a 10X objective (0.3 DIC L/N1 WD 16.0).
Images were processed and rendered in 3D using EZ-C1 3.70 FreeViewer software (Nikon
Instruments Inc.).

4.3.7 Rheometry
Storage (G’) and loss (G”) moduli of bulk hydrogels and scaffolds were measured at
room temperature with oscillatory shear rheometry (25 mm parallel plate) on a fluids
rheometer (RFS3, Rheometric Scientific). Viscoelasticity was measured at 5% strain within a
frequency range of 1-100 Hz. Scaffolds (1 mm thickness) were formed from PEG8VS/PEG8-amine microspheres (2:1 VS:amine) as above, with centrifugation in silanized
(Sigmacote) glass vials (25 mm diameter). Bulk hydrogels were prepared in situ on the
surface of the 25 mm parallel plate by mixing 200 mg/mL solutions of PEG8-VS (200 µL)
and PEG8-amine (200 µL) in PBS pH 10.0 at a 1:1 ratio.

4.3.8 Statistics
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A p-value < 0.05 was considered significant. Data were mean ± standard deviation.

4.4

Results

4.4.1 Formation of PEG-VS/PEG-Amine Microspheres
Reaction of PEG derivatives above the cloud point led to microsphere formation
only under specific conditions. To form microspheres at pH 7.4 and 37°C within 45 min,
initial reaction of the PEG macromonomers below the cloud point was required (‘prereaction’). We previously demonstrated that the extent of the crosslinking reaction between
eight-arm PEG-vinylsulfone (PEG8-VS; 10 kDa) and eight-arm PEG-amine (PEG8-amine;
10 kDa) at 20%(w/v) PEG and 37°C in phosphate buffered saline (PBS, pH 7.4) could be
monitored with dynamic light scattering (DLS) (Scott, Nichols et al. 2008). Well before
gelation, PEG oligomers/microgels with hydrodynamic radii ≥10 nm were observed by DLS
and reached a mean effective diameter (dPCS) of about 180 nm just prior to bulk gelation,
which normally occurred after 6.5 h. To form microspheres, solutions with dPCS ≅ 100 nm
by DLS were diluted to 2%(w/v) PEG in PBS + 0.6 M sodium sulfate at room temperature
and raised above the cloud point to 37°C. These conditions allowed mixing of polymer and
salt at room temperature and did not lead to bulk gelation while the solution was heated to
the cloud point. Above the cloud point, the spherical PEG-rich domains coarsened and
crosslinked over the course of 45 min, resulting in the formation of stable PEG
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a

b

c
10 µm
Figure 4.3: PEG or PEG/BSA microspheres were formed above the cloud point and then
buffer exchanged into PBS. Phase-contrast photomicrographs with a 20X objective of: (a)
PEG8-VS/PEG8-amine (b) PEG8-acrylate/PEG8-amine and (c) PEG8-VS/BSA
microspheres. Scale bar = 10 µm.
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microspheres. Following buffer exchange into PBS, the microspheres had mean diameters
of 6.65±1.65 µm and a polydispersity of 1.59† (Figure 4.3a). In contrast, when PEG8-VS
and PEG8- amine were mixed and immediately heated above the cloud point (i.e. without
pre-reaction), stable microspheres did not form after 45 min and further incubation
overnight produced a bulk hydrogel (Table 4.1, Fig 4.4). However, pre-reaction was not
necessary to form microspheres if the solution of PEG8-VS and PEG8-amine was rapidly
heated to 95°C instead of 37°C (Table 4.1 & Figure 4.4). The rate of coarsening affected
microsphere formation, as samples formed bulk gels within 45 min when vortexed above the
cloud point or when prepared with PBS + 1.5 M sodium sulfate (Table 1, Figure 4.4 & 4.5)‡.
Presumably, vortexing increased the encounter rate between the phase-separated domains
while high salt promoted ‘floating’ of the PEG-rich phase. The critical factor for
microsphere formation was thus the balance between the rates of gelation and coarsening.
The importance of pre-reacting the components before phase separation may have
been due to the dramatic difference in the cloud point between PEG8-VS and PEG8-amine.
The cloud point of 2% (w/v) PEG8-VS in PBS + 0.6 M sodium sulfate was close to room
temperature, while the cloud point of the cationic PEG8-amine was >100°C†. Eight-arm
PEG-acrylate (PEG8-acrylate, 10 kDa) was found to phase separate at lower temperatures
than PEG8-VS†. DLS was used to investigate the effects of the charged PEG8-amine on the
early stages of coarsening above the cloud point of PEG8-VS (Figure 4.6). A linear
relationship was found between the mean diameter of the phase-separated domains and
time, which is expected in the early stages of phase separation (Crist 1996). A plateau in

†

Microsphere sizing was performed by Michael D. Nichols using phase contrast photomicrographs of
microspheres at 20X. Briefly, >500 microspheres from three separately prepared samples were manually
thresholded and quantified with ImageJ software (NIH).
‡ Data was collected by Michael D. Nichols
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Table 4.1: Summary of products resulting from microsphere fabrication methods
Salt conc. (M
sodium sulfate
+PBS; pH 7.4)

Pre-reaction
(below the cloud
point) (dPCS)

Reaction temperature and
time (above the cloud point)

Result

Image

No microspheres or gel
Bulk gel of microspheres
Microspheres
Microspheres
Microspheres
Bulk gel with irregular
structure
Bulk gel of microspheres
Bulk gel of microspheres

Figure 4.4d
Figure 4.4a
Figure 4.4b
Figure 4.4c
Figure 4.3a

PEG8-vinylsulfone/PEG8-amine
0.6
0.6
0.6
0.6
0.6

None
None
None
100 nm
100 nm

0.6

100 nm

1.5
1.5

None
100 nm

37°C, 45 min
37°C, overnight
95°C, 3 min
95°C, 3 min
37°C, 45 min
37°C, 45 min, with 5 min
vortex
95°C, 5 min
95°C, 5 min

Figure 4.5
Figure 4.4e
Rig. 4.4f

PEG8-acrylate/PEG8-amine
0.45

100 nm

95°C, 10 min

0.45

100 nm

95°C, 5 min

0.45

100 nm

95°C, 3 min

High density
microspheres*
Medium density
microspheres*
Low density microspheres*

Figure
4.15a(i)
Figure 4.3b,
4.15a(ii)
Figure 4.15a

PEG8-vinylsulfone/BSA
0.65

100 nm

37°C, 25 min

0.65

100 nm

95°C, 10 min

*

Medium density
microspheres*
Denatured BSA

Figure4.3c
-

Density is relative to PEG8-vinylsulfone/PEG8-amine microspheres (dPCS = 100 nm, 45 min at 37°C in PBS +
0.6 M sodium sulfate)
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a

d

b

e

c

f

Figure 4.4: Formation of microspheres was influenced by pre-reaction of PEG derivatives
below the cloud point. PEG8-VS/PEG8-amine microsphere were formed with or without
pre-reaction followed by dilution to 2%(w/v) PEG in PBS + sodium sulfate. Phase-contrast
photomicrographs at 20X of: (a) Bulk gel formed from aggregated and crosslinked
microspheres fabricated without pre-reaction, PBS + 0.6 M sodium sulfate, 37°C for 12 h
(scale bar = 100 µm), (b) No pre-reaction, PBS + 0.6 M sodium sulfate, 95ºC for 3 min
(scale bar = 50 µm), and (c) Pre-reaction to dPCS ≅ 100 nm, PBS + 0.6 M sodium sulfate,
95ºC for 3 min (scale bar = 50 µm). Confocal microscopy at 10X of fluorescent PEG8-VS
(green) and PEG8-amine (blue) reacted under different conditions: (d) No pre-reaction, PBS
+ 0.6 M sodium sulfate, 37°C for 45 min (scale bare = 50 µm), (e) No pre-reaction, PBS +
1.5 M sodium sulfate, 95ºC for 5 min (scale bar = 200 µm), (f) Pre-reaction to dPCS ≅ 100 nm,
PBS + 1.5 M sodium sulfate, 95ºC for 5 min (scale bar = 200 µm).
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Figure 4.5: Crosslinking with vortexing during the initial reaction
ion produced bulk hydrogels.
Pre-reacted PEG8-VS
VS and PEG8-amine (1:1 VS:amine, dPCS ≅ 100 nm, 20%(w/v)) were
diluted 10x to 2%(w/v) in PBS + 0.6 M sodium sulfate. Solutions were vortexed for the
first 5 min after the temperature was raised to 37ºC, resul
resulting
ting in the formation of white
precipitates. The sample was then incubated without mixing at the same temperature for an
additional 40 min. Phase-contrast
contrast photomicrographs at ((a)) 10X (scale bar = 100 µm) and
(b) 20X (scale bar = 200 µ
µm) reveal a bulk hydrogel with an irregular structure.
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PEG8-VS 1%(w/v)
PEG8-VS 2%(w/v)
PEG8-VS/Am 2%(w/v) (not pre-reacted)
PEG8-VS/Am 2%(w/v) (pre-reacted)

Figure 4.6: DLS of PEG solutions above their cloud points demonstrated that mean
effective droplet diameters (dPCS values) increased linearly with time during early stages of
coarsening, as expected for this process by coalescence or Ostwald ripening. Later, an
apparent regime change to slower growth with time was observed, possibly corresponding to
a percolation-to-cluster transition. Both decreasing the concentration of PEG8-VS and
mixing PEG8-Am with the PEG8-VS (PEG8-VS/Am) slowed coarsening. Pre-reaction of
these components to dPCS ≅ 100 nm further reduced the rate of coarsening. Data represent
three independent samples averaged over 10 runs.
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coarsening was reached 3-5 minutes after phase separation that may correspond to a
percolation-to-cluster transition (Crist 1996). The rate of coarsening of a PEG8-VS solution
was not greatly affected by the presence of PEG8-amine if the two components were mixed
just prior to raising the temperature above the cloud point. However, pre-reaction of PEG8VS with PEG8-amine to a dPCS ≅ 100 nm increased the cloud point and produced a plateau in
coarsened microsphere size at 700 nm instead of 1400 nm, indicating that PEG8-amine may
have had a stabilizing or emulsifying effect on the phase-separated PEG.

4.4.2 Formation of PEG-Acrylate/PEG-Amine and PEG-VS/BSA
Microspheres
Having found suitable conditions for stable microsphere formation, we then
produced degradable microspheres for macropore formation and PEG/protein
microspheres for drug delivery (Figure 4.3b,c). To fabricate degradable microspheres, eightarm PEG-acrylate (PEG8-acrylate; 10 kDa) was reacted with PEG8-amine. Hydrolysis of the
ester bonds present due to the acrylate provided a mechanism for dissolution of the
microspheres (Elbert, Pratt et al. 2001). Compared to vinylsulfone, the acrylate group has a
slightly lower reactivity towards amines (Friedman 1965). The slower kinetics of the reaction
were overcome by pre-reaction to a dPCS ≅ 100 nm and incubation for 5 min at 95°C in PBS
+ 0.45 M sodium sulfate at 2%(w/v) PEG (Table 4.1). PEG/BSA microspheres were
produced for delivery of S1P from the scaffolds, since we previously demonstrated that
controlled release of S1P from PEG/BSA hydrogels enhances endothelial cell migration
(Wacker, Scott et al. 2006). The biocompatibility of PEG/BSA and 100% PEG hydrogel
surface coatings was previously compared and both were found to be highly resistant to
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non-specific cell adhesion (Scott, Nichols et al. 2008). In contrast to the 100% PEG
microspheres, production of PEG/BSA microspheres could not be performed at high
temperature due to denaturation of the BSA (Table 1). Formation of microspheres at 37°C
required pre-reaction of PEG8-VS with amine groups on BSA. PEG8-VS was pre-reacted
with BSA to a dPCS ≅ 100 nm, followed by incubation for 25 min at 37°C in PBS + 0.65 M
sodium sulfate at 0.8%(w/v) PEG and 1.2%(w/v) BSA. A negative zeta potential was
observed for the PEG/BSA microspheres due to the presence of BSA, while microspheres
made with PEG8-amine were positively charged (Figure 4.7).

4.4.3 Microsphere Ripening and Coalescence
Microsphere coarsening and crosslinking were further investigated using
fluorescently labeled microspheres. To observe Ostwald ripening, solutions of fluorescent
PEG8-vinylsulfone (green) and fluorescent PEG8-amine (blue) were separately raised above
their cloud points in PBS + 1.2 M sodium sulfate and then mixed (Figure 4.8a). Over time,
the fluorescent PEG derivatives transferred between the two types of spherical domains
without observing coalescence. The exchange must have occurred via mass transfer through
the majority phase, indicating that Ostwald ripening occurs during coarsening of the PEG
domains. Transfer of fluorescent PEG from smaller to larger droplets was additionally
observed to occur (Figure 4.8b). A salt concentration more typical for microsphere
formation (PBS + 0.6 M sodium sulfate) was used to observe coalescence. Fluorescent
PEG8-vinylsulfone and fluorescent PEG8-amine were pre-reacted to a dPCS of 100 nm. The
solution was then heated for 15 min at 37°C, followed by visualization on a confocal
microscope. PEG-rich domains with different ratios of PEG8-vinylsulfone (green) and
PEG8-amine (blue) were found, as judged by the relative fluorescence intensities. Some of
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Figure 4.7: Zeta potentials of microspheres were determined by the charge of the
crosslinker. Zeta potentials of PEG8-VS/PEG8-amine (PEG8-VS/Am),
VS/Am), PEG8acrylate/PEG8-amine
amine (PEG8-Ac/Am), and PEG8-VS/BSA
VS/BSA microspheres were measured.
Net positively charged microspheres formed when crosslinked with PEG8-amine
amine and net
negatively
ely charged microspheres formed when crosslinked with BSA. Data represent n = 3
independent samples averaged over 10 runs each.
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Figure 4.8: The formation of PEG8-VS/PEG8-amine
amine microspheres was monitored by
confocal microscopy at 20X magnification using fluorescently labeled PEG. (a)
( PEG8-VS
(green) and PEG8-amine
amine (PEG8-Am;
Am; blue) were separately added to PBS + 1.2 M sodium
sulfate to cause phase separation of both polymers at room temperature. The phase
separated solutions were then mixed. Mass ttransfer
ransfer occurred between the droplets without
coalescence, indicating that Ostwald ripening occurred. ((b)) Mass transfer was also directly
observed under these same conditions between touching PEG
PEG-rich
rich droplets.
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a

b

50 µm
Figure 4.9: PEG-rich droplets before (a) and after (b) coalescence. PEG8-VS (green) was
pre-reacted with PEG8-amine (blue) to dPCS ≅ 100 nm and then crosslinked above the cloud
point for 15 min at 37ºC in PBS + 0.6 M sodium sulfate.
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a

30 µm
b

50 µm
c

50 µm
Figure 4.10: Water-rich droplets were observed while monitoring the formation of PEG8VS/PEG8-amine microspheres by confocal microscopy at 20X magnification. Fluorescently
labeled PEG8-VS (green) was mixed with PEG8-amine (blue) in PBS + 0.6 M sodium sulfate
and heated at 37ºC for 15 min: (a-c) progression of coarsening of water-rich domains within
PEG-rich droplets over 15 min.
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these spherical domains were observed to coalesce, forming larger spheres with an
intermediate ratio of the two types of PEG (Figure 4.9). Over the course of 20 min,
coalescence of PEG-rich domains became less frequent and unlabeled regions began to
appear (Figure 4.10). Since both PEG derivatives were fluorescently labeled, the unlabeled
regions signified the presence of a water-rich, polymer-poor phase. Water-rich domains
grew in size within the PEG-rich spherical domains. Eventually, the water-rich droplets
ceased to grow in size suggesting that the PEG-rich domains had reached the gel point.
Additionally, small domains of PEG8-VS were often found to form within larger PEG8amine phases and vise verse, sometimes producing multiple emulsions (Figure 4.11). To
better visualize the structure of the formed microspheres, relatively large fluorescent
microspheres (≈100 µm instead of ≈10 µm) were generated by lowering the cloud point to
room temperature and allowing the solution to coarsen for 5 min before raising the
temperature to 37°C for 45 min. Results revealed that after gelation the water-rich domains
became pores in the microspheres (Figure 4.12a). Degradable PEG8-acrylate/PEG8-amine
and PEG8-VS/BSA microspheres possessed the same porous structures (Figure 4.12b,c ).

4.4.4 Assembly of Modular Scaffolds
After formation, microspheres were buffer exchanged into PBS or cell culture
medium and reacted to form scaffolds. Unreacted vinylsulfone and amine groups were
present on the surfaces of the microspheres, evidenced by the aggregation and crosslinking
of microspheres overnight in PBS. To increase the availability of reactive groups for
scaffold formation, microspheres were produced with 2:1 or 1:2 ratios of PEG8-VS to
PEG8-amine. The 2:1 and 1:2 ratio microspheres were mixed in PBS and compacted by
centrifugation in UV/vis cuvettes, permitting in situ visualization by confocal microscopy.
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Figure 4.11: PEG8-VS
VS and PEG8-amine
amine domains were found to form multiple emulsions
following coalescence. (a-d
d)) Progression of multiple emulsion formation within a PEGPEG
amine droplet. The final multiple droplet (d) is a PEG
PEG-amine/PEG-VS/PEG
VS/PEG-amine/water
emulsion.
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a

50 µm

b

50 µm

c

vi

50 µm
Figure 4.12: To visualize the porous structure, larger microspheres were produced by prereacting all samples to dPCS ≅ 100 nm and diluting in PBS + 0.8 M sodium sulfate, followed
by reaction for 5 min above the cloud point at 25°C prior to further reaction as noted: (a)
PEG8-VS/PEG8-amine (green), 37ºC for 45 min (b) PEG8-acrylate/PEG8-amine (blue),
95ºC for 5 min. (c) PEG8-VS/BSA (blue), 37ºC for 45 min. Scale bar = 50 µm.
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Stable scaffolds formed after 200 min at 2000g, conditions that may not be favorable for cell
survival. However, 2:1 ratio microspheres formed stable scaffolds when centrifuged for 10
min at 1000g in the presence of cell culture medium containing 2% serum followed by an
overnight incubation at 37°C. The presence of 2% serum was necessary for scaffold
formation, indicating that serum proteins served to crosslink the microspheres via reaction
of amines on the proteins with vinylsulfone groups on the microspheres. Scaffolds
supported their own weight in medium (Figure 4.13a) and had storage moduli that were
about an order of magnitude lower than bulk hydrogels formed from the same reactants
(Figure 4.13b). The storage moduli of the scaffolds were similar to liver tissue and higher
than Matrigel or collagen gels (Raeber, Lutolf et al. 2005; Cullen, Lessing et al. 2007;
Levental, Georges et al. 2007; Lai, Li et al. 2008). Scaffolds with greater stiffnesses were
fabricated by crosslinking microspheres above the cloud point, but these conditions were
not amenable to forming scaffolds in the presence of cells (Figure 4.14a). When placed in
high concentration salt solutions that decreased the cloud point to ≤ room temperature,
assembled scaffolds responded by shrinking in size by up to 300%, possibly due to a
combination of water extrusion and osmotic pressure (Figure 4.14b).
The distribution of macropores was controlled by the density (i.e. buoyancy) of the
porogenic microspheres relative to the other microsphere types. The density of the PEG8acrylate/PEG8-amine microspheres was changed by varying the length of the reaction at
95°C from 3 min to 10 min during their formation. Upon centrifugation, PEG8acrylate/PEG8-amine microspheres migrated to different locations relative to PEG8VS/BSA microspheres, producing gradients in porogenic microspheres (Figure 4.15). If the
densities of the different microsphere types were matched by selecting appropriate
microsphere formation conditions, scaffolds assembled from PEG8-VS/PEG8-amine
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a

b

Figure 4.13: Scaffolds may be formed by centrifuging microspheres in the presence of 2%
serum. (a) Photograph of a scaffold composed of PEG8-VS/PEG8-amine microspheres,
PEG8-acrylate/PEG8-amine microspheres and PEG8-VS/BSA microspheres. Microspheres
were compacted by centrifugation at 1000g for 10 min in the presence of HepG2 hepatoma
cells and then incubated for 12 h at 37°C in medium with 2% FBS. (b) Rheometric
measurements of storage (G’) and loss (G”) moduli of modular scaffolds formed from
PEG8-VS/PEG8-amine microspheres compared with bulk hydrogels formed by crosslinking
PEG8-VS with PEG8-amine below the cloud point.
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Figure 4.14: Photograph
Photographs of modular scaffolds. (a) Modular scaffold formed overnight in
high salt without centrifugation. Photo of a scaffold formed from PEG8-VS/PEG
VS/PEG8-amine
microspheres produced in PBS + 0.6 M sodium sulfate pH 7.4 incubated for 12 h instead of
45 min at 37ºC in
n a 1.5 mL centrifuge tube. Stable microspheres that formed in the solution
rose to the top due to their lower densities relative to the solution, allowing crosslinking
between unreacted vinylsulfone and amine groups on the microspheres. ((b)) Shrunken
modular
lar scaffold that was raised above the cloud point in sodium sulfate solution. Scaffold
was formed by centrifugation of PEG8-VS/PEG8-amine
amine microspheres at 1000g
1000 for 10 min
followed by incubation for 12 h at 37°C in medium with 2% FBS.
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Figure 4.15: Scaffolds could be fabricated with gradients of microspheres. Images were
obtained by confocal microscopy with a 10X objective. ((a)) Scaffolds formed by centrifuging
PEG8-VS/BSA
VS/BSA microspheres (green) with ((i) low, (ii)) medium or (iii) high density PEG8acrylate/PEG8-amine
amine microspheres (blue). The density of the PEG8-acrylate/PEG
acrylate/PEG8-amine
microspheres was varied by reacting solutions of PEG8-acrylate and PEG8-amine
amine in PBS +
0.45 M sodium sulfate at 95°C for: ((i) 3 min, (ii) 5 min or (iii) 10 min. (b)) 3D section
sectio of
gradient scaffold from (a(i)).
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microspheres and degradable PEG8-acrylate/PEG8-amine microspheres demonstrated an
even distribution of the two types of microspheres (Figure 4.16a). After incubation at 37°C
for 2 days, the PEG8-acrylate microspheres had completely dissolved, leaving behind a
porous scaffold of the PEG8-VS/PEG8-amine microspheres (Figure 4.16b). Some
microsphere aggregation prior to scaffold formation was generally observed, but this had the
desirable effect of increasing the size and connectivity of macropores that eventually formed
in the scaffolds. Assembly of all three types of microspheres with matched densities also led
to the formation of scaffolds with evenly distributed pores after two days at 37°C (Figure
4.17).

4.4.5 Cell Interactions with Scaffolds
The standard scaffold formation conditions were well-tolerated by living cells (1000g
for 10 min in medium with 2% serum followed by incubation at 37°C overnight). To
support cell adhesion, cysteine-containing RGD peptide was conjugated to PEG8-VS during
pre-reaction with PEG8-amine or BSA.(Elbert and Hubbell 2001) Cell-laden scaffolds were
formed by mixing the RGD peptide-derivatized microspheres with degradable microspheres
and HepG2 hepatoma cells prior to centrifugation. A live/dead assay revealed the viability
of HepG2 cells to be minimally impacted by centrifugation in the presence of the
microspheres (93.64 ± 3.34% live cells). Dissolution of porogenic microspheres over the
course of two days had no further effect on the survival of the HepG2 cells (91.94 ± 1.87%
live cells), demonstrating that the degradation products of the porogenic microspheres were
not cytotoxic (Figure 4.18a). The cells were evenly distributed in the scaffolds and
surrounded by but not encapsulated within microspheres. Each cell formed its own niche
within the scaffold that was further expanded upon dissolution of the porogenic
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Figure 4.16: Macroporosity was introduced in the presence of cells via dissolution
diss
of
porogenic microspheres. (a) A scaffold formed from PEG8-VS/PEG8-amine
amine microspheres
(green) and PEG8-acrylate/PEG
acrylate/PEG8-amine
amine microspheres (blue) with matched densities, imaged
12 h after centrifugation in cell culture medium at 37°C. ((b) Scaffold from
rom (a) after 48 h in
cell culture medium at 37°C. PEG8-acrylate/PEG8-amine
amine microspheres (blue) were no
longer detectable.
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Figure 4.17: Confocal microscopy at 10X of a macroporous scaffold composed of PEG8VS/PEG8-amine
amine microspheres (green), PEG8-acrylate/PEG8-amine
amine microspheres PEG8VS/BSA microspheres (blue), 48 h after formation. Microsphere densities were matched to
produce an even distribution of macropores following dissolution of PEG8-acrylate/PEG
8amine microspheres.
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Figure 4.18: Scaffolds
ds could be formed in the presence of cells. ((a)) HepG2 cell viability in a
scaffold composed of PEG8-VS/PEG8-amine microspheres, PEG8-acrylate/PEG
acrylate/PEG8-amine
microspheres (blue) and PEG8-VS/BSA microspheres. The PEG8-acrylate/PEG
acrylate/PEG8-amine
microspheres were no longer detectable, demonstrating complete hydrolysis of porogenic
microspheres. HepG2 cells were stained with fluorescein diacetate (green; live) and ethidium
bromide (red; dead). (b)) HepG2 cell viability in a scaffold similar tto
o (a) but composed of
PEG8-VS/PEG8-amine
amine microspheres, PEG8-VS/BSA
VS/BSA microspheres (blue) and PEG8acrylate/PEG8-amine
amine microspheres. HepG2 cells were evenly dispersed throughout the
macroporous scaffold and were surrounded by microspheres but not encapsulated
encapsulate in them.
Live/dead
ive/dead assays were performed 48 h after scaffold formation to allow porogen dissolution,
dissolution
revealing cell viability of 91.9 ± 1.87% ((n=3).
=3). Cells were imaged by confocal microscopy
with a 10X objective.
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microspheres (Figure 4.18b). Cell viability decreased to 43.4± 9. 7% after three weeks in
culture when the medium changes every two days.
The potential for directed vascularization into the modular scaffolds was assessed by
observing the infiltration of human aortic endothelial cells after dissolution of the porogen.
Due to the formation of a tight seal between the scaffolds and the sides of UV/vis cuvettes,
endothelial cell migration only occurred from the top of the scaffold (Figs. 4.19 & 4.20). For
confocal microscopy, the cuvettes were turned on their sides to allow imaging along the
entire length of the scaffold to a maximum observable depth of about 300 microns. The
influence of macroporosity on endothelial cell infiltration was investigated by introducing
gradients of porosity into scaffolds, which resulted in a highly porous 250-300 µm upper
layer and a less porous lower layer (Figure 4.21a). With RGD peptide incorporated in the
scaffold, endothelial cells labeled with Vybrant DiI (red) penetrated throughout the highly
porous upper layer within 24 h (Figure 4.21a(i)) and continued to migrate into the less
porous lower region by 48 h (Figure 4.21a(ii)). No endothelial cell infiltration was found
when the scaffolds were formed without the porogenic microspheres (Figure 4.21a(iii)).
With high porosity but no RGD peptide, endothelial cells were found only at the top of the
scaffold (Figure 4.21a(iv)). To specifically probe the influence of S1P release, endothelial cell
migration rates into scaffolds with uniform porosity were compared with and without
loading of S1P into the PEG8-VS/BSA microspheres (Figure 4.21b). The rate of endothelial
cell migration increased from 2.6 ± 0.8 µm/h to 5.4 ± 1.0 µm/h when S1P was delivered
from PEG/BSA microspheres (p < 1x10-5).
Finally, we observed the infiltration of endothelial cells into scaffolds containing
HepG2 cells. The scaffolds formed with HepG2 cells and all three microsphere types were
cultured for two days to allow pore formation by dissolution of the PEG8-acrylate/PEG8162

Figure 4.19: Modular scaffolds formed tight seals with the walls of UV/vis cuvettes in
which they were fabricated. Photograph of a scaffold fabricated by crosslinking PEG8VS/BSA microspheres, PEG8-VS/PEG8-amine microspheres, and PEG8-acrylate/PEG
acrylate/PEG8amine microspheres in cell media. The scaffold was not disturbed following formation
within the UV/vis cuvettes. A tight seal formed with the walls of the UV/vis cuvette walls,
allowing endothelial cell infiltration only from the top surface of the scaffold. Cell migration
migrati
could thus be measured for the entire height of the scaffold by imaging the scaffold on its
side, despite the 300 micron limit to the depth of field of the confocal microscope.
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Figure 4.20: Penetration of endothelial cells into surface pores of a mo
modular
dular scaffold.
Macropores were visible at the top surface of a modular scaffold composed of PEG8VS/PEG8-amine
amine microspheres, PEG8-VS/BSA
VS/BSA microspheres (green) and PEG8acrylate/PEG8-amine
amine microspheres. Scaffolds were imaged by confocal microscopy at 10X
magnification: (a) prior to cell seeding, ((b) after seeding Vybrant DiI-stained
stained endothelial cells
(red). Endothelial cells adhered to RGD peptide conjugated to microspheres, which allowed
migration into macropores.
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Figure 4.21: S1P, porosity
porosity, and RGD peptide affected endothelial cell migration in modular
scaffolds. (a)) Migration of Vybrant DiI stained endothelial cells (red) into scaffolds
composed of PEG8-VS/PEG
VS/PEG8-amine microspheres (green), PEG8-acrylate/PEG
acrylate/PEG8-amine
microspheres and PEG8-VS/B
VS/BSA
SA microspheres (blue). Scaffolds were formed with: (i)
(
RGD peptide and a highly porous 250
250-300 µm
m upper layer, imaged 24 h after cell seeding,
(ii)) Same location within scaffold from (i) at 48 h, ((iii)) RGD peptide but no porogenic
microspheres, 24 h, (iv)) No RGD peptide but with porogenic microspheres, 48 h. (b)
(
Migration of endothelial cells (red) into scaffolds with uniform porosity composed of PEG8VS/PEG8-amine
amine microspheres, PEG8-acrylate/PEG8-amine
amine microspheres and PEG8VS/BSA microspheres (with or without S1P-loaded, green): (i)) 60 h after cell seeding
without S1P-loading, (ii)) 108 h without S1P
S1P-loading, (iii) 60 h with S1P-loading,
loading, (iv)
( 108 h
with S1P-loading.
loading. The maximum extent of migration of endothelial cells was recorded at 50
µm increments within
thin each scaffold. The average rate of migration increased from
2.57±0.76 µm/h
m/h to 5.4±1.02 µm/h when S1P was released from the PEG8-VS/BSA
microspheres.
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Figure 4.22: Endothelial cell migration into scaffolds containing HepG2 cells. Modular
scaffolds were formed from all three types of microspheres in the presence of HepG2 cells
stained with Vybrant DiO (green). After crosslinking with media proteins and hydrolysis of
porogenic microspheres for 48 h, endothelial cells (red) were seeded onto all sides of the
scaffolds. The scaffolds contained: ((i) S1P-loaded PEG8-VS/BSA
VS/BSA microspheres (blue)
without RGD peptide, (ii)) PEG8-VS/BSA
VS/BSA microspheres (blue) loaded with S1P, with RGD,
(iii) PEG8-VS/BSA
VS/BSA microspheres (blue) not loaded with S1P, with RGD. Cells were imaged
by confocal microscopy with a 10X objective. Endothelial cells migrated to the maximum
observable distance (300 µm) within two days with or without S1P delivery. Scaffolds were
imaged by confocal microscopy with a 10X objective.
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amine microspheres. Scaffolds were dislodged from the cuvettes to permit endothelial cell
infiltration from all sides of the scaffolds. The HepG2 cells within these scaffolds were
labeled with Vybrant DiO (green) while the endothelial cells were labeled with Vybrant DiI
(red). The PEG8-VS/BSA microspheres were labeled with Dylight 633 (blue). In the
absence of RGD peptide, few endothelial cells were observed in the scaffolds by confocal
microscopy (Figure 4.22a). With conjugated RGD peptide, endothelial cell migration was
observed after two days up to the maximum imaging depth of 300 µm with or without S1P
delivery (Figs. 4.22a,b).

4.4

Discussion
In this study, we introduce a new method of constructing tissue engineering

scaffolds from novel PEG-based microspheres. The method is highly scalable and amenable
to macroporous scaffold formation in the presence of living cells. Rivest et al. recently
categorized different methods of forming hydrogel scaffolds as either “top-down”, i.e. pore
formation followed by cell seeding, or “bottom-up”, i.e. assembly of cell-laden hydrogel
modules (Rivest, Morrison et al. 2007). Our strategy does not fit either description and
represents a new methodology that combines beneficial aspects of both top-down and
bottom-up strategies. Similar to top-down strategies, macropores for cell infiltration are
produced using a degradable porogen, but unlike the commonly used porogens, PEG8acrylate/PEG8-amine microspheres are non-cytotoxic and form macropores in the presence
of cells. Similar to bottom-up strategies, the scaffolds are assembled from smaller modules,
but our modules may be assembled around cells due to their small size and do not require
cell encapsulation within crosslinked bulk hydrogel. Assembly of microspheres around cells
may enhance transport of nutrients and facilitate removal of waste products, while
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macropore formation may permit directed vascularization of scaffolds. Additionally, the
ability to produce microsphere gradients may be useful to introduce gradients in mechanical
stiffness or bioactive factors to influence cellular responses to the scaffolds (Engler, Griffin
et al. 2004; DeLong, Moon et al. 2005; Moore, Macsween et al. 2006). Gradients in these
properties may have applications in both the transplantation of cells in vivo and the
differentiation of stem cells in vitro.
Microsphere formation in aqueous systems without surfactant is rarely attempted
due to rapid aggregation and coarsening of the polymer phase prior to solidification or
gelation. We also observed some moderate aggregation, which likely resulted from the
reaction of residual vinylsulfone and amine groups present within the microspheres.
Occasionally, microspheres were observed that appeared to consist of two or more
microspheres that gelled while coalescing. Hennink and colleagues demonstrated that
vigorously mixed, phase separated all-aqueous solutions of PEG and dextran could be
polymerized by free-radical polymerization, resulting in crosslinked dextran or PEG
microspheres (Franssen and Hennink 1998; Van Thienen, Demeester et al. 2008; Van
Tomme, Mens et al. 2008). A similar method may be used to directly form macroporous
dextran scaffolds, as demonstrated by Shoichet and colleagues (Lévesque, Lim et al. 2005).
It was proposed that the scaffolds consisted of dextran microspheres gelled together, similar
to the bulk gel of microspheres observed under some conditions here (Table 1). To form
microspheres, we avoided these conditions by timing gelation to occur early in the
coarsening process, and therefore the resulting microspheres sizes were influenced by the
time required to reach the gel point. Increasing the solution temperature increased the rate
of the crosslinking reaction to allow the gel point to occur sooner. This decreased the time
allowed for coarsening and produced smaller microspheres.
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Coarsening of PEG
PEG-rich
rich droplets following phase separation supported an
growth law (Figure 4.6b). Such growth is indicative of hydrodynamic interactions that occur
in the early stages of spinodal decomposition (Lal and Bansil 1991).. After about 4 min, DLS
indicated a plateau or asymptote in domain size growth. These findings are consistent with
light scattering studies of polymer solutions following thermally induced phase separation, in
which an initially
tially linear growth regime was followed by a period of much slower growth
(Lauger, Lay et al. 1994).. The cessation of domain growth, or “spontaneous pinning”,
during spinodal decomposition has been frequently observed for high
high-molecular
molecular weight
polymer mixtures away from the critical concentration (Hashimoto, Takenaka et al. 1992).
1992)
Molecular dynamics simulations suggest that the growth has not in fact ceased, but instead
instea
undergone a percolation-to
to-cluster transition (PCT) from a
finally to a

to a

and

growth law (Crist and Nesarikar 1995; Crist 1996; Termonia 1997).
1997)

The physical
hysical occurrence responsible for the shift in growth law has been proposed to be the
disbanding of a percolated polymer network, present immediately after spinodal
decomposition, into isolated aggregates and droplets that grow by coalescence and Ostwald
ripening (Termonia 1997)..
DLS results demonstrated a difference in coarsening rate and PCT between the
different PEG solutions. The pre
pre-reacted PEG8-VS/PEG8-amine
amine samples coarsened at a
slower rate and reached the PCT at a smaller dPCS than the PEG-monomers
monomers solutions.
Several factors may have influenced the coarsening of PEG
PEG-rich
rich phases. The buoyancy of
PEG-rich
rich droplets caused by the high density ssalt
alt solutions is a possible explanation. PEG8amine has a higher LCST than PEG8-VS,
VS, and crosslinking of the two polymer results in an
intermediate cloud point. Thus a higher salt concentration was required to cause phase
separation at the same temperatur
temperature for PEG8-VS than for PEG8-VS/PEG8-amine
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reacted solutions, which could cause a discrepancy in the coarsening rate due to differences
in density of the salt solutions. Alternatively, the PEG8-amine may influence coarsening by
acting as a surfactant. The higher LCST for more highly charged PEG8-amine compared to
PEG8-VS is likely reflective of increased hydrogen bonding and may enable PEG8-amine to
function as a surfactant to stabilize PEG8-VS droplets. This is evidenced by the decrease in
coarsening rate that occurs when mixing PEG8-VS and PEG8-amine without pre-reaction.
In the pre-reacted sample, PEG8-amine may act as a reactive surfactant, which would
improve its ability to stabilize PEG-rich phases. This effect in combination with being
initially closer to the gel point could stabilize the PEG-rich domains for the pre-reacted
solutions and may contribute to the observed lower dPCS at the PCT.
The microspheres described herein were not only polydisperse but also porous.
Similar pores have been observed in gelatin coacervates following a decrease in temperature
(Kruyt 1949). In PEG/water biphasic systems, an increase in molecular weight broadens the
binodal curve, increasing the PEG equilibrium concentration in the PEG-rich domains (Bae,
Lambert et al. 1991). Thus, water should be released during crosslinking to form water-rich
domains inside the PEG-rich domain. The water-rich domains coarsen inside the PEG-rich
phase, resulting in pores after gelation if the water-rich domains are unable to diffuse to the
surface of the PEG-rich phase. This suggests that our method of microsphere formation is
similar to the coacervation method commonly used to form gelatin microcapsules for drug
encapsulation (Arshady 1990). Coacervates can be used to surround insoluble solid particles
or droplets of immiscible phases, making them well suited for microencapsulation strategies
(Bungenberg de Jong 1949; Russell E. Phares Jr. 1964). The Mikos group has used this
method to encapsulate growth factors within degradable gelatin microparticles for sustained,
localized drug release (Holland, Tessmar et al. 2004). When a sufficiently high sodium
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sulfate concentration was used to produce a triphasic PEG-VS/PEG-amine/water system,
the PEG-amine and PEG-VS domains were shown to envelop each other as well as the
water domains to form multiple emulsions. It may be possible to use this methodology in
the formation of multi-level PEG-coated drug particles that could perhaps display multiple
levels of degradation or drug delivery.
The original coacervation process developed by Bungenberg de Jong and Kruyt
involved the addition of ethanol to an aqueous gelatin solution to produce a triphasic system
(H. G. Bungenberg de Jon 1929). The more favorable interactions between water and
ethanol decreased the gelatin solubility to increase the interactions between the polymer
molecules (Reza Arshady 1990). We have observed that in an unreactive aqueous mixture of
PEG-OH and PEG-amine containing a sodium sulfate concentration suitable to cause phase
separation of PEG-OH but not PEG-amine, the PEG-amine preferentially associates with
the resulting PEG-OH coacervate layer. Thus in our standard biphasic system, the
interaction between PEG8-VS and PEG8-amine is likely to be heightened by the preferential
association of the soluble PEG8-amine with the insoluble PEG8-VS phase. Such an
association would drastically increase the rate of the crosslinking reaction, which was
reflected in our ability to decrease a typically 6-7 h reaction time to 45 min at 37°C and less
than 3 min at 95°C.

4.5

Conclusion
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In summary, the methods presented here for fabricating PEG microspheres allowed
us to advance the modular approach to the design of tissue engineering scaffolds. The
mechanism of microsphere formation bears a resemblance to classical coacervation
processes and may permit adaption to useful techniques such as microencapsulation. By
assembling multiple types of hydrogel microspheres with diverse properties, we developed a
highly scalable platform designed to enhance biocompatibility while allowing control over
bioactivity and porosity. Scalability resulted from solution-phase synthesis of microspheres
while biocompatibility was enhanced by the absence of surfactants, organic solvents and
copolymers. The enhanced biocompatibility allowed assembly of scaffolds in the presence
of cells, resulting in a homogenous cellular distribution. Bioactivity was introduced via RGD
peptide conjugation and S1P delivery, both of which promoted endothelial cell infiltration.
The use of porogenic microspheres with different densities allowed introduction of gradients
in macroporosity, suggesting the potential to develop highly complex scaffolds. Production
of PEG microsphere libraries may allow the development of advanced scaffolds with
application-specific architectures, bioactivity, mechanical properties and degradation kinetics.
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CHAPTER 5
Conclusions
5.1

Summary of Results
Leo Vroman proposed that the adsorption and distortion of proteins on the surfaces

of foreign materials exposed to blood may be an intrinsic defense mechanism that has
continued to evolve from amoebic origins (Vroman 2003). The contact activation system
appears to be a “large-scale Devaux effect”, wherein the hydrophobic cores of certain
enzymes become exposed, resulting in a cascade of protein-induced distortions (Vroman
1965). Acceleration of the coagulation cascade is initiated by surface-induced
conformational changes in factor XII. By relating the conformations of distorted proteins to
their biological responses, it may be possible to assess the biocompatibility of new materials
and improve the compatibility of current implantable devices. For this reason, the goal of
this thesis was to develop new methodologies for the advancement of biomaterials design by
focusing on information gained from the analysis of adsorbed protein films.
A key contributor to the progression of biomaterials design over the last half-century
has been the ability to assess the identity and conformation of adsorbed proteins in relation
to the properties of a material surface. This ability has been particularly vital to the study of
blood/material interfaces, since biological responses are communicated through protein
conformation. Hence the first objective of this thesis was to develop a technique capable of
probing these conformations to determine the exposure of cell adhesion motifs that elicit
thrombotic responses.
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Mass spectrometric mapping was presented in Chapter 2 for the assessment of the
thrombotic potential of adsorbed fibrinogen on PET surfaces. Fibrinogen solutions were
exposed to the surfaces of PET microparticles that were packed within columns to provide
extensive surface area for adsorption. After allowing sufficient time for post-adsorptive
conformational changes, the fibrinogen was reacted with biotin tags that could only react
with solution exposed lysine residues. Locations of the tagged residues were then
determined using MALDI-TOF. The experiment was performed at different solution
concentrations of fibrinogen and demonstrated a concentration-dependent change in
exposure of numerous cell adhesion motifs, of which the most important was the gamma
chain dodecapeptide essential to platelet adhesion. The effect of solution concentration on
fibrinogen spreading was monitored with OWLS and found to correlate with the mass
spectrometric mapping results. Increased exposures of lysines throughout the fibrinogen
molecule supported the association of hydrophilic residues with the solution and
hydrophobic residues with the PET surface at solid/liquid interfaces. While the MALDITOF results were informative, they proved to only be qualitative in nature. As a result, a
quantitative strategy was devised using a variation of SILAC entitled SILT-MS. We
developed a serum-free culture protocol for the expression of isotopically labeled fibrinogen
and other high concentration blood proteins from HepG2 hepatocellular carcinoma cells.
To demonstrate the quantitative ability of the technique, standard curves for isotopically
labeled fibrinogen, complement C3, and α2-macroglobulin were generated. The internal
standards proved to be highly accurate for relative protein quantification, producing
accuracies ranging from 2.9% -9.8%.
As described in section 1.3 of this thesis, history has clearly shown that the in vivo
environment is too dynamic and chemically diverse to be placated by a material with a
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simple first-generation surface. Biomaterials science has recently come to focus on the more
realistic aspiration of developing third-generation materials capable of inhibiting undesirable
biological responses and promoting specific cellular interactions. Therefore, the second goal
of this thesis was to develop materials with pro-active surfaces that could inhibit distortions
in protein structure while encouraging specific cell adhesion and migration.
Chapter 3 presented a method of applying covalent PEG coatings onto material
surfaces by taking advantage of pre-reacted oligomers and microgels. Surface grafting of
PEG chains onto materials typically requires high surface functionalization in order to obtain
sufficient surface coverage to prevent nonspecific protein adsorption. We addressed this
issue by increasing the size and functionality of the grafted molecule instead of increasing the
availability of reactive groups on material surfaces. An electrophilic 8-arm PEG derivative,
PEG-OVS, was partially crosslinked with nucleophilic 8-arm PEG-amine or lysines within
albumin to form solutions of large oligomers and microgel. Reaction of the
macromonomers was monitored with DLS and the reaction was arrested prior to bulk gel
formation. The resulting oligomer/microgel solutions were characterized by SDS-PAGE,
NMR, and GPC, revealing extensive end-group conversion prior to reaching the gel point.
These oligomer/microgels contained reactive vinyl sulfone groups that permitted grafting to
thiol or amine functionalized surfaces under mild physiologic conditions. The grafted
oligomers and microgels continued to react on the surface to produce dense hydrogel
coatings of controlled thickness. OWLS and QCM analysis verified the resistance of the
coatings to protein adsorption and, along with AFM, confirmed their nanoscale thickness.
With only a single layer, the coatings were shown to resist adhesion of CHO, fibroblast, and
endothelial cell lines superior to multi-layer coatings formed by covalently attaching
individual PEG monomers with layer-by-layer methodologies. Reaction conditions were
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adjusted to allow subsequent attachment of bioactive molecules to these hydrogel coatings to
promote cell adhesion. Due to the large size of the partially crosslinked molecules compared
to individual monomers, extensive surface coverage could be achieved on surfaces with with
low levels of functionalization. Thus simple air-plasma treatments provided sufficient
functionalization on PET to apply a covalent film for resistance to cell adhesion.
In Chapter 4, a novel method was described for fabricating 100% PEG microspheres
that allowed us to demonstrate the benefits of using a modular strategy in the design of
synthetic polymer scaffolds. The reactive PEG oligomers/microgels introduced in Chapter
3 were used in the fabrication of hydrogel microspheres, which were produced in aqueous
sodium sulfate solutions without the use of surfactants or copolymers. Microspheres were
formed if the gel point was reached following thermally induced phase separation and prior
to extensive coarsening of spherical PEG-rich domains. By assembling scaffolds from
multiple PEG microspheres with unique properties, we were able to develop a highly
scalable platform that presents biocompatibility, macroporosity and biochemical versatility
useful for a variety of tissue engineering applications. This solution-phase gelation method
allowed rapid fabrication of microspheres in quantities realistic for the development of large
scaffolds required during the tissue engineering of organs. The lack of additives maximized
the amount of PEG in the microspheres, permitting the fabrication of noncytotoxic PEGbased porogens and possibly improving the overall biocompatibility of assembled scaffolds.
Macroporous scaffold formation and cell seeding occured in a single step, and the
distribution and location of cells within the scaffolds was controlled by varying the
microsphere density. Use of microspheres with a tunable density allowed formation of
gradient and layering effects as demonstrated by the porosity gradient that induced rapid
endothelial cell infiltration into the outer edges of some scaffolds. Endothelial cell migration
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into the scaffolds was directed and enhanced through conjugation of RGD peptide and
delivery of S1P from microspheres crosslinked with albumin, a lipid carrier.

5.2

Future Directions
The mass spectrometric mapping experiments described in Chapter 2 provided

qualitative information on the accessibility of fibrinogen cell-interaction motifs after
adsorption onto hydrophobic PET surfaces at 1, 0.5, and 0.1 mg/mL. Future experiments
should be performed on materials with different surface charge, topography, and
hydrophilicity. Lower adsorbing concentrations of fibrinogen should also be tested to
further investigate more extensive fibrinogen spreading. Solutions of fibrinogen with other
proteins such as albumin should be used to observed post-adsorptive fibrinogen
conformation under conditions of competitive adsorption. The SILT-MS experiments
proved that labeled lysine locations could be quantified and that acetylated residues could be
identified reproducibly. A logical next step would be to analyze mass spectrometric mapping
experiments using SILT-MS. Together, the two methods may allow a quantitative analysis
of cell adhesion motif exposures. This could be accomplished by acetylating isotopically
labeled proteins to form internal standards that are both labeled and tagged. Although our
focus was on the adsorption of fibrinogen, our methodology could be utilized for the study
of multiple blood proteins simultaneously. Protein separation methods such as 2D SDSPAGE and multidimensional chromatography are routinely used in the analysis of large
proteomes. Thus it could be possible to expose biomaterial surfaces to human plasma and
use our labeled HepG2 media internal standards to quantify any blood proteins within
adsorbed protein layers that are also expressed by HepG2 cells. By incorporating mass
spectrometric mapping, the degree of exposure of protein residues essential for eliciting
177

cellular interactions could be measured within multiple proteins. Such a comprehensive
surface analysis technique could have immense applications in the prediction of the
compatibility and longevity of implantable devices, particularly small diameter vascular
devices that are prone to thrombus formation. In a broader application, our technique could
also be used to accurately quantify changes in the expression and post-translational
modification of multiple proteins within cell lines as well as blood samples for the diagnosis
of disease.
The nanoscale hydrogel PEG coatings presented in Chapter 3 were found to inhibit
nonspecific protein and cell adhesion on PET surfaces using a grafting strategy that could be
applied to many different surfaces. Future work with this method should first attempt to
generate coatings on other surfaces to demonstrate the versatility of the plasma-based
protocol. Although fibrinogen was covalently attached to the surfaces of the hydrogel layers
to promote cell adhesion, it would be beneficial to also conjugated specific cell adhesion
peptides. Surface functionalization using different plasmas should be attempted to improve
the initial surface functionalization step. Surface treatments with ammonia-based plasmas
have been shown to be much more effective than air-plasma treatments at functionalizing
surfaces with primary amines (Ben Rejeb, Tatoulian et al. 1998). Although the coatings are
very thin and likely unable to store therapeutic quantities of growth factors or drugs, it may
be possible to adapt the protocol for sustained drug delivery. Only a single layer of
oligomer/microgel was required to form a dense uniform coating on surfaces, but it may be
possible use this method with a layer-by-layer strategy that could increase coating thickness
or form alternating drug-loaded layers. The PEG-amine and PEG-OVS composition of the
oligomer/microgel solutions can be adjusted, and 2:1 and 1:2 ratios of PEG-OVS:PEG-OA
oligomers/microgels were formed to improve the crosslinking between PEG microspheres
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in Chapter 4. Similarly, 2:1 and 1:2 ratio microgels could be sequentially attached to surfaces
to form progressively thicker coatings that may be more effective at delivering therapeutic
agents than a single 100 nm thick coating. Additionally, due to the mild reaction conditions
required for conjugation to PEG-OA, it may be possible to covalently attach active enzymes
onto the coatings to allow in situ activation of compounds present in blood. Attachment of
the enzyme responsible for the phosphorylation of sphingosine into S1P, sphingosine kinase,
may prove to be beneficial for the in vivo recruitment of neo-intima onto surfaces of small
diameter blood-contacting devices. Finally, immediate steps should likely be taken to test
the efficacy of the PEG coatings in an animal model. The PEG-OVS/BSA coatings have
already been shown to be stable for up to 3 weeks, and by excluding the protein component,
the PEG-OVS/PEG-OA coatings may demonstrate improved longevity in vivo.
The scaffold strategy outlined in Chapter 4 can be applied to a wide range of tissue
engineering applications. An inherent advantage of this modular strategy is the ability to mix
and match components from a diverse microsphere library to fabricate customized scaffolds
for a particular therapy or experiment. While only three different microsphere types were
used in this thesis, it may be desirable to fabricate a large library of different PEG
microspheres. One could imagine the potential for stem cell differentiation and proliferation
within a macroporous scaffold assembled from a dozen different microspheres, each of
which delivers unique growth factors, presents different adhesion molecules, and is displayed
at diverse gradients. This biochemical versatility additionally provides freedom in the
selection of the molecules used to crosslink the microspheres together. While the proteins
present in cell media function as convenient crosslinkers, it is also possible to use
enzymatically degradable peptides that could permit transplanted cells to eventually replace
the scaffold and become functional tissue (Lutolf 2003). The stiffness of the scaffolds we
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utilized was similar to that of liver tissue and will have to be adjusted for other applications.
Mild centrifugation conditions were used to form these scaffolds in order to maintain high
cell viability, but further compaction may be able to produce stiffnesses up to and including
the modulus observed for bulk hydrogels. Increased compaction could be achieved by
decreasing the spacer arm length of crosslinking molecules or by allowing microsphere
buoyancy to compact microspheres into scaffolds without centrifugation as observed in Fig.
4.14a. The later method would not be amenable to formation in the presence of cells, but
other methods of cell seeding should be investigated. When raised above the cloud point,
the PEG within formed scaffolds responded by causing the scaffold to extrude water and
collapse into a shrunken state (Fig. 4.14b). If such a shrunken scaffold were to be made
porous and placed in media containing cells bellow the cloud point, the scaffold may swell
with media as well as the cells, providing a simple and convenient method of cell seeding.
The microspheres themselves may serve a variety of functions other than for the
modular assembly of scaffolds. As mentioned in Chapter 4, it may be possible to load drugs
into the microspheres using coacervation-based microencapsulation techniques. The
degradable PEG8-acrylate/PEG8-amine microspheres proved to be noncytotoxic and may
therefore serve as vehicles for timed drug release. Antibodies could be conjugated to
microsphere surfaces in a similar fashion to the covalent attachment of proteins to CNBr
resin, which also binds to lysine residues. Thus the microspheres could be used for
immunoprecipitation and possibly achieve higher pull-down specificity due to the superior
resistance to nonspecific protein adsorption of PEG. By both loading microspheres with
drugs and conjugating antibodies to their surfaces, targeted drug delivery strategies could be
developed. Finally, the porous structure, ability to conjugate antibodies, and resistance to
nonspecific protein adsorption may make functionalized PEG microspheres suitable as resin
180

for chromatographic applications. Such a resin may enhance and accelerate the proteomic
analysis of biological fluids by removing high abundance proteins.
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